id	sid	tid	token	lemma	pos
aiua-5738	1	1	stesura	stesura	PROPN
aiua-5738	1	2	seveso	seveso	PROPN
aiua-5738	1	3	archivio	archivio	PROPN
aiua-5738	1	4	italiano	italiano	X
aiua-5738	1	5	di	di	X
aiua-5738	1	6	urologia	urologia	PROPN
aiua-5738	1	7	e	e	PROPN
aiua-5738	1	8	andrologia	andrologia	NOUN
aiua-5738	1	9	2015	2015	NUM
aiua-5738	1	10	;	;	PUNCT
aiua-5738	1	11	87	87	NUM
aiua-5738	1	12	,	,	PUNCT
aiua-5738	1	13	4312	4312	NUM
aiua-5738	1	14	original	original	ADJ
aiua-5738	1	15	paper	paper	NOUN
aiua-5738	1	16	comments	comment	NOUN
aiua-5738	1	17	concerning	concern	VERB
aiua-5738	1	18	the	the	DET
aiua-5738	1	19	real	real	ADJ
aiua-5738	1	20	risk	risk	NOUN
aiua-5738	1	21	of	of	ADP
aiua-5738	1	22	sexual	sexual	ADJ
aiua-5738	1	23	adverse	adverse	ADJ
aiua-5738	1	24	events	event	NOUN
aiua-5738	1	25	secondary	secondary	ADJ
aiua-5738	1	26	to	to	ADP
aiua-5738	1	27	the	the	DET
aiua-5738	1	28	use	use	NOUN
aiua-5738	1	29	of	of	ADP
aiua-5738	1	30	5	5	NUM
aiua-5738	1	31	-	-	PUNCT
aiua-5738	1	32	aris	aris	PROPN
aiua-5738	1	33	furio	furio	PROPN
aiua-5738	1	34	pirozzi	pirozzi	PROPN
aiua-5738	1	35	farina	farina	PROPN
aiua-5738	1	36	,	,	PUNCT
aiua-5738	1	37	antonella	antonella	PROPN
aiua-5738	1	38	pischedda	pischedda	PROPN
aiua-5738	1	39	andrological	andrological	PROPN
aiua-5738	1	40	urology	urology	NOUN
aiua-5738	1	41	unit	unit	NOUN
aiua-5738	1	42	,	,	PUNCT
aiua-5738	1	43	aou	aou	PROPN
aiua-5738	1	44	di	di	X
aiua-5738	1	45	sassari	sassari	PROPN
aiua-5738	1	46	.	.	PUNCT
aiua-5738	2	1	treatment	treatment	NOUN
aiua-5738	2	2	-	-	PUNCT
aiua-5738	2	3	induced	induce	VERB
aiua-5738	2	4	sexual	sexual	ADJ
aiua-5738	2	5	dysfunctions	dysfunction	NOUN
aiua-5738	2	6	(	(	PUNCT
aiua-5738	2	7	sd	sd	NOUN
aiua-5738	2	8	)	)	PUNCT
aiua-5738	2	9	are	be	AUX
aiua-5738	2	10	a	a	DET
aiua-5738	2	11	recurrent	recurrent	ADJ
aiua-5738	2	12	and	and	CCONJ
aiua-5738	2	13	controversial	controversial	ADJ
aiua-5738	2	14	topic	topic	NOUN
aiua-5738	2	15	in	in	ADP
aiua-5738	2	16	recent	recent	ADJ
aiua-5738	2	17	literature	literature	NOUN
aiua-5738	2	18	on	on	ADP
aiua-5738	2	19	the	the	DET
aiua-5738	2	20	adverse	adverse	ADJ
aiua-5738	2	21	events	event	NOUN
aiua-5738	2	22	related	relate	VERB
aiua-5738	2	23	to	to	ADP
aiua-5738	2	24	the	the	DET
aiua-5738	2	25	use	use	NOUN
aiua-5738	2	26	of	of	ADP
aiua-5738	2	27	5	5	NUM
aiua-5738	2	28	-	-	PUNCT
aiua-5738	2	29	alpha	alpha	NOUN
aiua-5738	2	30	-	-	PUNCT
aiua-5738	2	31	reductase	reductase	NOUN
aiua-5738	2	32	inhibitors	inhibitor	NOUN
aiua-5738	2	33	(	(	PUNCT
aiua-5738	2	34	5aris	5aris	NUM
aiua-5738	2	35	)	)	PUNCT
aiua-5738	2	36	(	(	PUNCT
aiua-5738	2	37	1	1	NUM
aiua-5738	2	38	,	,	PUNCT
aiua-5738	2	39	2	2	NUM
aiua-5738	2	40	)	)	PUNCT
aiua-5738	2	41	.	.	PUNCT
aiua-5738	3	1	in	in	ADP
aiua-5738	3	2	order	order	NOUN
aiua-5738	3	3	to	to	PART
aiua-5738	3	4	deal	deal	VERB
aiua-5738	3	5	adequately	adequately	ADV
aiua-5738	3	6	with	with	ADP
aiua-5738	3	7	the	the	DET
aiua-5738	3	8	various	various	ADJ
aiua-5738	3	9	aspects	aspect	NOUN
aiua-5738	3	10	of	of	ADP
aiua-5738	3	11	this	this	DET
aiua-5738	3	12	topic	topic	NOUN
aiua-5738	3	13	,	,	PUNCT
aiua-5738	3	14	it	it	PRON
aiua-5738	3	15	is	be	AUX
aiua-5738	3	16	necessary	necessary	ADJ
aiua-5738	3	17	to	to	PART
aiua-5738	3	18	first	first	ADV
aiua-5738	3	19	cover	cover	VERB
aiua-5738	3	20	some	some	PRON
aiua-5738	3	21	of	of	ADP
aiua-5738	3	22	the	the	DET
aiua-5738	3	23	steps	step	NOUN
aiua-5738	3	24	that	that	PRON
aiua-5738	3	25	allow	allow	VERB
aiua-5738	3	26	a	a	DET
aiua-5738	3	27	better	well	ADJ
aiua-5738	3	28	definition	definition	NOUN
aiua-5738	3	29	and	and	CCONJ
aiua-5738	3	30	understanding	understanding	NOUN
aiua-5738	3	31	of	of	ADP
aiua-5738	3	32	the	the	DET
aiua-5738	3	33	subject	subject	NOUN
aiua-5738	3	34	.	.	PUNCT
aiua-5738	4	1	key	key	ADJ
aiua-5738	4	2	words	word	NOUN
aiua-5738	4	3	:	:	PUNCT
aiua-5738	4	4	5	5	NUM
aiua-5738	4	5	-	-	PUNCT
aiua-5738	4	6	alpha	alpha	NOUN
aiua-5738	4	7	-	-	PUNCT
aiua-5738	4	8	reductase	reductase	NOUN
aiua-5738	4	9	inhibitors	inhibitor	NOUN
aiua-5738	4	10	(	(	PUNCT
aiua-5738	4	11	5aris	5aris	NUM
aiua-5738	4	12	)	)	PUNCT
aiua-5738	4	13	;	;	PUNCT
aiua-5738	4	14	sexual	sexual	ADJ
aiua-5738	4	15	dysfunctions	dysfunction	NOUN
aiua-5738	4	16	;	;	PUNCT
aiua-5738	4	17	benign	benign	ADJ
aiua-5738	4	18	prostatic	prostatic	ADJ
aiua-5738	4	19	hyperplasia	hyperplasia	NOUN
aiua-5738	4	20	(	(	PUNCT
aiua-5738	4	21	bph	bph	NOUN
aiua-5738	4	22	)	)	PUNCT
aiua-5738	4	23	;	;	PUNCT
aiua-5738	4	24	androgenetic	androgenetic	ADJ
aiua-5738	4	25	alopecia	alopecia	NOUN
aiua-5738	4	26	.	.	PUNCT
aiua-5738	4	27	submitted	submit	VERB
aiua-5738	4	28	9	9	NUM
aiua-5738	4	29	november	november	NOUN
aiua-5738	4	30	;	;	PUNCT
aiua-5738	4	31	accepted	accept	VERB
aiua-5738	4	32	15	15	NUM
aiua-5738	4	33	december	december	PROPN
aiua-5738	4	34	summary	summary	NOUN
aiua-5738	4	35	no	no	DET
aiua-5738	4	36	conflict	conflict	NOUN
aiua-5738	4	37	of	of	ADP
aiua-5738	4	38	interest	interest	NOUN
aiua-5738	4	39	declared	declare	VERB
aiua-5738	4	40	.	.	PUNCT
aiua-5738	5	1	ondary	ondary	ADJ
aiua-5738	5	2	to	to	PART
aiua-5738	5	3	bph	bph	VERB
aiua-5738	5	4	with	with	ADP
aiua-5738	5	5	a	a	DET
aiua-5738	5	6	high	high	ADJ
aiua-5738	5	7	risk	risk	NOUN
aiua-5738	5	8	of	of	ADP
aiua-5738	5	9	progression	progression	NOUN
aiua-5738	5	10	,	,	PUNCT
aiua-5738	5	11	in	in	ADP
aiua-5738	5	12	order	order	NOUN
aiua-5738	5	13	to	to	PART
aiua-5738	5	14	reduce	reduce	VERB
aiua-5738	5	15	the	the	DET
aiua-5738	5	16	incidence	incidence	NOUN
aiua-5738	5	17	of	of	ADP
aiua-5738	5	18	the	the	DET
aiua-5738	5	19	risks	risk	NOUN
aiua-5738	5	20	connected	connect	VERB
aiua-5738	5	21	with	with	ADP
aiua-5738	5	22	disease	disease	NOUN
aiua-5738	5	23	progression	progression	NOUN
aiua-5738	5	24	(	(	PUNCT
aiua-5738	5	25	10	10	NUM
aiua-5738	5	26	)	)	PUNCT
aiua-5738	5	27	.	.	PUNCT
aiua-5738	6	1	these	these	DET
aiua-5738	6	2	risks	risk	NOUN
aiua-5738	6	3	consist	consist	VERB
aiua-5738	6	4	in	in	ADP
aiua-5738	6	5	acute	acute	ADJ
aiua-5738	6	6	urinary	urinary	ADJ
aiua-5738	6	7	retention	retention	NOUN
aiua-5738	6	8	(	(	PUNCT
aiua-5738	6	9	aur	aur	NOUN
aiua-5738	6	10	)	)	PUNCT
aiua-5738	6	11	and	and	CCONJ
aiua-5738	6	12	in	in	ADP
aiua-5738	6	13	the	the	DET
aiua-5738	6	14	need	need	NOUN
aiua-5738	6	15	for	for	ADP
aiua-5738	6	16	surgical	surgical	ADJ
aiua-5738	6	17	treatment	treatment	NOUN
aiua-5738	6	18	for	for	ADP
aiua-5738	6	19	prostatic	prostatic	ADJ
aiua-5738	6	20	adenoma	adenoma	NOUN
aiua-5738	6	21	(	(	PUNCT
aiua-5738	6	22	11	11	NUM
aiua-5738	6	23	)	)	PUNCT
aiua-5738	6	24	.	.	PUNCT
aiua-5738	7	1	over	over	ADP
aiua-5738	7	2	the	the	DET
aiua-5738	7	3	years	year	NOUN
aiua-5738	7	4	,	,	PUNCT
aiua-5738	7	5	a	a	DET
aiua-5738	7	6	great	great	ADJ
aiua-5738	7	7	number	number	NOUN
aiua-5738	7	8	of	of	ADP
aiua-5738	7	9	patients	patient	NOUN
aiua-5738	7	10	have	have	AUX
aiua-5738	7	11	benefitted	benefit	VERB
aiua-5738	7	12	from	from	ADP
aiua-5738	7	13	treatment	treatment	NOUN
aiua-5738	7	14	with	with	ADP
aiua-5738	7	15	5aris	5aris	NUM
aiua-5738	7	16	,	,	PUNCT
aiua-5738	7	17	especially	especially	ADV
aiua-5738	7	18	those	those	PRON
aiua-5738	7	19	with	with	ADP
aiua-5738	7	20	progressing	progressing	NOUN
aiua-5738	7	21	bph	bph	NOUN
aiua-5738	7	22	(	(	PUNCT
aiua-5738	7	23	11	11	NUM
aiua-5738	7	24	)	)	PUNCT
aiua-5738	7	25	.	.	PUNCT
aiua-5738	8	1	a	a	DET
aiua-5738	8	2	number	number	NOUN
aiua-5738	8	3	of	of	ADP
aiua-5738	8	4	studies	study	NOUN
aiua-5738	8	5	performed	perform	VERB
aiua-5738	8	6	on	on	ADP
aiua-5738	8	7	patients	patient	NOUN
aiua-5738	8	8	with	with	ADP
aiua-5738	8	9	bph	bph	NOUN
aiua-5738	8	10	treated	treat	VERB
aiua-5738	8	11	with	with	ADP
aiua-5738	8	12	5a	5a	NUM
aiua-5738	8	13	-	-	PUNCT
aiua-5738	8	14	ris	ris	X
aiua-5738	8	15	have	have	AUX
aiua-5738	8	16	reported	report	VERB
aiua-5738	8	17	positive	positive	ADJ
aiua-5738	8	18	effects	effect	NOUN
aiua-5738	8	19	such	such	ADJ
aiua-5738	8	20	as	as	ADP
aiua-5738	8	21	a	a	DET
aiua-5738	8	22	reduction	reduction	NOUN
aiua-5738	8	23	in	in	ADP
aiua-5738	8	24	prostatic	prostatic	ADJ
aiua-5738	8	25	volume	volume	NOUN
aiua-5738	8	26	,	,	PUNCT
aiua-5738	8	27	an	an	DET
aiua-5738	8	28	improvement	improvement	NOUN
aiua-5738	8	29	in	in	ADP
aiua-5738	8	30	ipss	ipss	PROPN
aiua-5738	8	31	questionnaire	questionnaire	NOUN
aiua-5738	8	32	scores	score	NOUN
aiua-5738	8	33	,	,	PUNCT
aiua-5738	8	34	an	an	DET
aiua-5738	8	35	improvement	improvement	NOUN
aiua-5738	8	36	in	in	ADP
aiua-5738	8	37	urinary	urinary	ADJ
aiua-5738	8	38	flow	flow	NOUN
aiua-5738	8	39	,	,	PUNCT
aiua-5738	8	40	a	a	DET
aiua-5738	8	41	reduction	reduction	NOUN
aiua-5738	8	42	in	in	ADP
aiua-5738	8	43	the	the	DET
aiua-5738	8	44	risk	risk	NOUN
aiua-5738	8	45	of	of	ADP
aiua-5738	8	46	acute	acute	ADJ
aiua-5738	8	47	urinary	urinary	ADJ
aiua-5738	8	48	retention	retention	NOUN
aiua-5738	8	49	and	and	CCONJ
aiua-5738	8	50	,	,	PUNCT
aiua-5738	8	51	most	most	ADV
aiua-5738	8	52	importantly	importantly	ADV
aiua-5738	8	53	,	,	PUNCT
aiua-5738	8	54	a	a	DET
aiua-5738	8	55	reduction	reduction	NOUN
aiua-5738	8	56	in	in	ADP
aiua-5738	8	57	the	the	DET
aiua-5738	8	58	number	number	NOUN
aiua-5738	8	59	of	of	ADP
aiua-5738	8	60	patients	patient	NOUN
aiua-5738	8	61	having	have	VERB
aiua-5738	8	62	to	to	PART
aiua-5738	8	63	undergo	undergo	VERB
aiua-5738	8	64	surgical	surgical	ADJ
aiua-5738	8	65	treatment	treatment	NOUN
aiua-5738	8	66	or	or	CCONJ
aiua-5738	8	67	other	other	ADJ
aiua-5738	8	68	invasive	invasive	ADJ
aiua-5738	8	69	or	or	CCONJ
aiua-5738	8	70	minimally	minimally	ADV
aiua-5738	8	71	-	-	PUNCT
aiua-5738	8	72	invasive	invasive	ADJ
aiua-5738	8	73	treatments	treatment	NOUN
aiua-5738	8	74	for	for	ADP
aiua-5738	8	75	bph	bph	NOUN
aiua-5738	8	76	(	(	PUNCT
aiua-5738	8	77	11	11	NUM
aiua-5738	8	78	,	,	PUNCT
aiua-5738	8	79	12	12	NUM
aiua-5738	8	80	)	)	PUNCT
aiua-5738	8	81	.	.	PUNCT
aiua-5738	9	1	however	however	ADV
aiua-5738	9	2	,	,	PUNCT
aiua-5738	9	3	these	these	DET
aiua-5738	9	4	therapies	therapy	NOUN
aiua-5738	9	5	allegedly	allegedly	ADV
aiua-5738	9	6	have	have	VERB
aiua-5738	9	7	a	a	DET
aiua-5738	9	8	high	high	ADJ
aiua-5738	9	9	risk	risk	NOUN
aiua-5738	9	10	of	of	ADP
aiua-5738	9	11	important	important	ADJ
aiua-5738	9	12	and	and	CCONJ
aiua-5738	9	13	irreversible	irreversible	ADJ
aiua-5738	9	14	side	side	NOUN
aiua-5738	9	15	effects	effect	NOUN
aiua-5738	9	16	that	that	PRON
aiua-5738	9	17	also	also	ADV
aiua-5738	9	18	involve	involve	VERB
aiua-5738	9	19	the	the	DET
aiua-5738	9	20	sexual	sexual	ADJ
aiua-5738	9	21	area	area	NOUN
aiua-5738	9	22	(	(	PUNCT
aiua-5738	9	23	1	1	NUM
aiua-5738	9	24	)	)	PUNCT
aiua-5738	9	25	.	.	PUNCT
aiua-5738	10	1	in	in	ADP
aiua-5738	10	2	addition	addition	NOUN
aiua-5738	10	3	to	to	ADP
aiua-5738	10	4	this	this	PRON
aiua-5738	10	5	,	,	PUNCT
aiua-5738	10	6	finasteride	finasteride	ADJ
aiua-5738	10	7	has	have	AUX
aiua-5738	10	8	also	also	ADV
aiua-5738	10	9	been	be	AUX
aiua-5738	10	10	approved	approve	VERB
aiua-5738	10	11	for	for	ADP
aiua-5738	10	12	the	the	DET
aiua-5738	10	13	treatment	treatment	NOUN
aiua-5738	10	14	of	of	ADP
aiua-5738	10	15	androgenetic	androgenetic	ADJ
aiua-5738	10	16	alopecia	alopecia	NOUN
aiua-5738	10	17	(	(	PUNCT
aiua-5738	10	18	aga	aga	NOUN
aiua-5738	10	19	)	)	PUNCT
aiua-5738	10	20	or	or	CCONJ
aiua-5738	10	21	male	male	ADJ
aiua-5738	10	22	pattern	pattern	NOUN
aiua-5738	10	23	baldness	baldness	NOUN
aiua-5738	10	24	,	,	PUNCT
aiua-5738	10	25	which	which	PRON
aiua-5738	10	26	affects	affect	VERB
aiua-5738	10	27	about	about	ADV
aiua-5738	10	28	50	50	NUM
aiua-5738	10	29	%	%	NOUN
aiua-5738	10	30	of	of	ADP
aiua-5738	10	31	males	male	NOUN
aiua-5738	10	32	(	(	PUNCT
aiua-5738	10	33	13	13	NUM
aiua-5738	10	34	)	)	PUNCT
aiua-5738	10	35	.	.	PUNCT
aiua-5738	11	1	sexual	sexual	ADJ
aiua-5738	11	2	adverse	adverse	ADJ
aiua-5738	11	3	events	event	NOUN
aiua-5738	11	4	of	of	ADP
aiua-5738	11	5	treatment	treatment	NOUN
aiua-5738	11	6	with	with	ADP
aiua-5738	11	7	5a	5a	NUM
aiua-5738	11	8	-	-	PUNCT
aiua-5738	11	9	r	r	NOUN
aiua-5738	11	10	inhibitors	inhibitor	NOUN
aiua-5738	11	11	(	(	PUNCT
aiua-5738	11	12	also	also	ADV
aiua-5738	11	13	known	know	VERB
aiua-5738	11	14	as	as	ADP
aiua-5738	11	15	post	post	ADJ
aiua-5738	11	16	-	-	ADJ
aiua-5738	11	17	finasteride	finasteride	ADJ
aiua-5738	11	18	syndrome	syndrome	NOUN
aiua-5738	11	19	)	)	PUNCT
aiua-5738	11	20	there	there	PRON
aiua-5738	11	21	are	be	VERB
aiua-5738	11	22	increasingly	increasingly	ADV
aiua-5738	11	23	frequent	frequent	ADJ
aiua-5738	11	24	reports	report	NOUN
aiua-5738	11	25	of	of	ADP
aiua-5738	11	26	problems	problem	NOUN
aiua-5738	11	27	that	that	PRON
aiua-5738	11	28	the	the	DET
aiua-5738	11	29	use	use	NOUN
aiua-5738	11	30	of	of	ADP
aiua-5738	11	31	5a	5a	NUM
aiua-5738	11	32	-	-	PUNCT
aiua-5738	11	33	ris	ris	X
aiua-5738	11	34	(	(	PUNCT
aiua-5738	11	35	finasteride	finasteride	ADJ
aiua-5738	11	36	and	and	CCONJ
aiua-5738	11	37	dutasteride	dutasteride	PROPN
aiua-5738	11	38	)	)	PUNCT
aiua-5738	11	39	may	may	AUX
aiua-5738	11	40	cause	cause	VERB
aiua-5738	11	41	to	to	ADP
aiua-5738	11	42	sexual	sexual	ADJ
aiua-5738	11	43	health	health	NOUN
aiua-5738	11	44	in	in	ADP
aiua-5738	11	45	a	a	DET
aiua-5738	11	46	subgroup	subgroup	NOUN
aiua-5738	11	47	of	of	ADP
aiua-5738	11	48	patients	patient	NOUN
aiua-5738	11	49	;	;	PUNCT
aiua-5738	11	50	in	in	ADP
aiua-5738	11	51	some	some	DET
aiua-5738	11	52	cases	case	NOUN
aiua-5738	11	53	,	,	PUNCT
aiua-5738	11	54	these	these	DET
aiua-5738	11	55	problems	problem	NOUN
aiua-5738	11	56	would	would	AUX
aiua-5738	11	57	appear	appear	VERB
aiua-5738	11	58	to	to	PART
aiua-5738	11	59	persist	persist	VERB
aiua-5738	11	60	even	even	ADV
aiua-5738	11	61	after	after	ADP
aiua-5738	11	62	the	the	DET
aiua-5738	11	63	discontinuation	discontinuation	NOUN
aiua-5738	11	64	of	of	ADP
aiua-5738	11	65	treatment	treatment	NOUN
aiua-5738	11	66	(	(	PUNCT
aiua-5738	11	67	14	14	NUM
aiua-5738	11	68	,	,	PUNCT
aiua-5738	11	69	15	15	NUM
aiua-5738	11	70	)	)	PUNCT
aiua-5738	11	71	.	.	PUNCT
aiua-5738	12	1	however	however	ADV
aiua-5738	12	2	,	,	PUNCT
aiua-5738	12	3	there	there	PRON
aiua-5738	12	4	are	be	VERB
aiua-5738	12	5	still	still	ADV
aiua-5738	12	6	very	very	ADV
aiua-5738	12	7	few	few	ADJ
aiua-5738	12	8	studies	study	NOUN
aiua-5738	12	9	on	on	ADP
aiua-5738	12	10	this	this	DET
aiua-5738	12	11	subject	subject	NOUN
aiua-5738	12	12	and	and	CCONJ
aiua-5738	12	13	knowledge	knowledge	NOUN
aiua-5738	12	14	is	be	AUX
aiua-5738	12	15	based	base	VERB
aiua-5738	12	16	either	either	CCONJ
aiua-5738	12	17	on	on	ADP
aiua-5738	12	18	scientific	scientific	ADJ
aiua-5738	12	19	concepts	concept	NOUN
aiua-5738	12	20	or	or	CCONJ
aiua-5738	12	21	on	on	ADP
aiua-5738	12	22	case	case	NOUN
aiua-5738	12	23	reports	report	NOUN
aiua-5738	12	24	submitted	submit	VERB
aiua-5738	12	25	by	by	ADP
aiua-5738	12	26	general	general	ADJ
aiua-5738	12	27	practitioners	practitioner	NOUN
aiua-5738	12	28	and	and	CCONJ
aiua-5738	12	29	based	base	VERB
aiua-5738	12	30	on	on	ADP
aiua-5738	12	31	reports	report	NOUN
aiua-5738	12	32	by	by	ADP
aiua-5738	12	33	patients	patient	NOUN
aiua-5738	12	34	(	(	PUNCT
aiua-5738	12	35	16	16	NUM
aiua-5738	12	36	)	)	PUNCT
aiua-5738	12	37	.	.	PUNCT
aiua-5738	13	1	in	in	ADP
aiua-5738	13	2	actual	actual	ADJ
aiua-5738	13	3	fact	fact	NOUN
aiua-5738	13	4	,	,	PUNCT
aiua-5738	13	5	a	a	DET
aiua-5738	13	6	study	study	NOUN
aiua-5738	13	7	by	by	ADP
aiua-5738	13	8	erdemir	erdemir	PROPN
aiua-5738	13	9	f	f	PROPN
aiua-5738	13	10	,	,	PUNCT
aiua-5738	13	11	et	et	PROPN
aiua-5738	13	12	al	al	PROPN
aiua-5738	13	13	.	.	PUNCT
aiua-5738	14	1	(	(	PUNCT
aiua-5738	14	2	2008	2008	NUM
aiua-5738	14	3	)	)	PUNCT
aiua-5738	14	4	reported	report	VERB
aiua-5738	14	5	that	that	SCONJ
aiua-5738	14	6	the	the	DET
aiua-5738	14	7	5aris	5aris	PROPN
aiua-5738	14	8	used	use	VERB
aiua-5738	14	9	to	to	PART
aiua-5738	14	10	treat	treat	VERB
aiua-5738	14	11	bph	bph	NOUN
aiua-5738	14	12	,	,	PUNCT
aiua-5738	14	13	caused	cause	VERB
aiua-5738	14	14	erectile	erectile	ADJ
aiua-5738	14	15	dysfunction	dysfunction	NOUN
aiua-5738	14	16	and/or	and/or	CCONJ
aiua-5738	14	17	a	a	DET
aiua-5738	14	18	loss	loss	NOUN
aiua-5738	14	19	of	of	ADP
aiua-5738	14	20	libido	libido	NOUN
aiua-5738	14	21	with	with	ADP
aiua-5738	14	22	an	an	DET
aiua-5738	14	23	incidence	incidence	NOUN
aiua-5738	14	24	of	of	ADP
aiua-5738	14	25	less	less	ADJ
aiua-5738	14	26	than	than	ADP
aiua-5738	14	27	10	10	NUM
aiua-5738	14	28	%	%	NOUN
aiua-5738	14	29	,	,	PUNCT
aiua-5738	14	30	for	for	ADP
aiua-5738	14	31	both	both	PRON
aiua-5738	14	32	monotherapy	monotherapy	NOUN
aiua-5738	14	33	and	and	CCONJ
aiua-5738	14	34	combination	combination	NOUN
aiua-5738	14	35	therapy	therapy	NOUN
aiua-5738	14	36	(	(	PUNCT
aiua-5738	14	37	dutasteride	dutasteride	NOUN
aiua-5738	14	38	+	+	CCONJ
aiua-5738	14	39	tamsulosin	tamsulosin	NOUN
aiua-5738	14	40	)	)	PUNCT
aiua-5738	14	41	.	.	PUNCT
aiua-5738	15	1	(	(	PUNCT
aiua-5738	15	2	17	17	NUM
aiua-5738	15	3	)	)	PUNCT
aiua-5738	15	4	in	in	ADP
aiua-5738	15	5	this	this	DET
aiua-5738	15	6	same	same	ADJ
aiua-5738	15	7	paper	paper	NOUN
aiua-5738	15	8	,	,	PUNCT
aiua-5738	15	9	the	the	DET
aiua-5738	15	10	authors	author	NOUN
aiua-5738	15	11	reported	report	VERB
aiua-5738	15	12	that	that	SCONJ
aiua-5738	15	13	finasterideand	finasterideand	PROPN
aiua-5738	15	14	dutasterideinduced	dutasterideinduce	VERB
aiua-5738	15	15	sexual	sexual	ADJ
aiua-5738	15	16	dysfunction	dysfunction	NOUN
aiua-5738	15	17	resolved	resolve	VERB
aiua-5738	15	18	completely	completely	ADV
aiua-5738	15	19	when	when	SCONJ
aiua-5738	15	20	treatment	treatment	NOUN
aiua-5738	15	21	was	be	AUX
aiua-5738	15	22	discontinued	discontinue	VERB
aiua-5738	15	23	and	and	CCONJ
aiua-5738	15	24	that	that	SCONJ
aiua-5738	15	25	,	,	PUNCT
aiua-5738	15	26	in	in	ADP
aiua-5738	15	27	any	any	DET
aiua-5738	15	28	case	case	NOUN
aiua-5738	15	29	,	,	PUNCT
aiua-5738	15	30	in	in	ADP
aiua-5738	15	31	approximately	approximately	ADV
aiua-5738	15	32	4	4	NUM
aiua-5738	15	33	%	%	NOUN
aiua-5738	15	34	of	of	ADP
aiua-5738	15	35	patients	patient	NOUN
aiua-5738	15	36	,	,	PUNCT
aiua-5738	15	37	treatment	treatment	NOUN
aiua-5738	15	38	was	be	AUX
aiua-5738	15	39	discontinued	discontinue	VERB
aiua-5738	15	40	due	due	ADJ
aiua-5738	15	41	to	to	ADP
aiua-5738	15	42	sexual	sexual	ADJ
aiua-5738	15	43	adverse	adverse	ADJ
aiua-5738	15	44	events	event	NOUN
aiua-5738	15	45	.	.	PUNCT
aiua-5738	16	1	(	(	PUNCT
aiua-5738	16	2	17	17	NUM
aiua-5738	16	3	)	)	PUNCT
aiua-5738	16	4	the	the	DET
aiua-5738	16	5	size	size	NOUN
aiua-5738	16	6	of	of	ADP
aiua-5738	16	7	the	the	DET
aiua-5738	16	8	problem	problem	NOUN
aiua-5738	16	9	was	be	AUX
aiua-5738	16	10	further	far	ADV
aiua-5738	16	11	put	put	VERB
aiua-5738	16	12	into	into	ADP
aiua-5738	16	13	perspective	perspective	ADJ
aiua-5738	16	14	doi	doi	NOUN
aiua-5738	16	15	:	:	PUNCT
aiua-5738	16	16	10.4081	10.4081	NUM
aiua-5738	16	17	/	/	SYM
aiua-5738	16	18	aiua.2015.4.312	aiua.2015.4.312	ADJ
aiua-5738	16	19	5	5	NUM
aiua-5738	16	20	-	-	PUNCT
aiua-5738	16	21	a	a	DET
aiua-5738	16	22	-	-	PUNCT
aiua-5738	16	23	reductases	reductase	NOUN
aiua-5738	16	24	and	and	CCONJ
aiua-5738	16	25	their	their	PRON
aiua-5738	16	26	inhibitors	inhibitor	NOUN
aiua-5738	16	27	5	5	NUM
aiua-5738	16	28	-	-	PUNCT
aiua-5738	16	29	a	a	DET
aiua-5738	16	30	-	-	PUNCT
aiua-5738	16	31	reductases	reductase	NOUN
aiua-5738	16	32	are	be	AUX
aiua-5738	16	33	enzymes	enzyme	NOUN
aiua-5738	16	34	able	able	ADJ
aiua-5738	16	35	to	to	PART
aiua-5738	16	36	reduce	reduce	VERB
aiua-5738	16	37	the	the	DET
aiua-5738	16	38	4,5	4,5	NUM
aiua-5738	16	39	bond	bond	NOUN
aiua-5738	16	40	of	of	ADP
aiua-5738	16	41	c19	c19	NOUN
aiua-5738	16	42	and	and	CCONJ
aiua-5738	16	43	c21	c21	PROPN
aiua-5738	16	44	steroids	steroid	NOUN
aiua-5738	16	45	,	,	PUNCT
aiua-5738	16	46	to	to	PART
aiua-5738	16	47	create	create	VERB
aiua-5738	16	48	the	the	DET
aiua-5738	16	49	5a	5a	NUM
aiua-5738	16	50	-	-	PUNCT
aiua-5738	16	51	reduced	reduce	VERB
aiua-5738	16	52	steroid	steroid	NOUN
aiua-5738	16	53	of	of	ADP
aiua-5738	16	54	a	a	DET
aiua-5738	16	55	precursor	precursor	NOUN
aiua-5738	16	56	steroid	steroid	NOUN
aiua-5738	16	57	(	(	PUNCT
aiua-5738	16	58	3	3	NUM
aiua-5738	16	59	)	)	PUNCT
aiua-5738	16	60	.	.	PUNCT
aiua-5738	17	1	two	two	NUM
aiua-5738	17	2	of	of	ADP
aiua-5738	17	3	this	this	DET
aiua-5738	17	4	type	type	NOUN
aiua-5738	17	5	of	of	ADP
aiua-5738	17	6	isoenzyme	isoenzyme	NOUN
aiua-5738	17	7	are	be	AUX
aiua-5738	17	8	known	know	VERB
aiua-5738	17	9	:	:	PUNCT
aiua-5738	17	10	5a	5a	NUM
aiua-5738	17	11	-	-	PUNCT
aiua-5738	17	12	r	r	NOUN
aiua-5738	17	13	type1	type1	NOUN
aiua-5738	17	14	(	(	PUNCT
aiua-5738	17	15	5a	5a	NUM
aiua-5738	17	16	-	-	PUNCT
aiua-5738	17	17	r1	r1	NOUN
aiua-5738	17	18	)	)	PUNCT
aiua-5738	17	19	and	and	CCONJ
aiua-5738	17	20	5a	5a	NUM
aiua-5738	17	21	-	-	PUNCT
aiua-5738	17	22	r	r	NOUN
aiua-5738	17	23	type	type	NOUN
aiua-5738	17	24	2	2	NUM
aiua-5738	17	25	(	(	PUNCT
aiua-5738	17	26	5a	5a	NUM
aiua-5738	17	27	-	-	PUNCT
aiua-5738	17	28	r2	r2	NOUN
aiua-5738	17	29	)	)	PUNCT
aiua-5738	17	30	(	(	PUNCT
aiua-5738	17	31	3	3	NUM
aiua-5738	17	32	)	)	PUNCT
aiua-5738	17	33	.	.	PUNCT
aiua-5738	18	1	both	both	PRON
aiua-5738	18	2	isoenzymes	isoenzyme	VERB
aiua-5738	18	3	trigger	trigger	VERB
aiua-5738	18	4	the	the	DET
aiua-5738	18	5	chain	chain	NOUN
aiua-5738	18	6	of	of	ADP
aiua-5738	18	7	events	event	NOUN
aiua-5738	18	8	that	that	PRON
aiua-5738	18	9	lead	lead	VERB
aiua-5738	18	10	to	to	ADP
aiua-5738	18	11	the	the	DET
aiua-5738	18	12	synthesis	synthesis	NOUN
aiua-5738	18	13	of	of	ADP
aiua-5738	18	14	other	other	ADJ
aiua-5738	18	15	steroids	steroid	NOUN
aiua-5738	18	16	,	,	PUNCT
aiua-5738	18	17	of	of	ADP
aiua-5738	18	18	which	which	PRON
aiua-5738	18	19	the	the	DET
aiua-5738	18	20	best	well	ADV
aiua-5738	18	21	known	know	VERB
aiua-5738	18	22	is	be	AUX
aiua-5738	18	23	5a	5a	NUM
aiua-5738	18	24	-	-	PUNCT
aiua-5738	18	25	dihydrotestosterone	dihydrotestosterone	NOUN
aiua-5738	18	26	(	(	PUNCT
aiua-5738	18	27	5a	5a	NUM
aiua-5738	18	28	-	-	PUNCT
aiua-5738	18	29	dht	dht	NOUN
aiua-5738	18	30	)	)	PUNCT
aiua-5738	18	31	(	(	PUNCT
aiua-5738	18	32	3	3	NUM
aiua-5738	18	33	)	)	PUNCT
aiua-5738	18	34	.	.	PUNCT
aiua-5738	19	1	5a	5a	NUM
aiua-5738	19	2	-	-	PUNCT
aiua-5738	19	3	dht	dht	NOUN
aiua-5738	19	4	is	be	AUX
aiua-5738	19	5	the	the	DET
aiua-5738	19	6	most	most	ADV
aiua-5738	19	7	active	active	ADJ
aiua-5738	19	8	androgen	androgen	NOUN
aiua-5738	19	9	in	in	ADP
aiua-5738	19	10	certain	certain	ADJ
aiua-5738	19	11	expressions	expression	NOUN
aiua-5738	19	12	of	of	ADP
aiua-5738	19	13	male	male	ADJ
aiua-5738	19	14	sexuality	sexuality	NOUN
aiua-5738	19	15	(	(	PUNCT
aiua-5738	19	16	4	4	NUM
aiua-5738	19	17	)	)	PUNCT
aiua-5738	19	18	and	and	CCONJ
aiua-5738	19	19	it	it	PRON
aiua-5738	19	20	is	be	AUX
aiua-5738	19	21	also	also	ADV
aiua-5738	19	22	the	the	DET
aiua-5738	19	23	most	most	ADV
aiua-5738	19	24	involved	involved	ADJ
aiua-5738	19	25	hormone	hormone	NOUN
aiua-5738	19	26	in	in	ADP
aiua-5738	19	27	prostate	prostate	NOUN
aiua-5738	19	28	gland	gland	NOUN
aiua-5738	19	29	function	function	NOUN
aiua-5738	19	30	and	and	CCONJ
aiua-5738	19	31	dysfunction	dysfunction	NOUN
aiua-5738	19	32	.	.	PUNCT
aiua-5738	20	1	(	(	PUNCT
aiua-5738	20	2	5	5	X
aiua-5738	20	3	)	)	PUNCT
aiua-5738	20	4	in	in	ADP
aiua-5738	20	5	addition	addition	NOUN
aiua-5738	20	6	,	,	PUNCT
aiua-5738	20	7	the	the	DET
aiua-5738	20	8	many	many	ADJ
aiua-5738	20	9	roles	role	NOUN
aiua-5738	20	10	played	play	VERB
aiua-5738	20	11	by	by	ADP
aiua-5738	20	12	5a	5a	NUM
aiua-5738	20	13	-	-	PUNCT
aiua-5738	20	14	dht	dht	NOUN
aiua-5738	20	15	also	also	ADV
aiua-5738	20	16	include	include	VERB
aiua-5738	20	17	a	a	DET
aiua-5738	20	18	direct	direct	ADJ
aiua-5738	20	19	involvement	involvement	NOUN
aiua-5738	20	20	in	in	ADP
aiua-5738	20	21	the	the	DET
aiua-5738	20	22	tone	tone	NOUN
aiua-5738	20	23	of	of	ADP
aiua-5738	20	24	the	the	DET
aiua-5738	20	25	scalp	scalp	NOUN
aiua-5738	20	26	’s	’s	PART
aiua-5738	20	27	piliferous	piliferous	ADJ
aiua-5738	20	28	bulbs	bulb	NOUN
aiua-5738	20	29	(	(	PUNCT
aiua-5738	20	30	6	6	NUM
aiua-5738	20	31	)	)	PUNCT
aiua-5738	20	32	.	.	PUNCT
aiua-5738	21	1	consequently	consequently	ADV
aiua-5738	21	2	,	,	PUNCT
aiua-5738	21	3	the	the	DET
aiua-5738	21	4	induction	induction	NOUN
aiua-5738	21	5	of	of	ADP
aiua-5738	21	6	a	a	DET
aiua-5738	21	7	reduction	reduction	NOUN
aiua-5738	21	8	in	in	ADP
aiua-5738	21	9	the	the	DET
aiua-5738	21	10	activity	activity	NOUN
aiua-5738	21	11	of	of	ADP
aiua-5738	21	12	5	5	NUM
aiua-5738	21	13	-	-	PUNCT
aiua-5738	21	14	a	a	DET
aiua-5738	21	15	-	-	PUNCT
aiua-5738	21	16	reductase	reductase	NOUN
aiua-5738	21	17	,	,	PUNCT
aiua-5738	21	18	through	through	ADP
aiua-5738	21	19	the	the	DET
aiua-5738	21	20	administration	administration	NOUN
aiua-5738	21	21	of	of	ADP
aiua-5738	21	22	5aris	5aris	NUM
aiua-5738	21	23	,	,	PUNCT
aiua-5738	21	24	is	be	AUX
aiua-5738	21	25	a	a	DET
aiua-5738	21	26	treatment	treatment	NOUN
aiua-5738	21	27	approach	approach	NOUN
aiua-5738	21	28	useful	useful	ADJ
aiua-5738	21	29	in	in	ADP
aiua-5738	21	30	the	the	DET
aiua-5738	21	31	treatment	treatment	NOUN
aiua-5738	21	32	of	of	ADP
aiua-5738	21	33	benign	benign	ADJ
aiua-5738	21	34	prostatic	prostatic	ADJ
aiua-5738	21	35	hyperplasia	hyperplasia	NOUN
aiua-5738	21	36	(	(	PUNCT
aiua-5738	21	37	bph	bph	NOUN
aiua-5738	21	38	)	)	PUNCT
aiua-5738	21	39	(	(	PUNCT
aiua-5738	21	40	7	7	NUM
aiua-5738	21	41	)	)	PUNCT
aiua-5738	21	42	and	and	CCONJ
aiua-5738	21	43	androgenetic	androgenetic	ADJ
aiua-5738	21	44	alopecia	alopecia	NOUN
aiua-5738	21	45	(	(	PUNCT
aiua-5738	21	46	8)	8)	NUM
aiua-5738	21	47	,	,	PUNCT
aiua-5738	21	48	as	as	SCONJ
aiua-5738	21	49	both	both	DET
aiua-5738	21	50	diseases	disease	NOUN
aiua-5738	21	51	are	be	AUX
aiua-5738	21	52	related	relate	VERB
aiua-5738	21	53	to	to	ADP
aiua-5738	21	54	5a	5a	NUM
aiua-5738	21	55	-	-	PUNCT
aiua-5738	21	56	dht	dht	NOUN
aiua-5738	21	57	.	.	PUNCT
aiua-5738	22	1	however	however	ADV
aiua-5738	22	2	,	,	PUNCT
aiua-5738	22	3	at	at	ADP
aiua-5738	22	4	the	the	DET
aiua-5738	22	5	same	same	ADJ
aiua-5738	22	6	time	time	NOUN
aiua-5738	22	7	,	,	PUNCT
aiua-5738	22	8	this	this	DET
aiua-5738	22	9	treatment	treatment	NOUN
aiua-5738	22	10	also	also	ADV
aiua-5738	22	11	theoretically	theoretically	ADV
aiua-5738	22	12	exposes	expose	VERB
aiua-5738	22	13	the	the	DET
aiua-5738	22	14	subject	subject	NOUN
aiua-5738	22	15	to	to	ADP
aiua-5738	22	16	repercussions	repercussion	NOUN
aiua-5738	22	17	in	in	ADP
aiua-5738	22	18	terms	term	NOUN
aiua-5738	22	19	of	of	ADP
aiua-5738	22	20	various	various	ADJ
aiua-5738	22	21	expressions	expression	NOUN
aiua-5738	22	22	of	of	ADP
aiua-5738	22	23	male	male	ADJ
aiua-5738	22	24	sexuality	sexuality	NOUN
aiua-5738	22	25	.	.	PUNCT
aiua-5738	23	1	the	the	DET
aiua-5738	23	2	5a	5a	NUM
aiua-5738	23	3	-	-	PUNCT
aiua-5738	23	4	ris	ris	NOUN
aiua-5738	23	5	used	use	VERB
aiua-5738	23	6	for	for	ADP
aiua-5738	23	7	therapy	therapy	NOUN
aiua-5738	23	8	are	be	AUX
aiua-5738	23	9	finasteride	finasteride	ADJ
aiua-5738	23	10	and	and	CCONJ
aiua-5738	23	11	dutasteride	dutasteride	PROPN
aiua-5738	23	12	.	.	PUNCT
aiua-5738	24	1	dutasteride	dutasteride	PROPN
aiua-5738	24	2	is	be	AUX
aiua-5738	24	3	a	a	DET
aiua-5738	24	4	selective	selective	ADJ
aiua-5738	24	5	inhibitor	inhibitor	NOUN
aiua-5738	24	6	of	of	ADP
aiua-5738	24	7	5a	5a	NUM
aiua-5738	24	8	-	-	PUNCT
aiua-5738	24	9	r1	r1	NOUN
aiua-5738	24	10	and	and	CCONJ
aiua-5738	24	11	5a	5a	NUM
aiua-5738	24	12	-	-	PUNCT
aiua-5738	24	13	r2	r2	NOUN
aiua-5738	24	14	and	and	CCONJ
aiua-5738	24	15	reduces	reduce	VERB
aiua-5738	24	16	serum	serum	NOUN
aiua-5738	24	17	5a	5a	NUM
aiua-5738	24	18	-	-	PUNCT
aiua-5738	24	19	dht	dht	NOUN
aiua-5738	24	20	by	by	ADP
aiua-5738	24	21	approximately	approximately	ADV
aiua-5738	24	22	90	90	NUM
aiua-5738	24	23	%	%	NOUN
aiua-5738	24	24	(	(	PUNCT
aiua-5738	24	25	9	9	NUM
aiua-5738	24	26	)	)	PUNCT
aiua-5738	24	27	.	.	PUNCT
aiua-5738	25	1	finasteride	finasteride	ADJ
aiua-5738	25	2	is	be	AUX
aiua-5738	25	3	above	above	ADP
aiua-5738	25	4	all	all	DET
aiua-5738	25	5	an	an	DET
aiua-5738	25	6	inhibitor	inhibitor	NOUN
aiua-5738	25	7	of	of	ADP
aiua-5738	25	8	5a	5a	NUM
aiua-5738	25	9	-	-	PUNCT
aiua-5738	25	10	r2	r2	NOUN
aiua-5738	25	11	and	and	CCONJ
aiua-5738	25	12	is	be	AUX
aiua-5738	25	13	approximately	approximately	ADV
aiua-5738	25	14	50	50	NUM
aiua-5738	25	15	times	time	NOUN
aiua-5738	25	16	weaker	weak	ADJ
aiua-5738	25	17	in	in	ADP
aiua-5738	25	18	inhibiting	inhibit	VERB
aiua-5738	25	19	5ar1	5ar1	NUM
aiua-5738	25	20	than	than	ADP
aiua-5738	25	21	5a	5a	NUM
aiua-5738	25	22	-	-	PUNCT
aiua-5738	25	23	r2	r2	NOUN
aiua-5738	25	24	;	;	PUNCT
aiua-5738	25	25	for	for	ADP
aiua-5738	25	26	this	this	DET
aiua-5738	25	27	reason	reason	NOUN
aiua-5738	25	28	,	,	PUNCT
aiua-5738	25	29	finasteride	finasteride	ADV
aiua-5738	25	30	is	be	AUX
aiua-5738	25	31	able	able	ADJ
aiua-5738	25	32	to	to	PART
aiua-5738	25	33	reduce	reduce	VERB
aiua-5738	25	34	serum	serum	NOUN
aiua-5738	25	35	5a	5a	NUM
aiua-5738	25	36	-	-	NOUN
aiua-5738	25	37	dht	dht	NOUN
aiua-5738	25	38	by	by	ADP
aiua-5738	25	39	about	about	ADV
aiua-5738	25	40	70	70	NUM
aiua-5738	25	41	%	%	NOUN
aiua-5738	25	42	(	(	PUNCT
aiua-5738	25	43	9	9	NUM
aiua-5738	25	44	)	)	PUNCT
aiua-5738	25	45	.	.	PUNCT
aiua-5738	26	1	indications	indication	NOUN
aiua-5738	26	2	for	for	ADP
aiua-5738	26	3	treatment	treatment	NOUN
aiua-5738	26	4	with	with	ADP
aiua-5738	26	5	5a	5a	NUM
aiua-5738	26	6	-	-	PUNCT
aiua-5738	26	7	r	r	NOUN
aiua-5738	26	8	inhibitors	inhibitor	NOUN
aiua-5738	26	9	the	the	DET
aiua-5738	26	10	5a	5a	NUM
aiua-5738	26	11	-	-	PUNCT
aiua-5738	26	12	ris	ris	NOUN
aiua-5738	26	13	finasteride	finasteride	NOUN
aiua-5738	26	14	and	and	CCONJ
aiua-5738	26	15	dutasteride	dutasteride	PROPN
aiua-5738	26	16	were	be	AUX
aiua-5738	26	17	developed	develop	VERB
aiua-5738	26	18	for	for	ADP
aiua-5738	26	19	the	the	DET
aiua-5738	26	20	treatment	treatment	NOUN
aiua-5738	26	21	of	of	ADP
aiua-5738	26	22	patients	patient	NOUN
aiua-5738	26	23	with	with	ADP
aiua-5738	26	24	urinary	urinary	ADJ
aiua-5738	26	25	disorders	disorder	NOUN
aiua-5738	26	26	sec313archivio	sec313archivio	VERB
aiua-5738	26	27	italiano	italiano	ADJ
aiua-5738	26	28	di	di	X
aiua-5738	26	29	urologia	urologia	PROPN
aiua-5738	26	30	e	e	PROPN
aiua-5738	26	31	andrologia	andrologia	NOUN
aiua-5738	26	32	2015	2015	NUM
aiua-5738	26	33	;	;	PUNCT
aiua-5738	26	34	87	87	NUM
aiua-5738	26	35	,	,	PUNCT
aiua-5738	26	36	4	4	NUM
aiua-5738	26	37	comments	comment	NOUN
aiua-5738	26	38	concerning	concern	VERB
aiua-5738	26	39	the	the	DET
aiua-5738	26	40	real	real	ADJ
aiua-5738	26	41	risk	risk	NOUN
aiua-5738	26	42	of	of	ADP
aiua-5738	26	43	sexual	sexual	ADJ
aiua-5738	26	44	adverse	adverse	ADJ
aiua-5738	26	45	events	event	NOUN
aiua-5738	26	46	secondary	secondary	ADJ
aiua-5738	26	47	to	to	ADP
aiua-5738	26	48	the	the	DET
aiua-5738	26	49	use	use	NOUN
aiua-5738	26	50	of	of	ADP
aiua-5738	26	51	5	5	NUM
aiua-5738	26	52	-	-	PUNCT
aiua-5738	26	53	aris	aris	NOUN
aiua-5738	26	54	by	by	ADP
aiua-5738	26	55	a	a	DET
aiua-5738	26	56	recent	recent	ADJ
aiua-5738	26	57	literature	literature	NOUN
aiua-5738	26	58	review	review	NOUN
aiua-5738	26	59	by	by	ADP
aiua-5738	26	60	abdulmaged	abdulmage	VERB
aiua-5738	26	61	mt	mt	PROPN
aiua-5738	26	62	,	,	PUNCT
aiua-5738	26	63	et	et	PROPN
aiua-5738	26	64	al	al	PROPN
aiua-5738	26	65	.	.	PUNCT
aiua-5738	27	1	(	(	PUNCT
aiua-5738	27	2	2011	2011	NUM
aiua-5738	27	3	)	)	PUNCT
aiua-5738	27	4	,	,	PUNCT
aiua-5738	27	5	in	in	ADP
aiua-5738	27	6	which	which	PRON
aiua-5738	27	7	the	the	DET
aiua-5738	27	8	finding	finding	NOUN
aiua-5738	27	9	of	of	ADP
aiua-5738	27	10	sexual	sexual	ADJ
aiua-5738	27	11	adverse	adverse	ADJ
aiua-5738	27	12	events	event	NOUN
aiua-5738	27	13	attributed	attribute	VERB
aiua-5738	27	14	to	to	ADP
aiua-5738	27	15	the	the	DET
aiua-5738	27	16	use	use	NOUN
aiua-5738	27	17	of	of	ADP
aiua-5738	27	18	5a	5a	NUM
aiua-5738	27	19	-	-	PUNCT
aiua-5738	27	20	ris	ris	NOUN
aiua-5738	27	21	is	be	AUX
aiua-5738	27	22	compared	compare	VERB
aiua-5738	27	23	with	with	ADP
aiua-5738	27	24	data	datum	NOUN
aiua-5738	27	25	relating	relate	VERB
aiua-5738	27	26	to	to	ADP
aiua-5738	27	27	the	the	DET
aiua-5738	27	28	use	use	NOUN
aiua-5738	27	29	of	of	ADP
aiua-5738	27	30	placebo	placebo	NOUN
aiua-5738	27	31	(	(	PUNCT
aiua-5738	27	32	2	2	NUM
aiua-5738	27	33	)	)	PUNCT
aiua-5738	27	34	.	.	PUNCT
aiua-5738	28	1	the	the	DET
aiua-5738	28	2	findings	finding	NOUN
aiua-5738	28	3	of	of	ADP
aiua-5738	28	4	this	this	DET
aiua-5738	28	5	review	review	NOUN
aiua-5738	28	6	can	can	AUX
aiua-5738	28	7	be	be	AUX
aiua-5738	28	8	summarised	summarise	VERB
aiua-5738	28	9	as	as	SCONJ
aiua-5738	28	10	follows	follow	VERB
aiua-5738	28	11	:	:	PUNCT
aiua-5738	28	12	erectile	erectile	ADJ
aiua-5738	28	13	dysfunction	dysfunction	NOUN
aiua-5738	28	14	6%-8	6%-8	NUM
aiua-5738	28	15	%	%	NOUN
aiua-5738	28	16	vs.	vs.	ADP
aiua-5738	28	17	4	4	NUM
aiua-5738	28	18	%	%	NOUN
aiua-5738	28	19	with	with	ADP
aiua-5738	28	20	placebo	placebo	NOUN
aiua-5738	28	21	;	;	PUNCT
aiua-5738	28	22	loss	loss	NOUN
aiua-5738	28	23	/	/	SYM
aiua-5738	28	24	reduction	reduction	NOUN
aiua-5738	28	25	in	in	ADP
aiua-5738	28	26	libido	libido	NOUN
aiua-5738	28	27	1.3%-4.4	1.3%-4.4	NUM
aiua-5738	28	28	%	%	NOUN
aiua-5738	28	29	vs.	vs.	ADP
aiua-5738	28	30	1.8	1.8	NUM
aiua-5738	28	31	%	%	NOUN
aiua-5738	28	32	with	with	ADP
aiua-5738	28	33	placebo	placebo	NOUN
aiua-5738	28	34	and	and	CCONJ
aiua-5738	28	35	ejaculatory	ejaculatory	NOUN
aiua-5738	28	36	disorders	disorder	NOUN
aiua-5738	28	37	2.8	2.8	NUM
aiua-5738	28	38	%	%	NOUN
aiua-5738	28	39	vs.	vs.	ADP
aiua-5738	28	40	1	1	NUM
aiua-5738	28	41	%	%	NOUN
aiua-5738	28	42	with	with	ADP
aiua-5738	28	43	placebo	placebo	NOUN
aiua-5738	28	44	(	(	PUNCT
aiua-5738	28	45	2	2	NUM
aiua-5738	28	46	)	)	PUNCT
aiua-5738	28	47	.	.	PUNCT
aiua-5738	29	1	as	as	ADV
aiua-5738	29	2	far	far	ADV
aiua-5738	29	3	as	as	SCONJ
aiua-5738	29	4	the	the	DET
aiua-5738	29	5	persistence	persistence	NOUN
aiua-5738	29	6	of	of	ADP
aiua-5738	29	7	sexual	sexual	ADJ
aiua-5738	29	8	adverse	adverse	ADJ
aiua-5738	29	9	events	event	NOUN
aiua-5738	29	10	is	be	AUX
aiua-5738	29	11	concerned	concern	VERB
aiua-5738	29	12	,	,	PUNCT
aiua-5738	29	13	an	an	DET
aiua-5738	29	14	important	important	ADJ
aiua-5738	29	15	finding	finding	NOUN
aiua-5738	29	16	was	be	AUX
aiua-5738	29	17	reported	report	VERB
aiua-5738	29	18	by	by	ADP
aiua-5738	29	19	the	the	DET
aiua-5738	29	20	medicine	medicine	NOUN
aiua-5738	29	21	health	health	PROPN
aiua-5738	29	22	care	care	PROPN
aiua-5738	29	23	products	product	NOUN
aiua-5738	29	24	regulatory	regulatory	ADJ
aiua-5738	29	25	agency	agency	NOUN
aiua-5738	29	26	(	(	PUNCT
aiua-5738	29	27	mhra	mhra	NOUN
aiua-5738	29	28	)	)	PUNCT
aiua-5738	29	29	,	,	PUNCT
aiua-5738	29	30	which	which	PRON
aiua-5738	29	31	,	,	PUNCT
aiua-5738	29	32	in	in	ADP
aiua-5738	29	33	its	its	PRON
aiua-5738	29	34	2009	2009	NUM
aiua-5738	29	35	report	report	NOUN
aiua-5738	29	36	states	state	NOUN
aiua-5738	29	37	,	,	PUNCT
aiua-5738	29	38	that	that	SCONJ
aiua-5738	29	39	“	"	PUNCT
aiua-5738	29	40	...	...	PUNCT
aiua-5738	29	41	in	in	ADP
aiua-5738	29	42	postmarketing	postmarkete	VERB
aiua-5738	29	43	experience	experience	NOUN
aiua-5738	29	44	,	,	PUNCT
aiua-5738	29	45	in	in	ADP
aiua-5738	29	46	certain	certain	ADJ
aiua-5738	29	47	patients	patient	NOUN
aiua-5738	29	48	the	the	DET
aiua-5738	29	49	ed	ed	NOUN
aiua-5738	29	50	that	that	PRON
aiua-5738	29	51	appeared	appear	VERB
aiua-5738	29	52	with	with	ADP
aiua-5738	29	53	the	the	DET
aiua-5738	29	54	introduction	introduction	NOUN
aiua-5738	29	55	of	of	ADP
aiua-5738	29	56	propecia	propecia	NOUN
aiua-5738	29	57	is	be	AUX
aiua-5738	29	58	thought	think	VERB
aiua-5738	29	59	to	to	PART
aiua-5738	29	60	persist	persist	VERB
aiua-5738	29	61	even	even	ADV
aiua-5738	29	62	after	after	ADP
aiua-5738	29	63	discontinuation	discontinuation	NOUN
aiua-5738	29	64	of	of	ADP
aiua-5738	29	65	the	the	DET
aiua-5738	29	66	medicinal	medicinal	ADJ
aiua-5738	29	67	product	product	NOUN
aiua-5738	29	68	”	"	PUNCT
aiua-5738	29	69	.	.	PUNCT
aiua-5738	30	1	(	(	PUNCT
aiua-5738	30	2	medicine	medicine	NOUN
aiua-5738	30	3	health	health	NOUN
aiua-5738	30	4	care	care	NOUN
aiua-5738	30	5	products	product	NOUN
aiua-5738	30	6	regulatory	regulatory	ADJ
aiua-5738	30	7	agency	agency	NOUN
aiua-5738	30	8	(	(	PUNCT
aiua-5738	30	9	mhra	mhra	NOUN
aiua-5738	30	10	december	december	PROPN
aiua-5738	30	11	2009	2009	NUM
aiua-5738	30	12	sect	sect	NOUN
aiua-5738	30	13	.	.	PUNCT
aiua-5738	31	1	4.8	4.8	NUM
aiua-5738	31	2	)	)	PUNCT
aiua-5738	31	3	however	however	ADV
aiua-5738	31	4	,	,	PUNCT
aiua-5738	31	5	again	again	ADV
aiua-5738	31	6	on	on	ADP
aiua-5738	31	7	the	the	DET
aiua-5738	31	8	subject	subject	NOUN
aiua-5738	31	9	of	of	ADP
aiua-5738	31	10	alopecia	alopecia	NOUN
aiua-5738	31	11	,	,	PUNCT
aiua-5738	31	12	sato	sato	NOUN
aiua-5738	31	13	and	and	CCONJ
aiua-5738	31	14	takeda	takeda	X
aiua-5738	31	15	(	(	PUNCT
aiua-5738	31	16	2012	2012	NUM
aiua-5738	31	17	)	)	PUNCT
aiua-5738	31	18	conducted	conduct	VERB
aiua-5738	31	19	a	a	DET
aiua-5738	31	20	study	study	NOUN
aiua-5738	31	21	on	on	ADP
aiua-5738	31	22	the	the	DET
aiua-5738	31	23	efficacy	efficacy	NOUN
aiua-5738	31	24	and	and	CCONJ
aiua-5738	31	25	safety	safety	NOUN
aiua-5738	31	26	of	of	ADP
aiua-5738	31	27	finasteride	finasteride	ADJ
aiua-5738	31	28	1	1	NUM
aiua-5738	31	29	mg	mg	NOUN
aiua-5738	31	30	administered	administer	VERB
aiua-5738	31	31	for	for	ADP
aiua-5738	31	32	41	41	NUM
aiua-5738	31	33	months	month	NOUN
aiua-5738	31	34	in	in	ADP
aiua-5738	31	35	3177	3177	NUM
aiua-5738	31	36	patients	patient	NOUN
aiua-5738	31	37	with	with	ADP
aiua-5738	31	38	androgenetic	androgenetic	ADJ
aiua-5738	31	39	alopecia	alopecia	NOUN
aiua-5738	31	40	,	,	PUNCT
aiua-5738	31	41	concluding	conclude	VERB
aiua-5738	31	42	that	that	SCONJ
aiua-5738	31	43	the	the	DET
aiua-5738	31	44	treatment	treatment	NOUN
aiua-5738	31	45	allowed	allow	VERB
aiua-5738	31	46	progressive	progressive	ADJ
aiua-5738	31	47	hair	hair	NOUN
aiua-5738	31	48	growth	growth	NOUN
aiua-5738	31	49	without	without	ADP
aiua-5738	31	50	any	any	DET
aiua-5738	31	51	side	side	NOUN
aiua-5738	31	52	effects	effect	NOUN
aiua-5738	31	53	being	be	AUX
aiua-5738	31	54	observed	observe	VERB
aiua-5738	31	55	(	(	PUNCT
aiua-5738	31	56	18	18	NUM
aiua-5738	31	57	)	)	PUNCT
aiua-5738	31	58	.	.	PUNCT
aiua-5738	32	1	in	in	ADP
aiua-5738	32	2	this	this	DET
aiua-5738	32	3	contradictory	contradictory	ADJ
aiua-5738	32	4	series	series	NOUN
aiua-5738	32	5	of	of	ADP
aiua-5738	32	6	data	data	PROPN
aiua-5738	32	7	,	,	PUNCT
aiua-5738	32	8	it	it	PRON
aiua-5738	32	9	can	can	AUX
aiua-5738	32	10	be	be	AUX
aiua-5738	32	11	said	say	VERB
aiua-5738	32	12	that	that	SCONJ
aiua-5738	32	13	the	the	DET
aiua-5738	32	14	nature	nature	NOUN
aiua-5738	32	15	of	of	ADP
aiua-5738	32	16	the	the	DET
aiua-5738	32	17	persistence	persistence	NOUN
aiua-5738	32	18	of	of	ADP
aiua-5738	32	19	these	these	DET
aiua-5738	32	20	disorders	disorder	NOUN
aiua-5738	32	21	is	be	AUX
aiua-5738	32	22	still	still	ADV
aiua-5738	32	23	an	an	DET
aiua-5738	32	24	active	active	ADJ
aiua-5738	32	25	field	field	NOUN
aiua-5738	32	26	of	of	ADP
aiua-5738	32	27	research	research	NOUN
aiua-5738	32	28	.	.	PUNCT
aiua-5738	33	1	therefore	therefore	ADV
aiua-5738	33	2	,	,	PUNCT
aiua-5738	33	3	as	as	ADP
aiua-5738	33	4	a	a	DET
aiua-5738	33	5	precautionary	precautionary	ADJ
aiua-5738	33	6	measure	measure	NOUN
aiua-5738	33	7	,	,	PUNCT
aiua-5738	33	8	both	both	DET
aiua-5738	33	9	doctors	doctor	NOUN
aiua-5738	33	10	prescribing	prescribe	VERB
aiua-5738	33	11	5a	5a	NUM
aiua-5738	33	12	-	-	PUNCT
aiua-5738	33	13	ris	ris	PROPN
aiua-5738	33	14	,	,	PUNCT
aiua-5738	33	15	and	and	CCONJ
aiua-5738	33	16	patients	patient	NOUN
aiua-5738	33	17	taking	take	VERB
aiua-5738	33	18	this	this	DET
aiua-5738	33	19	class	class	NOUN
aiua-5738	33	20	of	of	ADP
aiua-5738	33	21	drugs	drug	NOUN
aiua-5738	33	22	,	,	PUNCT
aiua-5738	33	23	must	must	AUX
aiua-5738	33	24	be	be	AUX
aiua-5738	33	25	made	make	VERB
aiua-5738	33	26	aware	aware	ADJ
aiua-5738	33	27	of	of	ADP
aiua-5738	33	28	the	the	DET
aiua-5738	33	29	potential	potential	ADJ
aiua-5738	33	30	permanent	permanent	ADJ
aiua-5738	33	31	sexual	sexual	ADJ
aiua-5738	33	32	adverse	adverse	ADJ
aiua-5738	33	33	events	event	NOUN
aiua-5738	33	34	that	that	PRON
aiua-5738	33	35	could	could	AUX
aiua-5738	33	36	,	,	PUNCT
aiua-5738	33	37	according	accord	VERB
aiua-5738	33	38	to	to	ADP
aiua-5738	33	39	certain	certain	ADJ
aiua-5738	33	40	authors	author	NOUN
aiua-5738	33	41	,	,	PUNCT
aiua-5738	33	42	be	be	AUX
aiua-5738	33	43	related	relate	VERB
aiua-5738	33	44	to	to	ADP
aiua-5738	33	45	them	they	PRON
aiua-5738	33	46	(	(	PUNCT
aiua-5738	33	47	19	19	NUM
aiua-5738	33	48	)	)	PUNCT
aiua-5738	33	49	.	.	PUNCT
aiua-5738	34	1	at	at	ADP
aiua-5738	34	2	this	this	DET
aiua-5738	34	3	point	point	NOUN
aiua-5738	34	4	,	,	PUNCT
aiua-5738	34	5	the	the	DET
aiua-5738	34	6	question	question	NOUN
aiua-5738	34	7	is	be	AUX
aiua-5738	34	8	:	:	PUNCT
aiua-5738	34	9	if	if	SCONJ
aiua-5738	34	10	the	the	DET
aiua-5738	34	11	reduction	reduction	NOUN
aiua-5738	34	12	in	in	ADP
aiua-5738	34	13	5a	5a	NUM
aiua-5738	34	14	-	-	PUNCT
aiua-5738	34	15	dht	dht	NOUN
aiua-5738	34	16	induced	induce	VERB
aiua-5738	34	17	by	by	ADP
aiua-5738	34	18	5a	5a	NUM
aiua-5738	34	19	-	-	PUNCT
aiua-5738	34	20	ris	ris	X
aiua-5738	34	21	is	be	AUX
aiua-5738	34	22	a	a	DET
aiua-5738	34	23	sufficient	sufficient	ADJ
aiua-5738	34	24	condition	condition	NOUN
aiua-5738	34	25	to	to	PART
aiua-5738	34	26	cause	cause	VERB
aiua-5738	34	27	sexual	sexual	ADJ
aiua-5738	34	28	dysfunction	dysfunction	NOUN
aiua-5738	34	29	which	which	PRON
aiua-5738	34	30	,	,	PUNCT
aiua-5738	34	31	in	in	ADP
aiua-5738	34	32	some	some	DET
aiua-5738	34	33	cases	case	NOUN
aiua-5738	34	34	,	,	PUNCT
aiua-5738	34	35	can	can	AUX
aiua-5738	34	36	be	be	AUX
aiua-5738	34	37	permanent	permanent	ADJ
aiua-5738	34	38	,	,	PUNCT
aiua-5738	34	39	why	why	SCONJ
aiua-5738	34	40	does	do	AUX
aiua-5738	34	41	this	this	PRON
aiua-5738	34	42	not	not	PART
aiua-5738	34	43	occur	occur	VERB
aiua-5738	34	44	in	in	ADP
aiua-5738	34	45	all	all	DET
aiua-5738	34	46	patients	patient	NOUN
aiua-5738	34	47	treated	treat	VERB
aiua-5738	34	48	,	,	PUNCT
aiua-5738	34	49	and	and	CCONJ
aiua-5738	34	50	in	in	ADP
aiua-5738	34	51	particular	particular	ADJ
aiua-5738	34	52	in	in	ADP
aiua-5738	34	53	those	those	PRON
aiua-5738	34	54	in	in	ADP
aiua-5738	34	55	whom	whom	PRON
aiua-5738	34	56	normal	normal	ADJ
aiua-5738	34	57	sexual	sexual	ADJ
aiua-5738	34	58	function	function	NOUN
aiua-5738	34	59	was	be	AUX
aiua-5738	34	60	confirmed	confirm	VERB
aiua-5738	34	61	prior	prior	ADV
aiua-5738	34	62	to	to	ADP
aiua-5738	34	63	treatment	treatment	NOUN
aiua-5738	34	64	?	?	PUNCT
aiua-5738	35	1	amongst	amongst	ADP
aiua-5738	35	2	the	the	DET
aiua-5738	35	3	various	various	ADJ
aiua-5738	35	4	hypotheses	hypothesis	NOUN
aiua-5738	35	5	,	,	PUNCT
aiua-5738	35	6	it	it	PRON
aiua-5738	35	7	is	be	AUX
aiua-5738	35	8	possible	possible	ADJ
aiua-5738	35	9	that	that	SCONJ
aiua-5738	35	10	the	the	DET
aiua-5738	35	11	answer	answer	NOUN
aiua-5738	35	12	should	should	AUX
aiua-5738	35	13	be	be	AUX
aiua-5738	35	14	sought	seek	VERB
aiua-5738	35	15	in	in	ADP
aiua-5738	35	16	the	the	DET
aiua-5738	35	17	genetic	genetic	ADJ
aiua-5738	35	18	differences	difference	NOUN
aiua-5738	35	19	existing	exist	VERB
aiua-5738	35	20	between	between	ADP
aiua-5738	35	21	individuals	individual	NOUN
aiua-5738	35	22	,	,	PUNCT
aiua-5738	35	23	such	such	ADJ
aiua-5738	35	24	as	as	ADP
aiua-5738	35	25	postulable	postulable	ADJ
aiua-5738	35	26	5a	5a	NUM
aiua-5738	35	27	-	-	PUNCT
aiua-5738	35	28	reductase	reductase	NOUN
aiua-5738	35	29	polymorphisms	polymorphism	NOUN
aiua-5738	35	30	,	,	PUNCT
aiua-5738	35	31	which	which	PRON
aiua-5738	35	32	could	could	AUX
aiua-5738	35	33	contribute	contribute	VERB
aiua-5738	35	34	to	to	ADP
aiua-5738	35	35	an	an	DET
aiua-5738	35	36	inter	inter	ADJ
aiua-5738	35	37	-	-	ADJ
aiua-5738	35	38	individual	individual	ADJ
aiua-5738	35	39	variability	variability	NOUN
aiua-5738	35	40	in	in	ADP
aiua-5738	35	41	the	the	DET
aiua-5738	35	42	response	response	NOUN
aiua-5738	35	43	to	to	ADP
aiua-5738	35	44	5a	5a	NUM
aiua-5738	35	45	-	-	PUNCT
aiua-5738	35	46	ris	ris	X
aiua-5738	35	47	(	(	PUNCT
aiua-5738	35	48	20	20	NUM
aiua-5738	35	49	)	)	PUNCT
aiua-5738	35	50	.	.	PUNCT
aiua-5738	36	1	regardless	regardless	ADV
aiua-5738	36	2	of	of	ADP
aiua-5738	36	3	the	the	DET
aiua-5738	36	4	cause	cause	NOUN
aiua-5738	36	5	and	and	CCONJ
aiua-5738	36	6	actual	actual	ADJ
aiua-5738	36	7	incidence	incidence	NOUN
aiua-5738	36	8	of	of	ADP
aiua-5738	36	9	the	the	DET
aiua-5738	36	10	risk	risk	NOUN
aiua-5738	36	11	of	of	ADP
aiua-5738	36	12	sexual	sexual	ADJ
aiua-5738	36	13	adverse	adverse	ADJ
aiua-5738	36	14	events	event	NOUN
aiua-5738	36	15	in	in	ADP
aiua-5738	36	16	patients	patient	NOUN
aiua-5738	36	17	treated	treat	VERB
aiua-5738	36	18	with	with	ADP
aiua-5738	36	19	5a	5a	NUM
aiua-5738	36	20	-	-	PUNCT
aiua-5738	36	21	ris	ris	PROPN
aiua-5738	36	22	,	,	PUNCT
aiua-5738	36	23	both	both	CCONJ
aiua-5738	36	24	clinical	clinical	ADJ
aiua-5738	36	25	and	and	CCONJ
aiua-5738	36	26	ethical	ethical	ADJ
aiua-5738	36	27	importance	importance	NOUN
aiua-5738	36	28	undoubtedly	undoubtedly	ADV
aiua-5738	36	29	vary	vary	VERB
aiua-5738	36	30	with	with	ADP
aiua-5738	36	31	the	the	DET
aiua-5738	36	32	age	age	NOUN
aiua-5738	36	33	of	of	ADP
aiua-5738	36	34	patients	patient	NOUN
aiua-5738	36	35	and	and	CCONJ
aiua-5738	36	36	the	the	DET
aiua-5738	36	37	condition	condition	NOUN
aiua-5738	36	38	for	for	ADP
aiua-5738	36	39	which	which	PRON
aiua-5738	36	40	the	the	DET
aiua-5738	36	41	5a	5a	NUM
aiua-5738	36	42	-	-	PUNCT
aiua-5738	36	43	ris	ri	NOUN
aiua-5738	36	44	are	be	AUX
aiua-5738	36	45	used	use	VERB
aiua-5738	36	46	.	.	PUNCT
aiua-5738	37	1	for	for	ADP
aiua-5738	37	2	this	this	DET
aiua-5738	37	3	reason	reason	NOUN
aiua-5738	37	4	,	,	PUNCT
aiua-5738	37	5	it	it	PRON
aiua-5738	37	6	is	be	AUX
aiua-5738	37	7	believed	believe	VERB
aiua-5738	37	8	that	that	SCONJ
aiua-5738	37	9	the	the	DET
aiua-5738	37	10	chronic	chronic	ADJ
aiua-5738	37	11	administration	administration	NOUN
aiua-5738	37	12	of	of	ADP
aiua-5738	37	13	finasteride	finasteride	ADJ
aiua-5738	37	14	1	1	NUM
aiua-5738	37	15	mg	mg	NOUN
aiua-5738	37	16	in	in	ADP
aiua-5738	37	17	young	young	ADJ
aiua-5738	37	18	patients	patient	NOUN
aiua-5738	37	19	with	with	ADP
aiua-5738	37	20	androgenetic	androgenetic	ADJ
aiua-5738	37	21	alopecia	alopecia	NOUN
aiua-5738	37	22	(	(	PUNCT
aiua-5738	37	23	aga	aga	NOUN
aiua-5738	37	24	)	)	PUNCT
aiua-5738	37	25	constitutes	constitute	VERB
aiua-5738	37	26	a	a	DET
aiua-5738	37	27	“	"	PUNCT
aiua-5738	37	28	cosmetic	cosmetic	ADJ
aiua-5738	37	29	”	"	PUNCT
aiua-5738	37	30	treatment	treatment	NOUN
aiua-5738	37	31	,	,	PUNCT
aiua-5738	37	32	although	although	SCONJ
aiua-5738	37	33	it	it	PRON
aiua-5738	37	34	is	be	AUX
aiua-5738	37	35	also	also	ADV
aiua-5738	37	36	sometimes	sometimes	ADV
aiua-5738	37	37	prescribed	prescribe	VERB
aiua-5738	37	38	to	to	PART
aiua-5738	37	39	minimise	minimise	VERB
aiua-5738	37	40	the	the	DET
aiua-5738	37	41	relational	relational	ADJ
aiua-5738	37	42	psychological	psychological	ADJ
aiua-5738	37	43	repercussions	repercussion	NOUN
aiua-5738	37	44	that	that	PRON
aiua-5738	37	45	hair	hair	NOUN
aiua-5738	37	46	loss	loss	NOUN
aiua-5738	37	47	can	can	AUX
aiua-5738	37	48	have	have	VERB
aiua-5738	37	49	.	.	PUNCT
aiua-5738	38	1	on	on	ADP
aiua-5738	38	2	the	the	DET
aiua-5738	38	3	other	other	ADJ
aiua-5738	38	4	hand	hand	NOUN
aiua-5738	38	5	,	,	PUNCT
aiua-5738	38	6	a	a	DET
aiua-5738	38	7	comparison	comparison	NOUN
aiua-5738	38	8	must	must	AUX
aiua-5738	38	9	be	be	AUX
aiua-5738	38	10	made	make	VERB
aiua-5738	38	11	between	between	ADP
aiua-5738	38	12	the	the	DET
aiua-5738	38	13	risk	risk	NOUN
aiua-5738	38	14	of	of	ADP
aiua-5738	38	15	sexual	sexual	ADJ
aiua-5738	38	16	adverse	adverse	ADJ
aiua-5738	38	17	events	event	NOUN
aiua-5738	38	18	deriving	derive	VERB
aiua-5738	38	19	from	from	ADP
aiua-5738	38	20	the	the	DET
aiua-5738	38	21	use	use	NOUN
aiua-5738	38	22	of	of	ADP
aiua-5738	38	23	5a	5a	NUM
aiua-5738	38	24	-	-	PUNCT
aiua-5738	38	25	ris	ris	X
aiua-5738	38	26	(	(	PUNCT
aiua-5738	38	27	alone	alone	ADV
aiua-5738	38	28	or	or	CCONJ
aiua-5738	38	29	combined	combine	VERB
aiua-5738	38	30	with	with	ADP
aiua-5738	38	31	alpha	alpha	ADJ
aiua-5738	38	32	adrenergic	adrenergic	ADJ
aiua-5738	38	33	blockers	blocker	NOUN
aiua-5738	38	34	)	)	PUNCT
aiua-5738	38	35	in	in	ADP
aiua-5738	38	36	patients	patient	NOUN
aiua-5738	38	37	with	with	ADP
aiua-5738	38	38	lower	low	ADJ
aiua-5738	38	39	urinary	urinary	ADJ
aiua-5738	38	40	tract	tract	NOUN
aiua-5738	38	41	symptoms	symptom	NOUN
aiua-5738	38	42	secondary	secondary	ADJ
aiua-5738	38	43	to	to	ADP
aiua-5738	38	44	bph	bph	NOUN
aiua-5738	38	45	at	at	ADP
aiua-5738	38	46	a	a	DET
aiua-5738	38	47	high	high	ADJ
aiua-5738	38	48	risk	risk	NOUN
aiua-5738	38	49	of	of	ADP
aiua-5738	38	50	progression	progression	NOUN
aiua-5738	38	51	,	,	PUNCT
aiua-5738	38	52	and	and	CCONJ
aiua-5738	38	53	the	the	DET
aiua-5738	38	54	far	far	ADV
aiua-5738	38	55	more	more	ADV
aiua-5738	38	56	pressing	press	VERB
aiua-5738	38	57	issue	issue	NOUN
aiua-5738	38	58	of	of	ADP
aiua-5738	38	59	important	important	ADJ
aiua-5738	38	60	sexual	sexual	ADJ
aiua-5738	38	61	and	and	CCONJ
aiua-5738	38	62	other	other	ADJ
aiua-5738	38	63	adverse	adverse	ADJ
aiua-5738	38	64	events	event	NOUN
aiua-5738	38	65	deriving	derive	VERB
aiua-5738	38	66	from	from	ADP
aiua-5738	38	67	the	the	DET
aiua-5738	38	68	underlying	underlie	VERB
aiua-5738	38	69	prostatic	prostatic	ADJ
aiua-5738	38	70	condition	condition	NOUN
aiua-5738	38	71	(	(	PUNCT
aiua-5738	38	72	acute	acute	ADJ
aiua-5738	38	73	urinary	urinary	ADJ
aiua-5738	38	74	retention	retention	NOUN
aiua-5738	38	75	,	,	PUNCT
aiua-5738	38	76	bph	bph	NOUN
aiua-5738	38	77	surgery	surgery	NOUN
aiua-5738	38	78	-	-	PUNCT
aiua-5738	38	79	related	relate	VERB
aiua-5738	38	80	symptoms	symptom	NOUN
aiua-5738	38	81	and	and	CCONJ
aiua-5738	38	82	clinical	clinical	ADJ
aiua-5738	38	83	progression	progression	NOUN
aiua-5738	38	84	)	)	PUNCT
aiua-5738	38	85	,	,	PUNCT
aiua-5738	38	86	and	and	CCONJ
aiua-5738	38	87	the	the	DET
aiua-5738	38	88	treatment	treatment	NOUN
aiua-5738	38	89	options	option	NOUN
aiua-5738	38	90	for	for	ADP
aiua-5738	38	91	bph	bph	NOUN
aiua-5738	38	92	that	that	PRON
aiua-5738	38	93	are	be	AUX
aiua-5738	38	94	alternative	alternative	ADJ
aiua-5738	38	95	to	to	ADP
aiua-5738	38	96	5a	5a	NUM
aiua-5738	38	97	-	-	PUNCT
aiua-5738	38	98	ris	ris	X
aiua-5738	38	99	.	.	PUNCT
aiua-5738	39	1	specifically	specifically	ADV
aiua-5738	39	2	,	,	PUNCT
aiua-5738	39	3	the	the	DET
aiua-5738	39	4	awareness	awareness	NOUN
aiua-5738	39	5	of	of	ADP
aiua-5738	39	6	all	all	DET
aiua-5738	39	7	the	the	DET
aiua-5738	39	8	potential	potential	ADJ
aiua-5738	39	9	adverse	adverse	ADJ
aiua-5738	39	10	events	event	NOUN
aiua-5738	39	11	related	relate	VERB
aiua-5738	39	12	to	to	ADP
aiua-5738	39	13	invasive	invasive	ADJ
aiua-5738	39	14	and	and	CCONJ
aiua-5738	39	15	minimally	minimally	ADV
aiua-5738	39	16	invasive	invasive	ADJ
aiua-5738	39	17	treatments	treatment	NOUN
aiua-5738	39	18	for	for	ADP
aiua-5738	39	19	bph	bph	NOUN
aiua-5738	39	20	is	be	AUX
aiua-5738	39	21	very	very	ADV
aiua-5738	39	22	important	important	ADJ
aiua-5738	39	23	(	(	PUNCT
aiua-5738	39	24	21	21	NUM
aiua-5738	39	25	)	)	PUNCT
aiua-5738	39	26	.	.	PUNCT
aiua-5738	40	1	this	this	DET
aiua-5738	40	2	balance	balance	NOUN
aiua-5738	40	3	is	be	AUX
aiua-5738	40	4	well	well	ADV
aiua-5738	40	5	expressed	express	VERB
aiua-5738	40	6	in	in	ADP
aiua-5738	40	7	two	two	NUM
aiua-5738	40	8	pivotal	pivotal	ADJ
aiua-5738	40	9	studies	study	NOUN
aiua-5738	40	10	conducted	conduct	VERB
aiua-5738	40	11	on	on	ADP
aiua-5738	40	12	a	a	DET
aiua-5738	40	13	large	large	ADJ
aiua-5738	40	14	number	number	NOUN
aiua-5738	40	15	of	of	ADP
aiua-5738	40	16	patients	patient	NOUN
aiua-5738	40	17	with	with	ADP
aiua-5738	40	18	bph	bph	NOUN
aiua-5738	40	19	treated	treat	VERB
aiua-5738	40	20	with	with	ADP
aiua-5738	40	21	dutasteride	dutasteride	PROPN
aiua-5738	40	22	0.5	0.5	NUM
aiua-5738	40	23	mg	mg	NOUN
aiua-5738	40	24	+	+	NUM
aiua-5738	40	25	tamsulosina	tamsulosina	NOUN
aiua-5738	40	26	4	4	NUM
aiua-5738	40	27	mg	mg	NOUN
aiua-5738	40	28	(	(	PUNCT
aiua-5738	40	29	combat	combat	NOUN
aiua-5738	40	30	study	study	NOUN
aiua-5738	40	31	)	)	PUNCT
aiua-5738	40	32	(	(	PUNCT
aiua-5738	40	33	22	22	NUM
aiua-5738	40	34	)	)	PUNCT
aiua-5738	40	35	and	and	CCONJ
aiua-5738	40	36	with	with	ADP
aiua-5738	40	37	finasteride	finasteride	ADJ
aiua-5738	40	38	5	5	NUM
aiua-5738	40	39	mg	mg	NOUN
aiua-5738	40	40	(	(	PUNCT
aiua-5738	40	41	pless	pless	PROPN
aiua-5738	40	42	study	study	PROPN
aiua-5738	40	43	)	)	PUNCT
aiua-5738	40	44	(	(	PUNCT
aiua-5738	40	45	23	23	NUM
aiua-5738	40	46	)	)	PUNCT
aiua-5738	40	47	.	.	PUNCT
aiua-5738	41	1	combat	combat	NOUN
aiua-5738	41	2	study	study	NOUN
aiua-5738	41	3	(	(	PUNCT
aiua-5738	41	4	dutasteride	dutasteride	PROPN
aiua-5738	41	5	0.5	0.5	NUM
aiua-5738	41	6	mg	mg	NOUN
aiua-5738	41	7	and	and	CCONJ
aiua-5738	41	8	tamsulosina	tamsulosina	NOUN
aiua-5738	41	9	4	4	NUM
aiua-5738	41	10	mg	mg	PROPN
aiua-5738	41	11	,	,	PUNCT
aiua-5738	41	12	in	in	ADP
aiua-5738	41	13	combination	combination	NOUN
aiua-5738	41	14	or	or	CCONJ
aiua-5738	41	15	monotherapy	monotherapy	NOUN
aiua-5738	41	16	)	)	PUNCT
aiua-5738	41	17	;	;	PUNCT
aiua-5738	41	18	4844	4844	NUM
aiua-5738	41	19	pt	pt	X
aiua-5738	41	20	(	(	PUNCT
aiua-5738	41	21	≥	≥	NOUN
aiua-5738	41	22	50	50	NUM
aiua-5738	41	23	years	year	NOUN
aiua-5738	41	24	)	)	PUNCT
aiua-5738	41	25	observed	observe	VERB
aiua-5738	41	26	for	for	ADP
aiua-5738	41	27	4	4	NUM
aiua-5738	41	28	years	year	NOUN
aiua-5738	41	29	.	.	PUNCT
aiua-5738	42	1	(	(	PUNCT
aiua-5738	42	2	22	22	NUM
aiua-5738	42	3	)	)	PUNCT
aiua-5738	42	4	the	the	DET
aiua-5738	42	5	study	study	NOUN
aiua-5738	42	6	was	be	AUX
aiua-5738	42	7	conducted	conduct	VERB
aiua-5738	42	8	to	to	PART
aiua-5738	42	9	evaluate	evaluate	VERB
aiua-5738	42	10	the	the	DET
aiua-5738	42	11	efficacy	efficacy	NOUN
aiua-5738	42	12	of	of	ADP
aiua-5738	42	13	the	the	DET
aiua-5738	42	14	therapy	therapy	NOUN
aiua-5738	42	15	with	with	ADP
aiua-5738	42	16	dutasteride	dutasteride	NOUN
aiua-5738	42	17	and	and	CCONJ
aiua-5738	42	18	tamsulosin	tamsulosin	NOUN
aiua-5738	42	19	,	,	PUNCT
aiua-5738	42	20	administered	administer	VERB
aiua-5738	42	21	as	as	ADP
aiua-5738	42	22	monotherapy	monotherapy	NOUN
aiua-5738	42	23	or	or	CCONJ
aiua-5738	42	24	in	in	ADP
aiua-5738	42	25	combination	combination	NOUN
aiua-5738	42	26	,	,	PUNCT
aiua-5738	42	27	in	in	ADP
aiua-5738	42	28	the	the	DET
aiua-5738	42	29	prevention	prevention	NOUN
aiua-5738	42	30	of	of	ADP
aiua-5738	42	31	major	major	ADJ
aiua-5738	42	32	complications	complication	NOUN
aiua-5738	42	33	secondary	secondary	ADJ
aiua-5738	42	34	to	to	ADP
aiua-5738	42	35	bph	bph	NOUN
aiua-5738	42	36	:	:	PUNCT
aiua-5738	42	37	disease	disease	NOUN
aiua-5738	42	38	progression	progression	NOUN
aiua-5738	42	39	,	,	PUNCT
aiua-5738	42	40	acute	acute	ADJ
aiua-5738	42	41	urinary	urinary	ADJ
aiua-5738	42	42	retention	retention	NOUN
aiua-5738	42	43	(	(	PUNCT
aiua-5738	42	44	aur	aur	NOUN
aiua-5738	42	45	)	)	PUNCT
aiua-5738	42	46	,	,	PUNCT
aiua-5738	42	47	bph	bph	NOUN
aiua-5738	42	48	-	-	PUNCT
aiua-5738	42	49	related	relate	VERB
aiua-5738	42	50	surgery	surgery	NOUN
aiua-5738	42	51	(	(	PUNCT
aiua-5738	42	52	22	22	NUM
aiua-5738	42	53	)	)	PUNCT
aiua-5738	42	54	.	.	PUNCT
aiua-5738	43	1	this	this	DET
aiua-5738	43	2	study	study	NOUN
aiua-5738	43	3	showed	show	VERB
aiua-5738	43	4	that	that	SCONJ
aiua-5738	43	5	combination	combination	NOUN
aiua-5738	43	6	treatment	treatment	NOUN
aiua-5738	43	7	with	with	ADP
aiua-5738	43	8	dutasteride	dutasteride	NOUN
aiua-5738	43	9	+	+	CCONJ
aiua-5738	43	10	tamsulosin	tamsulosin	NOUN
aiua-5738	43	11	significantly	significantly	ADV
aiua-5738	43	12	reduces	reduce	VERB
aiua-5738	43	13	the	the	DET
aiua-5738	43	14	relative	relative	ADJ
aiua-5738	43	15	risk	risk	NOUN
aiua-5738	43	16	of	of	ADP
aiua-5738	43	17	aur	aur	NOUN
aiua-5738	43	18	and	and	CCONJ
aiua-5738	43	19	bph	bph	NOUN
aiua-5738	43	20	-	-	PUNCT
aiua-5738	43	21	related	relate	VERB
aiua-5738	43	22	surgery	surgery	NOUN
aiua-5738	43	23	(	(	PUNCT
aiua-5738	43	24	primary	primary	ADJ
aiua-5738	43	25	endpoint	endpoint	NOUN
aiua-5738	43	26	at	at	ADP
aiua-5738	43	27	four	four	NUM
aiua-5738	43	28	years	year	NOUN
aiua-5738	43	29	)	)	PUNCT
aiua-5738	43	30	compared	compare	VERB
aiua-5738	43	31	to	to	ADP
aiua-5738	43	32	monotherapy	monotherapy	NOUN
aiua-5738	43	33	with	with	ADP
aiua-5738	43	34	tamsulosin	tamsulosin	NOUN
aiua-5738	43	35	(	(	PUNCT
aiua-5738	43	36	22	22	NUM
aiua-5738	43	37	)	)	PUNCT
aiua-5738	43	38	.	.	PUNCT
aiua-5738	44	1	this	this	DET
aiua-5738	44	2	study	study	NOUN
aiua-5738	44	3	also	also	ADV
aiua-5738	44	4	showed	show	VERB
aiua-5738	44	5	that	that	SCONJ
aiua-5738	44	6	the	the	DET
aiua-5738	44	7	incidence	incidence	NOUN
aiua-5738	44	8	of	of	ADP
aiua-5738	44	9	adverse	adverse	ADJ
aiua-5738	44	10	events	event	NOUN
aiua-5738	44	11	in	in	ADP
aiua-5738	44	12	the	the	DET
aiua-5738	44	13	sexual	sexual	ADJ
aiua-5738	44	14	field	field	NOUN
aiua-5738	44	15	(	(	PUNCT
aiua-5738	44	16	ed	ed	NOUN
aiua-5738	44	17	)	)	PUNCT
aiua-5738	44	18	drops	drop	VERB
aiua-5738	44	19	with	with	ADP
aiua-5738	44	20	the	the	DET
aiua-5738	44	21	years	year	NOUN
aiua-5738	44	22	of	of	ADP
aiua-5738	44	23	use	use	NOUN
aiua-5738	44	24	of	of	ADP
aiua-5738	44	25	treatment	treatment	NOUN
aiua-5738	44	26	(	(	PUNCT
aiua-5738	44	27	22	22	NUM
aiua-5738	44	28	&	&	CCONJ
aiua-5738	44	29	avodart	avodart	PROPN
aiua-5738	44	30	european	european	PROPN
aiua-5738	44	31	summary	summary	NOUN
aiua-5738	44	32	of	of	ADP
aiua-5738	44	33	product	product	NOUN
aiua-5738	44	34	characteristics	characteristic	NOUN
aiua-5738	44	35	february	february	PROPN
aiua-5738	44	36	2011	2011	NUM
aiua-5738	44	37	)	)	PUNCT
aiua-5738	44	38	.	.	PUNCT
aiua-5738	45	1	pless	pless	PROPN
aiua-5738	45	2	study	study	PROPN
aiua-5738	45	3	(	(	PUNCT
aiua-5738	45	4	the	the	DET
aiua-5738	45	5	proscar	proscar	NOUN
aiua-5738	45	6	long	long	ADJ
aiua-5738	45	7	-	-	PUNCT
aiua-5738	45	8	term	term	NOUN
aiua-5738	45	9	efficacy	efficacy	NOUN
aiua-5738	45	10	and	and	CCONJ
aiua-5738	45	11	safety	safety	NOUN
aiua-5738	45	12	study	study	NOUN
aiua-5738	45	13	)	)	PUNCT
aiua-5738	45	14	;	;	PUNCT
aiua-5738	45	15	3040	3040	NUM
aiua-5738	45	16	pt	pt	NOUN
aiua-5738	45	17	.	.	PROPN
aiua-5738	45	18	(	(	PUNCT
aiua-5738	45	19	45	45	NUM
aiua-5738	45	20	-	-	SYM
aiua-5738	45	21	78	78	NUM
aiua-5738	45	22	years	year	NOUN
aiua-5738	45	23	)	)	PUNCT
aiua-5738	45	24	,	,	PUNCT
aiua-5738	45	25	observed	observe	VERB
aiua-5738	45	26	for	for	ADP
aiua-5738	45	27	4	4	NUM
aiua-5738	45	28	years	year	NOUN
aiua-5738	45	29	,	,	PUNCT
aiua-5738	45	30	rct	rct	PROPN
aiua-5738	45	31	,	,	PUNCT
aiua-5738	45	32	finasteride	finasteride	NOUN
aiua-5738	45	33	vs.	vs.	ADP
aiua-5738	45	34	placebo	placebo	NOUN
aiua-5738	45	35	(	(	PUNCT
aiua-5738	45	36	23	23	NUM
aiua-5738	45	37	)	)	PUNCT
aiua-5738	45	38	.	.	PUNCT
aiua-5738	46	1	–	–	PUNCT
aiua-5738	46	2	at	at	ADP
aiua-5738	46	3	screening	screen	VERB
aiua-5738	46	4	,	,	PUNCT
aiua-5738	46	5	46	46	NUM
aiua-5738	46	6	%	%	NOUN
aiua-5738	46	7	of	of	ADP
aiua-5738	46	8	patients	patient	NOUN
aiua-5738	46	9	in	in	ADP
aiua-5738	46	10	both	both	DET
aiua-5738	46	11	groups	group	NOUN
aiua-5738	46	12	said	say	VERB
aiua-5738	46	13	they	they	PRON
aiua-5738	46	14	had	have	VERB
aiua-5738	46	15	a	a	DET
aiua-5738	46	16	history	history	NOUN
aiua-5738	46	17	of	of	ADP
aiua-5738	46	18	sexual	sexual	ADJ
aiua-5738	46	19	dysfunction	dysfunction	NOUN
aiua-5738	46	20	(	(	PUNCT
aiua-5738	46	21	sd	sd	NOUN
aiua-5738	46	22	)	)	PUNCT
aiua-5738	46	23	(	(	PUNCT
aiua-5738	46	24	23	23	NUM
aiua-5738	46	25	)	)	PUNCT
aiua-5738	46	26	–	–	PUNCT
aiua-5738	46	27	the	the	DET
aiua-5738	46	28	sexual	sexual	ADJ
aiua-5738	46	29	side	side	NOUN
aiua-5738	46	30	effects	effect	NOUN
aiua-5738	46	31	were	be	AUX
aiua-5738	46	32	only	only	ADV
aiua-5738	46	33	significant	significant	ADJ
aiua-5738	46	34	during	during	ADP
aiua-5738	46	35	the	the	DET
aiua-5738	46	36	first	first	ADJ
aiua-5738	46	37	year	year	NOUN
aiua-5738	46	38	(	(	PUNCT
aiua-5738	46	39	15	15	NUM
aiua-5738	46	40	%	%	NOUN
aiua-5738	46	41	vs.	vs.	ADP
aiua-5738	46	42	7	7	NUM
aiua-5738	46	43	%	%	NOUN
aiua-5738	46	44	)	)	PUNCT
aiua-5738	46	45	(	(	PUNCT
aiua-5738	46	46	23	23	NUM
aiua-5738	46	47	)	)	PUNCT
aiua-5738	46	48	–	–	PUNCT
aiua-5738	46	49	there	there	PRON
aiua-5738	46	50	were	be	VERB
aiua-5738	46	51	no	no	DET
aiua-5738	46	52	significant	significant	ADJ
aiua-5738	46	53	differences	difference	NOUN
aiua-5738	46	54	between	between	ADP
aiua-5738	46	55	the	the	DET
aiua-5738	46	56	second	second	ADJ
aiua-5738	46	57	and	and	CCONJ
aiua-5738	46	58	the	the	DET
aiua-5738	46	59	fourth	fourth	ADJ
aiua-5738	46	60	year	year	NOUN
aiua-5738	46	61	(	(	PUNCT
aiua-5738	46	62	7	7	NUM
aiua-5738	46	63	%	%	NOUN
aiua-5738	46	64	in	in	ADP
aiua-5738	46	65	both	both	DET
aiua-5738	46	66	groups	group	NOUN
aiua-5738	46	67	)	)	PUNCT
aiua-5738	46	68	(	(	PUNCT
aiua-5738	46	69	23	23	NUM
aiua-5738	46	70	)	)	PUNCT
aiua-5738	46	71	–	–	PUNCT
aiua-5738	46	72	only	only	ADV
aiua-5738	46	73	4	4	NUM
aiua-5738	46	74	%	%	NOUN
aiua-5738	46	75	of	of	ADP
aiua-5738	46	76	patients	patient	NOUN
aiua-5738	46	77	treated	treat	VERB
aiua-5738	46	78	with	with	ADP
aiua-5738	46	79	finasteride	finasteride	ADJ
aiua-5738	46	80	and	and	CCONJ
aiua-5738	46	81	2	2	NUM
aiua-5738	46	82	%	%	NOUN
aiua-5738	46	83	of	of	ADP
aiua-5738	46	84	patients	patient	NOUN
aiua-5738	46	85	treated	treat	VERB
aiua-5738	46	86	with	with	ADP
aiua-5738	46	87	placebo	placebo	NOUN
aiua-5738	46	88	interrupted	interrupt	VERB
aiua-5738	46	89	the	the	DET
aiua-5738	46	90	study	study	NOUN
aiua-5738	46	91	due	due	ADP
aiua-5738	46	92	to	to	ADP
aiua-5738	46	93	sexual	sexual	ADJ
aiua-5738	46	94	adverse	adverse	ADJ
aiua-5738	46	95	events	event	NOUN
aiua-5738	46	96	(	(	PUNCT
aiua-5738	46	97	23	23	NUM
aiua-5738	46	98	)	)	PUNCT
aiua-5738	46	99	•	•	NUM
aiua-5738	46	100	50	50	NUM
aiua-5738	46	101	%	%	NOUN
aiua-5738	46	102	of	of	ADP
aiua-5738	46	103	patients	patient	NOUN
aiua-5738	46	104	treated	treat	VERB
aiua-5738	46	105	with	with	ADP
aiua-5738	46	106	finasteride	finasteride	NOUN
aiua-5738	46	107	said	say	VERB
aiua-5738	46	108	the	the	DET
aiua-5738	46	109	sd	sd	NOUN
aiua-5738	46	110	persisted	persist	VERB
aiua-5738	46	111	after	after	ADP
aiua-5738	46	112	the	the	DET
aiua-5738	46	113	suspension	suspension	NOUN
aiua-5738	46	114	of	of	ADP
aiua-5738	46	115	the	the	DET
aiua-5738	46	116	treatment	treatment	NOUN
aiua-5738	46	117	(	(	PUNCT
aiua-5738	46	118	23	23	NUM
aiua-5738	46	119	)	)	PUNCT
aiua-5738	46	120	•	•	NOUN
aiua-5738	46	121	59	59	NUM
aiua-5738	46	122	%	%	NOUN
aiua-5738	46	123	of	of	ADP
aiua-5738	46	124	patients	patient	NOUN
aiua-5738	46	125	treated	treat	VERB
aiua-5738	46	126	with	with	ADP
aiua-5738	46	127	placebo	placebo	NOUN
aiua-5738	46	128	said	say	VERB
aiua-5738	46	129	the	the	DET
aiua-5738	46	130	sd	sd	NOUN
aiua-5738	46	131	persisted	persist	VERB
aiua-5738	46	132	after	after	ADP
aiua-5738	46	133	the	the	DET
aiua-5738	46	134	suspension	suspension	NOUN
aiua-5738	46	135	of	of	ADP
aiua-5738	46	136	the	the	DET
aiua-5738	46	137	treatment	treatment	NOUN
aiua-5738	46	138	(	(	PUNCT
aiua-5738	46	139	23	23	NUM
aiua-5738	46	140	)	)	PUNCT
aiua-5738	46	141	to	to	PART
aiua-5738	46	142	conclude	conclude	VERB
aiua-5738	46	143	,	,	PUNCT
aiua-5738	46	144	on	on	ADP
aiua-5738	46	145	the	the	DET
aiua-5738	46	146	subject	subject	NOUN
aiua-5738	46	147	of	of	ADP
aiua-5738	46	148	sexual	sexual	ADJ
aiua-5738	46	149	adverse	adverse	ADJ
aiua-5738	46	150	events	event	NOUN
aiua-5738	46	151	,	,	PUNCT
aiua-5738	46	152	the	the	DET
aiua-5738	46	153	results	result	NOUN
aiua-5738	46	154	of	of	ADP
aiua-5738	46	155	this	this	DET
aiua-5738	46	156	study	study	NOUN
aiua-5738	46	157	can	can	AUX
aiua-5738	46	158	be	be	AUX
aiua-5738	46	159	summarised	summarise	VERB
aiua-5738	46	160	by	by	ADP
aiua-5738	46	161	stating	state	VERB
aiua-5738	46	162	that	that	SCONJ
aiua-5738	46	163	there	there	PRON
aiua-5738	46	164	is	be	VERB
aiua-5738	46	165	a	a	DET
aiua-5738	46	166	low	low	ADJ
aiua-5738	46	167	and	and	CCONJ
aiua-5738	46	168	equivalent	equivalent	ADJ
aiua-5738	46	169	prevalence	prevalence	NOUN
aiua-5738	46	170	of	of	ADP
aiua-5738	46	171	adverse	adverse	ADJ
aiua-5738	46	172	events	event	NOUN
aiua-5738	46	173	at	at	ADP
aiua-5738	46	174	2	2	NUM
aiua-5738	46	175	-	-	SYM
aiua-5738	46	176	4	4	NUM
aiua-5738	46	177	years	year	NOUN
aiua-5738	46	178	with	with	ADP
aiua-5738	46	179	both	both	CCONJ
aiua-5738	46	180	finasteride	finasteride	ADJ
aiua-5738	46	181	and	and	CCONJ
aiua-5738	46	182	placebo	placebo	NOUN
aiua-5738	46	183	,	,	PUNCT
aiua-5738	46	184	and	and	CCONJ
aiua-5738	46	185	that	that	SCONJ
aiua-5738	46	186	59	59	NUM
aiua-5738	46	187	%	%	NOUN
aiua-5738	46	188	of	of	ADP
aiua-5738	46	189	patients	patient	NOUN
aiua-5738	46	190	treated	treat	VERB
aiua-5738	46	191	with	with	ADP
aiua-5738	46	192	placebo	placebo	NOUN
aiua-5738	46	193	who	who	PRON
aiua-5738	46	194	suspended	suspend	VERB
aiua-5738	46	195	use	use	NOUN
aiua-5738	46	196	due	due	ADP
aiua-5738	46	197	to	to	ADP
aiua-5738	46	198	sexual	sexual	ADJ
aiua-5738	46	199	adverse	adverse	ADJ
aiua-5738	46	200	events	event	NOUN
aiua-5738	46	201	,	,	PUNCT
aiua-5738	46	202	reported	report	VERB
aiua-5738	46	203	persistent	persistent	ADJ
aiua-5738	46	204	sexual	sexual	ADJ
aiua-5738	46	205	dysfunction	dysfunction	NOUN
aiua-5738	46	206	(	(	PUNCT
aiua-5738	46	207	23	23	NUM
aiua-5738	46	208	)	)	PUNCT
aiua-5738	46	209	.	.	PUNCT
aiua-5738	47	1	the	the	DET
aiua-5738	47	2	“	"	PUNCT
aiua-5738	47	3	nocebo	nocebo	NOUN
aiua-5738	47	4	”	"	PUNCT
aiua-5738	47	5	effect	effect	NOUN
aiua-5738	47	6	of	of	ADP
aiua-5738	47	7	treatment	treatment	NOUN
aiua-5738	47	8	with	with	ADP
aiua-5738	47	9	5a	5a	NUM
aiua-5738	47	10	-	-	PUNCT
aiua-5738	47	11	r	r	NOUN
aiua-5738	47	12	inhibitors	inhibitor	NOUN
aiua-5738	47	13	the	the	DET
aiua-5738	47	14	numerous	numerous	ADJ
aiua-5738	47	15	contradictions	contradiction	NOUN
aiua-5738	47	16	that	that	PRON
aiua-5738	47	17	emerge	emerge	VERB
aiua-5738	47	18	from	from	ADP
aiua-5738	47	19	recent	recent	ADJ
aiua-5738	47	20	literature	literature	NOUN
aiua-5738	47	21	concerning	concern	VERB
aiua-5738	47	22	the	the	DET
aiua-5738	47	23	presumed	presume	VERB
aiua-5738	47	24	sexual	sexual	ADJ
aiua-5738	47	25	repercussions	repercussion	NOUN
aiua-5738	47	26	observed	observe	VERB
aiua-5738	47	27	in	in	ADP
aiua-5738	47	28	certain	certain	ADJ
aiua-5738	47	29	groups	group	NOUN
aiua-5738	47	30	of	of	ADP
aiua-5738	47	31	patients	patient	NOUN
aiua-5738	47	32	treated	treat	VERB
aiua-5738	47	33	with	with	ADP
aiua-5738	47	34	5aris	5aris	NUM
aiua-5738	47	35	,	,	PUNCT
aiua-5738	47	36	arouse	arouse	VERB
aiua-5738	47	37	doubts	doubt	NOUN
aiua-5738	47	38	as	as	ADP
aiua-5738	47	39	to	to	ADP
aiua-5738	47	40	the	the	DET
aiua-5738	47	41	methods	method	NOUN
aiua-5738	47	42	used	use	VERB
aiua-5738	47	43	to	to	PART
aiua-5738	47	44	investigate	investigate	VERB
aiua-5738	47	45	the	the	DET
aiua-5738	47	46	parameters	parameter	NOUN
aiua-5738	47	47	of	of	ADP
aiua-5738	47	48	sexual	sexual	ADJ
aiua-5738	47	49	health	health	NOUN
aiua-5738	47	50	in	in	ADP
aiua-5738	47	51	patients	patient	NOUN
aiua-5738	47	52	eligible	eligible	ADJ
aiua-5738	47	53	for	for	ADP
aiua-5738	47	54	treatment	treatment	NOUN
aiua-5738	47	55	with	with	ADP
aiua-5738	47	56	5a	5a	NUM
aiua-5738	47	57	-	-	PUNCT
aiua-5738	47	58	ris	ris	NOUN
aiua-5738	47	59	.	.	PUNCT
aiua-5738	48	1	specifically	specifically	ADV
aiua-5738	48	2	,	,	PUNCT
aiua-5738	48	3	this	this	PRON
aiua-5738	48	4	applies	apply	VERB
aiua-5738	48	5	for	for	ADP
aiua-5738	48	6	an	an	DET
aiua-5738	48	7	adequate	adequate	ADJ
aiua-5738	48	8	definition	definition	NOUN
aiua-5738	48	9	of	of	ADP
aiua-5738	48	10	the	the	DET
aiua-5738	48	11	parameters	parameter	NOUN
aiua-5738	48	12	of	of	ADP
aiua-5738	48	13	sexual	sexual	ADJ
aiua-5738	48	14	health	health	NOUN
aiua-5738	48	15	(	(	PUNCT
aiua-5738	48	16	libido	libido	NOUN
aiua-5738	48	17	,	,	PUNCT
aiua-5738	48	18	erection	erection	NOUN
aiua-5738	48	19	,	,	PUNCT
aiua-5738	48	20	ejaculation	ejaculation	NOUN
aiua-5738	48	21	)	)	PUNCT
aiua-5738	48	22	immediately	immediately	ADV
aiua-5738	48	23	prior	prior	ADV
aiua-5738	48	24	to	to	ADP
aiua-5738	48	25	the	the	DET
aiua-5738	48	26	start	start	NOUN
aiua-5738	48	27	of	of	ADP
aiua-5738	48	28	treatment	treatment	NOUN
aiua-5738	48	29	with	with	ADP
aiua-5738	48	30	5a	5a	NUM
aiua-5738	48	31	-	-	PUNCT
aiua-5738	48	32	ris	ris	PROPN
aiua-5738	48	33	.	.	PUNCT
aiua-5738	49	1	archivio	archivio	NOUN
aiua-5738	49	2	italiano	italiano	PROPN
aiua-5738	49	3	di	di	X
aiua-5738	49	4	urologia	urologia	PROPN
aiua-5738	49	5	e	e	PROPN
aiua-5738	49	6	andrologia	andrologia	NOUN
aiua-5738	49	7	2015	2015	NUM
aiua-5738	49	8	;	;	PUNCT
aiua-5738	49	9	87	87	NUM
aiua-5738	49	10	,	,	PUNCT
aiua-5738	49	11	4	4	NUM
aiua-5738	49	12	f.	f.	PROPN
aiua-5738	49	13	pirozzi	pirozzi	PROPN
aiua-5738	49	14	farina	farina	PROPN
aiua-5738	49	15	,	,	PUNCT
aiua-5738	49	16	a.	a.	NOUN
aiua-5738	49	17	pischedda	pischedda	PROPN
aiua-5738	49	18	314	314	NUM
aiua-5738	49	19	moreover	moreover	ADV
aiua-5738	49	20	,	,	PUNCT
aiua-5738	49	21	the	the	DET
aiua-5738	49	22	sexual	sexual	ADJ
aiua-5738	49	23	medicine	medicine	NOUN
aiua-5738	49	24	society	society	NOUN
aiua-5738	49	25	of	of	ADP
aiua-5738	49	26	north	north	PROPN
aiua-5738	49	27	america	america	PROPN
aiua-5738	49	28	has	have	AUX
aiua-5738	49	29	reported	report	VERB
aiua-5738	49	30	that	that	SCONJ
aiua-5738	49	31	treatment	treatment	NOUN
aiua-5738	49	32	with	with	ADP
aiua-5738	49	33	5a	5a	NUM
aiua-5738	49	34	-	-	PUNCT
aiua-5738	49	35	ris	ris	PROPN
aiua-5738	49	36	is	be	AUX
aiua-5738	49	37	associated	associate	VERB
aiua-5738	49	38	with	with	ADP
aiua-5738	49	39	sexual	sexual	ADJ
aiua-5738	49	40	side	side	NOUN
aiua-5738	49	41	effects	effect	NOUN
aiua-5738	49	42	that	that	PRON
aiua-5738	49	43	can	can	AUX
aiua-5738	49	44	persist	persist	VERB
aiua-5738	49	45	even	even	ADV
aiua-5738	49	46	after	after	ADP
aiua-5738	49	47	the	the	DET
aiua-5738	49	48	discontinuation	discontinuation	NOUN
aiua-5738	49	49	of	of	ADP
aiua-5738	49	50	the	the	DET
aiua-5738	49	51	treatment	treatment	NOUN
aiua-5738	49	52	;	;	PUNCT
aiua-5738	49	53	however	however	ADV
aiua-5738	49	54	,	,	PUNCT
aiua-5738	49	55	it	it	PRON
aiua-5738	49	56	specifies	specify	VERB
aiua-5738	49	57	that	that	SCONJ
aiua-5738	49	58	,	,	PUNCT
aiua-5738	49	59	at	at	ADP
aiua-5738	49	60	the	the	DET
aiua-5738	49	61	current	current	ADJ
aiua-5738	49	62	time	time	NOUN
aiua-5738	49	63	,	,	PUNCT
aiua-5738	49	64	there	there	PRON
aiua-5738	49	65	are	be	VERB
aiua-5738	49	66	no	no	DET
aiua-5738	49	67	proven	prove	VERB
aiua-5738	49	68	causal	causal	ADJ
aiua-5738	49	69	connections	connection	NOUN
aiua-5738	49	70	between	between	ADP
aiua-5738	49	71	5a	5a	NUM
aiua-5738	49	72	-	-	PUNCT
aiua-5738	49	73	ris	ris	NOUN
aiua-5738	49	74	and	and	CCONJ
aiua-5738	49	75	the	the	DET
aiua-5738	49	76	symptoms	symptom	NOUN
aiua-5738	49	77	of	of	ADP
aiua-5738	49	78	sexual	sexual	ADJ
aiua-5738	49	79	dysfunction	dysfunction	NOUN
aiua-5738	49	80	reported	report	VERB
aiua-5738	49	81	by	by	ADP
aiua-5738	49	82	patients	patient	NOUN
aiua-5738	49	83	,	,	PUNCT
aiua-5738	49	84	and	and	CCONJ
aiua-5738	49	85	therefore	therefore	ADV
aiua-5738	49	86	further	further	ADJ
aiua-5738	49	87	studies	study	NOUN
aiua-5738	49	88	on	on	ADP
aiua-5738	49	89	the	the	DET
aiua-5738	49	90	matter	matter	NOUN
aiua-5738	49	91	are	be	AUX
aiua-5738	49	92	required	require	VERB
aiua-5738	49	93	(	(	PUNCT
aiua-5738	49	94	24	24	NUM
aiua-5738	49	95	)	)	PUNCT
aiua-5738	49	96	.	.	PUNCT
aiua-5738	50	1	this	this	PRON
aiua-5738	50	2	suggests	suggest	VERB
aiua-5738	50	3	that	that	SCONJ
aiua-5738	50	4	doctors	doctor	NOUN
aiua-5738	50	5	could	could	AUX
aiua-5738	50	6	perceive	perceive	VERB
aiua-5738	50	7	a	a	DET
aiua-5738	50	8	greater	great	ADJ
aiua-5738	50	9	incidence	incidence	NOUN
aiua-5738	50	10	of	of	ADP
aiua-5738	50	11	sexual	sexual	ADJ
aiua-5738	50	12	adverse	adverse	ADJ
aiua-5738	50	13	events	event	NOUN
aiua-5738	50	14	in	in	ADP
aiua-5738	50	15	clinical	clinical	ADJ
aiua-5738	50	16	practice	practice	NOUN
aiua-5738	50	17	than	than	SCONJ
aiua-5738	50	18	observed	observe	VERB
aiua-5738	50	19	during	during	ADP
aiua-5738	50	20	clinical	clinical	ADJ
aiua-5738	50	21	trials	trial	NOUN
aiua-5738	50	22	,	,	PUNCT
aiua-5738	50	23	although	although	SCONJ
aiua-5738	50	24	there	there	PRON
aiua-5738	50	25	is	be	VERB
aiua-5738	50	26	currently	currently	ADV
aiua-5738	50	27	no	no	DET
aiua-5738	50	28	objective	objective	ADJ
aiua-5738	50	29	evidence	evidence	NOUN
aiua-5738	50	30	of	of	ADP
aiua-5738	50	31	this	this	DET
aiua-5738	50	32	greater	great	ADJ
aiua-5738	50	33	incidence	incidence	NOUN
aiua-5738	50	34	.	.	PUNCT
aiua-5738	51	1	moreover	moreover	ADV
aiua-5738	51	2	,	,	PUNCT
aiua-5738	51	3	a	a	DET
aiua-5738	51	4	potential	potential	ADJ
aiua-5738	51	5	“	"	PUNCT
aiua-5738	51	6	nocebo	nocebo	NOUN
aiua-5738	51	7	effect	effect	NOUN
aiua-5738	51	8	”	"	PUNCT
aiua-5738	51	9	has	have	AUX
aiua-5738	51	10	been	be	AUX
aiua-5738	51	11	proven	prove	VERB
aiua-5738	51	12	that	that	PRON
aiua-5738	51	13	could	could	AUX
aiua-5738	51	14	be	be	AUX
aiua-5738	51	15	attributed	attribute	VERB
aiua-5738	51	16	to	to	ADP
aiua-5738	51	17	the	the	DET
aiua-5738	51	18	ways	way	NOUN
aiua-5738	51	19	in	in	ADP
aiua-5738	51	20	which	which	PRON
aiua-5738	51	21	patients	patient	NOUN
aiua-5738	51	22	are	be	AUX
aiua-5738	51	23	informed	inform	VERB
aiua-5738	51	24	about	about	ADP
aiua-5738	51	25	the	the	DET
aiua-5738	51	26	use	use	NOUN
aiua-5738	51	27	of	of	ADP
aiua-5738	51	28	5a	5a	NUM
aiua-5738	51	29	-	-	PUNCT
aiua-5738	51	30	ris	ris	NOUN
aiua-5738	51	31	.	.	PUNCT
aiua-5738	52	1	to	to	PART
aiua-5738	52	2	investigate	investigate	VERB
aiua-5738	52	3	this	this	PRON
aiua-5738	52	4	,	,	PUNCT
aiua-5738	52	5	mondaini	mondaini	PROPN
aiua-5738	52	6	n	n	CCONJ
aiua-5738	52	7	,	,	PUNCT
aiua-5738	52	8	et	et	PROPN
aiua-5738	52	9	al	al	PROPN
aiua-5738	52	10	.	.	PUNCT
aiua-5738	53	1	(	(	PUNCT
aiua-5738	53	2	2007	2007	NUM
aiua-5738	53	3	)	)	PUNCT
aiua-5738	53	4	studied	study	VERB
aiua-5738	53	5	120	120	NUM
aiua-5738	53	6	patients	patient	NOUN
aiua-5738	53	7	with	with	ADP
aiua-5738	53	8	bph	bph	NOUN
aiua-5738	53	9	and	and	CCONJ
aiua-5738	53	10	iief	iief	ADJ
aiua-5738	53	11	-	-	PUNCT
aiua-5738	53	12	ef	ef	NOUN
aiua-5738	53	13	score	score	NOUN
aiua-5738	53	14	≥	≥	PROPN
aiua-5738	53	15	25	25	NUM
aiua-5738	53	16	treated	treat	VERB
aiua-5738	53	17	for	for	ADP
aiua-5738	53	18	one	one	NUM
aiua-5738	53	19	year	year	NOUN
aiua-5738	53	20	with	with	ADP
aiua-5738	53	21	5	5	NUM
aiua-5738	53	22	mg	mg	NOUN
aiua-5738	53	23	of	of	ADP
aiua-5738	53	24	finasteride	finasteride	ADV
aiua-5738	53	25	,	,	PUNCT
aiua-5738	53	26	masked	mask	VERB
aiua-5738	53	27	as	as	ADP
aiua-5738	53	28	“	"	PUNCT
aiua-5738	53	29	compound	compound	NOUN
aiua-5738	53	30	x	x	PUNCT
aiua-5738	53	31	with	with	ADP
aiua-5738	53	32	proven	prove	VERB
aiua-5738	53	33	efficacy	efficacy	NOUN
aiua-5738	53	34	for	for	ADP
aiua-5738	53	35	the	the	DET
aiua-5738	53	36	treatment	treatment	NOUN
aiua-5738	53	37	of	of	ADP
aiua-5738	53	38	bph	bph	NOUN
aiua-5738	53	39	”	"	PUNCT
aiua-5738	53	40	.	.	PUNCT
aiua-5738	54	1	patients	patient	NOUN
aiua-5738	54	2	were	be	AUX
aiua-5738	54	3	assigned	assign	VERB
aiua-5738	54	4	to	to	ADP
aiua-5738	54	5	two	two	NUM
aiua-5738	54	6	groups	group	NOUN
aiua-5738	54	7	(	(	PUNCT
aiua-5738	54	8	26	26	NUM
aiua-5738	54	9	)	)	PUNCT
aiua-5738	54	10	.	.	PUNCT
aiua-5738	55	1	those	those	PRON
aiua-5738	55	2	in	in	ADP
aiua-5738	55	3	group	group	NOUN
aiua-5738	55	4	1	1	NUM
aiua-5738	55	5	did	do	AUX
aiua-5738	55	6	not	not	PART
aiua-5738	55	7	received	receive	VERB
aiua-5738	55	8	information	information	NOUN
aiua-5738	55	9	about	about	ADP
aiua-5738	55	10	the	the	DET
aiua-5738	55	11	possible	possible	ADJ
aiua-5738	55	12	sexual	sexual	ADJ
aiua-5738	55	13	repercussions	repercussion	NOUN
aiua-5738	55	14	of	of	ADP
aiua-5738	55	15	the	the	DET
aiua-5738	55	16	drug	drug	NOUN
aiua-5738	55	17	;	;	PUNCT
aiua-5738	55	18	patients	patient	NOUN
aiua-5738	55	19	in	in	ADP
aiua-5738	55	20	group	group	NOUN
aiua-5738	55	21	2	2	NUM
aiua-5738	55	22	,	,	PUNCT
aiua-5738	55	23	on	on	ADP
aiua-5738	55	24	the	the	DET
aiua-5738	55	25	other	other	ADJ
aiua-5738	55	26	hand	hand	NOUN
aiua-5738	55	27	,	,	PUNCT
aiua-5738	55	28	were	be	AUX
aiua-5738	55	29	provided	provide	VERB
aiua-5738	55	30	with	with	ADP
aiua-5738	55	31	the	the	DET
aiua-5738	55	32	following	follow	VERB
aiua-5738	55	33	information	information	NOUN
aiua-5738	55	34	:	:	PUNCT
aiua-5738	55	35	“	"	PUNCT
aiua-5738	55	36	...	...	PUNCT
aiua-5738	55	37	may	may	AUX
aiua-5738	55	38	cause	cause	VERB
aiua-5738	55	39	erectile	erectile	ADJ
aiua-5738	55	40	dysfunction	dysfunction	NOUN
aiua-5738	55	41	,	,	PUNCT
aiua-5738	55	42	loss	loss	NOUN
aiua-5738	55	43	of	of	ADP
aiua-5738	55	44	libido	libido	NOUN
aiua-5738	55	45	and	and	CCONJ
aiua-5738	55	46	ejaculation	ejaculation	NOUN
aiua-5738	55	47	disorders	disorder	NOUN
aiua-5738	55	48	,	,	PUNCT
aiua-5738	55	49	however	however	ADV
aiua-5738	55	50	these	these	PRON
aiua-5738	55	51	are	be	AUX
aiua-5738	55	52	not	not	PART
aiua-5738	55	53	common	common	ADJ
aiua-5738	55	54	’	'	PUNCT
aiua-5738	55	55	.	.	PUNCT
aiua-5738	56	1	(	(	PUNCT
aiua-5738	56	2	26	26	NUM
aiua-5738	56	3	)	)	PUNCT
aiua-5738	56	4	all	all	DET
aiua-5738	56	5	the	the	DET
aiua-5738	56	6	patients	patient	NOUN
aiua-5738	56	7	were	be	AUX
aiua-5738	56	8	evaluated	evaluate	VERB
aiua-5738	56	9	at	at	ADP
aiua-5738	56	10	6	6	NUM
aiua-5738	56	11	and	and	CCONJ
aiua-5738	56	12	12	12	NUM
aiua-5738	56	13	months	month	NOUN
aiua-5738	56	14	using	use	VERB
aiua-5738	56	15	the	the	DET
aiua-5738	56	16	male	male	ADJ
aiua-5738	56	17	sexual	sexual	ADJ
aiua-5738	56	18	function	function	NOUN
aiua-5738	56	19	questionnaire	questionnaire	NOUN
aiua-5738	56	20	-4	-4	PUNCT
aiua-5738	56	21	(	(	PUNCT
aiua-5738	56	22	msf4	msf4	PROPN
aiua-5738	56	23	)	)	PUNCT
aiua-5738	56	24	.	.	PUNCT
aiua-5738	57	1	the	the	DET
aiua-5738	57	2	authors	author	NOUN
aiua-5738	57	3	’	’	PART
aiua-5738	57	4	results	result	NOUN
aiua-5738	57	5	are	be	AUX
aiua-5738	57	6	provided	provide	VERB
aiua-5738	57	7	below	below	ADP
aiua-5738	57	8	(	(	PUNCT
aiua-5738	57	9	table1	table1	PROPN
aiua-5738	57	10	)	)	PUNCT
aiua-5738	57	11	(	(	PUNCT
aiua-5738	57	12	26	26	NUM
aiua-5738	57	13	)	)	PUNCT
aiua-5738	57	14	.	.	PUNCT
aiua-5738	58	1	on	on	ADP
aiua-5738	58	2	the	the	DET
aiua-5738	58	3	basis	basis	NOUN
aiua-5738	58	4	of	of	ADP
aiua-5738	58	5	these	these	DET
aiua-5738	58	6	results	result	NOUN
aiua-5738	58	7	,	,	PUNCT
aiua-5738	58	8	the	the	DET
aiua-5738	58	9	authors	author	NOUN
aiua-5738	58	10	concluded	conclude	VERB
aiua-5738	58	11	that	that	SCONJ
aiua-5738	58	12	patients	patient	NOUN
aiua-5738	58	13	in	in	ADP
aiua-5738	58	14	group	group	NOUN
aiua-5738	58	15	2	2	NUM
aiua-5738	58	16	simulate	simulate	VERB
aiua-5738	58	17	the	the	DET
aiua-5738	58	18	side	side	NOUN
aiua-5738	58	19	effects	effect	NOUN
aiua-5738	58	20	indicated	indicate	VERB
aiua-5738	58	21	in	in	ADP
aiua-5738	58	22	medical	medical	ADJ
aiua-5738	58	23	information	information	NOUN
aiua-5738	58	24	and	and	CCONJ
aiua-5738	58	25	in	in	ADP
aiua-5738	58	26	the	the	DET
aiua-5738	58	27	information	information	NOUN
aiua-5738	58	28	leaflet	leaflet	NOUN
aiua-5738	58	29	,	,	PUNCT
aiua-5738	58	30	which	which	PRON
aiua-5738	58	31	would	would	AUX
aiua-5738	58	32	suggest	suggest	VERB
aiua-5738	58	33	that	that	SCONJ
aiua-5738	58	34	the	the	DET
aiua-5738	58	35	information	information	NOUN
aiua-5738	58	36	/	/	SYM
aiua-5738	58	37	illustration	illustration	NOUN
aiua-5738	58	38	has	have	VERB
aiua-5738	58	39	a	a	DET
aiua-5738	58	40	nocebo	nocebo	NOUN
aiua-5738	58	41	effect	effect	NOUN
aiua-5738	58	42	(	(	PUNCT
aiua-5738	58	43	26	26	NUM
aiua-5738	58	44	)	)	PUNCT
aiua-5738	58	45	.	.	PUNCT
aiua-5738	59	1	how	how	SCONJ
aiua-5738	59	2	to	to	PART
aiua-5738	59	3	optimise	optimise	VERB
aiua-5738	59	4	the	the	DET
aiua-5738	59	5	medical	medical	ADJ
aiua-5738	59	6	treatment	treatment	NOUN
aiua-5738	59	7	of	of	ADP
aiua-5738	59	8	bph	bph	NOUN
aiua-5738	59	9	and	and	CCONJ
aiua-5738	59	10	of	of	ADP
aiua-5738	59	11	the	the	DET
aiua-5738	59	12	related	related	ADJ
aiua-5738	59	13	urinary	urinary	ADJ
aiua-5738	59	14	symptoms	symptom	NOUN
aiua-5738	59	15	at	at	ADP
aiua-5738	59	16	the	the	DET
aiua-5738	59	17	current	current	ADJ
aiua-5738	59	18	time	time	NOUN
aiua-5738	59	19	,	,	PUNCT
aiua-5738	59	20	the	the	DET
aiua-5738	59	21	optimisation	optimisation	NOUN
aiua-5738	59	22	of	of	ADP
aiua-5738	59	23	medical	medical	ADJ
aiua-5738	59	24	treatment	treatment	NOUN
aiua-5738	59	25	for	for	ADP
aiua-5738	59	26	lower	low	ADJ
aiua-5738	59	27	urinary	urinary	ADJ
aiua-5738	59	28	tract	tract	NOUN
aiua-5738	59	29	symptoms	symptom	NOUN
aiua-5738	59	30	secondary	secondary	ADJ
aiua-5738	59	31	to	to	ADP
aiua-5738	59	32	bph	bph	NOUN
aiua-5738	59	33	consists	consist	VERB
aiua-5738	59	34	in	in	ADP
aiua-5738	59	35	knowing	know	VERB
aiua-5738	59	36	how	how	SCONJ
aiua-5738	59	37	to	to	PART
aiua-5738	59	38	create	create	VERB
aiua-5738	59	39	the	the	DET
aiua-5738	59	40	most	most	ADV
aiua-5738	59	41	individualised	individualised	ADJ
aiua-5738	59	42	treatment	treatment	NOUN
aiua-5738	59	43	plan	plan	NOUN
aiua-5738	59	44	possible	possible	ADJ
aiua-5738	59	45	.	.	PUNCT
aiua-5738	60	1	this	this	PRON
aiua-5738	60	2	means	mean	VERB
aiua-5738	60	3	setting	set	VERB
aiua-5738	60	4	oneself	oneself	PRON
aiua-5738	60	5	the	the	DET
aiua-5738	60	6	following	follow	VERB
aiua-5738	60	7	objectives	objective	NOUN
aiua-5738	60	8	:	:	PUNCT
aiua-5738	60	9	minimising	minimise	VERB
aiua-5738	60	10	dysuria	dysuria	ADJ
aiua-5738	60	11	symptoms	symptom	NOUN
aiua-5738	60	12	;	;	PUNCT
aiua-5738	60	13	stopping	stop	VERB
aiua-5738	60	14	or	or	CCONJ
aiua-5738	60	15	slowing	slow	VERB
aiua-5738	60	16	bph	bph	NOUN
aiua-5738	60	17	when	when	SCONJ
aiua-5738	60	18	at	at	ADP
aiua-5738	60	19	high	high	ADJ
aiua-5738	60	20	risk	risk	NOUN
aiua-5738	60	21	of	of	ADP
aiua-5738	60	22	progression	progression	NOUN
aiua-5738	60	23	,	,	PUNCT
aiua-5738	60	24	avoiding	avoid	VERB
aiua-5738	60	25	or	or	CCONJ
aiua-5738	60	26	delaying	delay	VERB
aiua-5738	60	27	the	the	DET
aiua-5738	60	28	surgical	surgical	ADJ
aiua-5738	60	29	solution	solution	NOUN
aiua-5738	60	30	;	;	PUNCT
aiua-5738	60	31	safeguarding	safeguard	VERB
aiua-5738	60	32	the	the	DET
aiua-5738	60	33	patient	patient	NOUN
aiua-5738	60	34	’s	’s	PART
aiua-5738	60	35	sexual	sexual	ADJ
aiua-5738	60	36	health	health	NOUN
aiua-5738	60	37	in	in	ADP
aiua-5738	60	38	the	the	DET
aiua-5738	60	39	best	good	ADJ
aiua-5738	60	40	way	way	NOUN
aiua-5738	60	41	possible	possible	ADJ
aiua-5738	60	42	;	;	PUNCT
aiua-5738	60	43	as	as	ADV
aiua-5738	60	44	far	far	ADV
aiua-5738	60	45	as	as	ADP
aiua-5738	60	46	possible	possible	ADJ
aiua-5738	60	47	following	follow	VERB
aiua-5738	60	48	the	the	DET
aiua-5738	60	49	wishes	wish	NOUN
aiua-5738	60	50	of	of	ADP
aiua-5738	60	51	the	the	DET
aiua-5738	60	52	patient	patient	NOUN
aiua-5738	60	53	,	,	PUNCT
aiua-5738	60	54	who	who	PRON
aiua-5738	60	55	must	must	AUX
aiua-5738	60	56	in	in	ADP
aiua-5738	60	57	any	any	DET
aiua-5738	60	58	case	case	NOUN
aiua-5738	60	59	receive	receive	VERB
aiua-5738	60	60	comprehensible	comprehensible	ADJ
aiua-5738	60	61	information	information	NOUN
aiua-5738	60	62	on	on	ADP
aiua-5738	60	63	the	the	DET
aiua-5738	60	64	mechanism	mechanism	NOUN
aiua-5738	60	65	of	of	ADP
aiua-5738	60	66	action	action	NOUN
aiua-5738	60	67	of	of	ADP
aiua-5738	60	68	the	the	DET
aiua-5738	60	69	drugs	drug	NOUN
aiua-5738	60	70	suggested	suggest	VERB
aiua-5738	60	71	,	,	PUNCT
aiua-5738	60	72	the	the	DET
aiua-5738	60	73	incidence	incidence	NOUN
aiua-5738	60	74	of	of	ADP
aiua-5738	60	75	any	any	DET
aiua-5738	60	76	events	event	NOUN
aiua-5738	60	77	that	that	PRON
aiua-5738	60	78	can	can	AUX
aiua-5738	60	79	be	be	AUX
aiua-5738	60	80	attributed	attribute	VERB
aiua-5738	60	81	to	to	ADP
aiua-5738	60	82	the	the	DET
aiua-5738	60	83	various	various	ADJ
aiua-5738	60	84	therapies	therapy	NOUN
aiua-5738	60	85	and	and	CCONJ
aiua-5738	60	86	their	their	PRON
aiua-5738	60	87	reversibility	reversibility	NOUN
aiua-5738	60	88	before	before	ADP
aiua-5738	60	89	starting	start	VERB
aiua-5738	60	90	treatment	treatment	NOUN
aiua-5738	60	91	.	.	PUNCT
aiua-5738	61	1	on	on	ADP
aiua-5738	61	2	this	this	DET
aiua-5738	61	3	basis	basis	NOUN
aiua-5738	61	4	,	,	PUNCT
aiua-5738	61	5	at	at	ADV
aiua-5738	61	6	least	least	ADV
aiua-5738	61	7	three	three	NUM
aiua-5738	61	8	main	main	ADJ
aiua-5738	61	9	patient	patient	NOUN
aiua-5738	61	10	classes	class	NOUN
aiua-5738	61	11	can	can	AUX
aiua-5738	61	12	be	be	AUX
aiua-5738	61	13	summarised	summarise	VERB
aiua-5738	61	14	:	:	PUNCT
aiua-5738	61	15	patients	patient	NOUN
aiua-5738	61	16	with	with	ADP
aiua-5738	61	17	bph	bph	NOUN
aiua-5738	61	18	-	-	PUNCT
aiua-5738	61	19	related	relate	VERB
aiua-5738	61	20	lower	low	ADJ
aiua-5738	61	21	urinary	urinary	ADJ
aiua-5738	61	22	tract	tract	NOUN
aiua-5738	61	23	symptoms	symptom	NOUN
aiua-5738	61	24	at	at	ADP
aiua-5738	61	25	low	low	ADJ
aiua-5738	61	26	risk	risk	NOUN
aiua-5738	61	27	of	of	ADP
aiua-5738	61	28	progression	progression	NOUN
aiua-5738	61	29	.	.	PUNCT
aiua-5738	62	1	in	in	ADP
aiua-5738	62	2	this	this	DET
aiua-5738	62	3	type	type	NOUN
aiua-5738	62	4	of	of	ADP
aiua-5738	62	5	patient	patient	NOUN
aiua-5738	62	6	,	,	PUNCT
aiua-5738	62	7	a	a	DET
aiua-5738	62	8	first	first	ADJ
aiua-5738	62	9	therapeutic	therapeutic	ADJ
aiua-5738	62	10	approach	approach	NOUN
aiua-5738	62	11	could	could	AUX
aiua-5738	62	12	be	be	AUX
aiua-5738	62	13	a1a	a1a	ADJ
aiua-5738	62	14	adrenergic	adrenergic	ADJ
aiua-5738	62	15	blocker	blocker	NOUN
aiua-5738	62	16	monotherapy	monotherapy	NOUN
aiua-5738	62	17	when	when	SCONJ
aiua-5738	62	18	the	the	DET
aiua-5738	62	19	urinary	urinary	ADJ
aiua-5738	62	20	symptoms	symptom	NOUN
aiua-5738	62	21	are	be	AUX
aiua-5738	62	22	not	not	PART
aiua-5738	62	23	associated	associate	VERB
aiua-5738	62	24	with	with	ADP
aiua-5738	62	25	pre	pre	ADJ
aiua-5738	62	26	-	-	ADJ
aiua-5738	62	27	existent	existent	ADJ
aiua-5738	62	28	erectile	erectile	NOUN
aiua-5738	62	29	dysfunction	dysfunction	NOUN
aiua-5738	62	30	(	(	PUNCT
aiua-5738	62	31	ed	ed	NOUN
aiua-5738	62	32	)	)	PUNCT
aiua-5738	62	33	.	.	PUNCT
aiua-5738	63	1	otherwise	otherwise	ADV
aiua-5738	63	2	,	,	PUNCT
aiua-5738	63	3	it	it	PRON
aiua-5738	63	4	is	be	AUX
aiua-5738	63	5	possible	possible	ADJ
aiua-5738	63	6	to	to	PART
aiua-5738	63	7	suggest	suggest	VERB
aiua-5738	63	8	treatment	treatment	NOUN
aiua-5738	63	9	with	with	ADP
aiua-5738	63	10	the	the	DET
aiua-5738	63	11	pde5	pde5	NOUN
aiua-5738	63	12	-	-	PUNCT
aiua-5738	63	13	inhibitor	inhibitor	NOUN
aiua-5738	63	14	tadalafil	tadalafil	NOUN
aiua-5738	63	15	5	5	NUM
aiua-5738	63	16	mg	mg	NOUN
aiua-5738	63	17	once	once	ADV
aiua-5738	63	18	daily	daily	ADV
aiua-5738	63	19	,	,	PUNCT
aiua-5738	63	20	a	a	DET
aiua-5738	63	21	treatment	treatment	NOUN
aiua-5738	63	22	regimen	regimen	NOUN
aiua-5738	63	23	approved	approve	VERB
aiua-5738	63	24	for	for	ADP
aiua-5738	63	25	patients	patient	NOUN
aiua-5738	63	26	with	with	ADP
aiua-5738	63	27	bph	bph	NOUN
aiua-5738	63	28	with	with	ADP
aiua-5738	63	29	obstructive	obstructive	ADJ
aiua-5738	63	30	symptoms	symptom	NOUN
aiua-5738	63	31	of	of	ADP
aiua-5738	63	32	the	the	DET
aiua-5738	63	33	lower	low	ADJ
aiua-5738	63	34	urinary	urinary	ADJ
aiua-5738	63	35	tract	tract	NOUN
aiua-5738	63	36	,	,	PUNCT
aiua-5738	63	37	with	with	ADP
aiua-5738	63	38	or	or	CCONJ
aiua-5738	63	39	without	without	ADP
aiua-5738	63	40	ed	ed	PROPN
aiua-5738	63	41	(	(	PUNCT
aiua-5738	63	42	27	27	NUM
aiua-5738	63	43	)	)	PUNCT
aiua-5738	63	44	.	.	PUNCT
aiua-5738	64	1	patients	patient	NOUN
aiua-5738	64	2	with	with	ADP
aiua-5738	64	3	bph	bph	NOUN
aiua-5738	64	4	-	-	PUNCT
aiua-5738	64	5	related	relate	VERB
aiua-5738	64	6	lower	low	ADJ
aiua-5738	64	7	urinary	urinary	ADJ
aiua-5738	64	8	tract	tract	NOUN
aiua-5738	64	9	symptoms	symptom	NOUN
aiua-5738	64	10	at	at	ADP
aiua-5738	64	11	high	high	ADJ
aiua-5738	64	12	risk	risk	NOUN
aiua-5738	64	13	of	of	ADP
aiua-5738	64	14	progression	progression	NOUN
aiua-5738	64	15	.	.	PUNCT
aiua-5738	65	1	in	in	ADP
aiua-5738	65	2	this	this	DET
aiua-5738	65	3	class	class	NOUN
aiua-5738	65	4	of	of	ADP
aiua-5738	65	5	patients	patient	NOUN
aiua-5738	65	6	the	the	DET
aiua-5738	65	7	ideal	ideal	ADJ
aiua-5738	65	8	treatment	treatment	NOUN
aiua-5738	65	9	approach	approach	NOUN
aiua-5738	65	10	is	be	AUX
aiua-5738	65	11	5a	5a	NUM
aiua-5738	65	12	-	-	PUNCT
aiua-5738	65	13	ri	ri	NOUN
aiua-5738	65	14	prescription	prescription	NOUN
aiua-5738	65	15	.	.	PUNCT
aiua-5738	66	1	the	the	DET
aiua-5738	66	2	drugs	drug	NOUN
aiua-5738	66	3	can	can	AUX
aiua-5738	66	4	be	be	AUX
aiua-5738	66	5	administered	administer	VERB
aiua-5738	66	6	as	as	ADP
aiua-5738	66	7	monotherapy	monotherapy	NOUN
aiua-5738	66	8	or	or	CCONJ
aiua-5738	66	9	,	,	PUNCT
aiua-5738	66	10	in	in	ADP
aiua-5738	66	11	order	order	NOUN
aiua-5738	66	12	to	to	PART
aiua-5738	66	13	obtain	obtain	VERB
aiua-5738	66	14	a	a	DET
aiua-5738	66	15	faster	fast	ADJ
aiua-5738	66	16	and	and	CCONJ
aiua-5738	66	17	more	more	ADV
aiua-5738	66	18	beneficial	beneficial	ADJ
aiua-5738	66	19	therapeutic	therapeutic	ADJ
aiua-5738	66	20	result	result	NOUN
aiua-5738	66	21	on	on	ADP
aiua-5738	66	22	symptoms	symptom	NOUN
aiua-5738	66	23	,	,	PUNCT
aiua-5738	66	24	the	the	DET
aiua-5738	66	25	5a	5a	NUM
aiua-5738	66	26	-	-	PUNCT
aiua-5738	66	27	ri	ri	NOUN
aiua-5738	66	28	dutasteride	dutasteride	NOUN
aiua-5738	66	29	can	can	AUX
aiua-5738	66	30	be	be	AUX
aiua-5738	66	31	prescribed	prescribe	VERB
aiua-5738	66	32	in	in	ADP
aiua-5738	66	33	combination	combination	NOUN
aiua-5738	66	34	with	with	ADP
aiua-5738	66	35	an	an	DET
aiua-5738	66	36	a1a	a1a	ADJ
aiua-5738	66	37	-	-	ADJ
aiua-5738	66	38	adrenergic	adrenergic	ADJ
aiua-5738	66	39	blocker	blocker	NOUN
aiua-5738	66	40	(	(	PUNCT
aiua-5738	66	41	22	22	NUM
aiua-5738	66	42	)	)	PUNCT
aiua-5738	66	43	.	.	PUNCT
aiua-5738	67	1	moreover	moreover	ADV
aiua-5738	67	2	,	,	PUNCT
aiua-5738	67	3	as	as	SCONJ
aiua-5738	67	4	the	the	DET
aiua-5738	67	5	pde5inhibitor	pde5inhibitor	PROPN
aiua-5738	67	6	tadalafil	tadalafil	VERB
aiua-5738	67	7	5	5	NUM
aiua-5738	67	8	mg	mg	NOUN
aiua-5738	67	9	once	once	ADV
aiua-5738	67	10	daily	daily	ADV
aiua-5738	67	11	has	have	AUX
aiua-5738	67	12	been	be	AUX
aiua-5738	67	13	approved	approve	VERB
aiua-5738	67	14	for	for	ADP
aiua-5738	67	15	the	the	DET
aiua-5738	67	16	treatment	treatment	NOUN
aiua-5738	67	17	of	of	ADP
aiua-5738	67	18	obstructive	obstructive	ADJ
aiua-5738	67	19	lower	low	ADJ
aiua-5738	67	20	urinary	urinary	ADJ
aiua-5738	67	21	tract	tract	NOUN
aiua-5738	67	22	symptoms	symptom	NOUN
aiua-5738	67	23	secondary	secondary	ADJ
aiua-5738	67	24	to	to	ADP
aiua-5738	67	25	bhp	bhp	PROPN
aiua-5738	67	26	(	(	PUNCT
aiua-5738	67	27	27	27	NUM
aiua-5738	67	28	)	)	PUNCT
aiua-5738	67	29	,	,	PUNCT
aiua-5738	67	30	the	the	DET
aiua-5738	67	31	5a	5a	NUM
aiua-5738	67	32	-	-	PUNCT
aiua-5738	67	33	ri	ri	NOUN
aiua-5738	67	34	dutasteride	dutasteride	NOUN
aiua-5738	67	35	can	can	AUX
aiua-5738	67	36	,	,	PUNCT
aiua-5738	67	37	currently	currently	ADV
aiua-5738	67	38	,	,	PUNCT
aiua-5738	67	39	be	be	AUX
aiua-5738	67	40	suggested	suggest	VERB
aiua-5738	67	41	in	in	ADP
aiua-5738	67	42	combination	combination	NOUN
aiua-5738	67	43	with	with	ADP
aiua-5738	67	44	tadalafil	tadalafil	NOUN
aiua-5738	67	45	5	5	NUM
aiua-5738	67	46	mg	mg	NOUN
aiua-5738	67	47	once	once	ADV
aiua-5738	67	48	daily	daily	ADV
aiua-5738	67	49	,	,	PUNCT
aiua-5738	67	50	with	with	ADP
aiua-5738	67	51	or	or	CCONJ
aiua-5738	67	52	without	without	ADP
aiua-5738	67	53	concomitant	concomitant	ADJ
aiua-5738	67	54	ed	ed	NOUN
aiua-5738	67	55	(	(	PUNCT
aiua-5738	67	56	28	28	NUM
aiua-5738	67	57	)	)	PUNCT
aiua-5738	67	58	.	.	PUNCT
aiua-5738	68	1	patients	patient	NOUN
aiua-5738	68	2	with	with	ADP
aiua-5738	68	3	bph	bph	NOUN
aiua-5738	68	4	-	-	PUNCT
aiua-5738	68	5	related	relate	VERB
aiua-5738	68	6	lower	low	ADJ
aiua-5738	68	7	urinary	urinary	ADJ
aiua-5738	68	8	tract	tract	NOUN
aiua-5738	68	9	symptoms	symptom	NOUN
aiua-5738	68	10	at	at	ADP
aiua-5738	68	11	high	high	ADJ
aiua-5738	68	12	risk	risk	NOUN
aiua-5738	68	13	of	of	ADP
aiua-5738	68	14	progression	progression	NOUN
aiua-5738	68	15	and	and	CCONJ
aiua-5738	68	16	concomitant	concomitant	ADJ
aiua-5738	68	17	ed	ed	NOUN
aiua-5738	68	18	.	.	PUNCT
aiua-5738	69	1	the	the	DET
aiua-5738	69	2	simultaneous	simultaneous	ADJ
aiua-5738	69	3	administration	administration	NOUN
aiua-5738	69	4	of	of	ADP
aiua-5738	69	5	tadalafil	tadalafil	PROPN
aiua-5738	69	6	and	and	CCONJ
aiua-5738	69	7	finasteride	finasteride	ADJ
aiua-5738	69	8	would	would	AUX
aiua-5738	69	9	appear	appear	VERB
aiua-5738	69	10	to	to	PART
aiua-5738	69	11	allow	allow	VERB
aiua-5738	69	12	a	a	DET
aiua-5738	69	13	rapid	rapid	ADJ
aiua-5738	69	14	improvement	improvement	NOUN
aiua-5738	69	15	in	in	ADP
aiua-5738	69	16	obstructive	obstructive	ADJ
aiua-5738	69	17	and	and	CCONJ
aiua-5738	69	18	irritation	irritation	NOUN
aiua-5738	69	19	symptoms	symptom	NOUN
aiua-5738	69	20	of	of	ADP
aiua-5738	69	21	the	the	DET
aiua-5738	69	22	lower	low	ADJ
aiua-5738	69	23	unit	unit	NOUN
aiua-5738	69	24	urinary	urinary	ADJ
aiua-5738	69	25	tract	tract	NOUN
aiua-5738	69	26	in	in	ADP
aiua-5738	69	27	men	man	NOUN
aiua-5738	69	28	with	with	ADP
aiua-5738	69	29	bph	bph	NOUN
aiua-5738	69	30	(	(	PUNCT
aiua-5738	69	31	29	29	NUM
aiua-5738	69	32	)	)	PUNCT
aiua-5738	69	33	.	.	PUNCT
aiua-5738	70	1	tadalafil	tadalafil	PROPN
aiua-5738	70	2	co	co	VERB
aiua-5738	70	3	-	-	VERB
aiua-5738	70	4	administered	administer	VERB
aiua-5738	70	5	with	with	ADP
aiua-5738	70	6	finasteride	finasteride	NOUN
aiua-5738	70	7	is	be	AUX
aiua-5738	70	8	also	also	ADV
aiua-5738	70	9	thought	think	VERB
aiua-5738	70	10	to	to	PART
aiua-5738	70	11	improve	improve	VERB
aiua-5738	70	12	erectile	erectile	ADJ
aiua-5738	70	13	function	function	NOUN
aiua-5738	70	14	in	in	ADP
aiua-5738	70	15	those	those	DET
aiua-5738	70	16	men	man	NOUN
aiua-5738	70	17	with	with	ADP
aiua-5738	70	18	concomitant	concomitant	ADJ
aiua-5738	70	19	erectile	erectile	NOUN
aiua-5738	70	20	dysfunction	dysfunction	NOUN
aiua-5738	70	21	(	(	PUNCT
aiua-5738	70	22	29	29	NUM
aiua-5738	70	23	)	)	PUNCT
aiua-5738	70	24	.	.	PUNCT
aiua-5738	71	1	regardless	regardless	ADV
aiua-5738	71	2	of	of	ADP
aiua-5738	71	3	the	the	DET
aiua-5738	71	4	treatment	treatment	NOUN
aiua-5738	71	5	prescribed	prescribe	VERB
aiua-5738	71	6	or	or	CCONJ
aiua-5738	71	7	proposed	propose	VERB
aiua-5738	71	8	–	–	PUNCT
aiua-5738	71	9	as	as	ADP
aiua-5738	71	10	a	a	DET
aiua-5738	71	11	general	general	ADJ
aiua-5738	71	12	rule	rule	NOUN
aiua-5738	71	13	the	the	DET
aiua-5738	71	14	fully	fully	ADV
aiua-5738	71	15	reimbursed	reimburse	VERB
aiua-5738	71	16	agents	agent	NOUN
aiua-5738	71	17	are	be	AUX
aiua-5738	71	18	prescribed	prescribe	VERB
aiua-5738	71	19	and	and	CCONJ
aiua-5738	71	20	those	those	PRON
aiua-5738	71	21	not	not	PART
aiua-5738	71	22	reimbursed	reimburse	VERB
aiua-5738	71	23	are	be	AUX
aiua-5738	71	24	proposed	propose	VERB
aiua-5738	71	25	–	–	PUNCT
aiua-5738	71	26	appropriately	appropriately	ADV
aiua-5738	71	27	timed	time	VERB
aiua-5738	71	28	regular	regular	ADJ
aiua-5738	71	29	clinical	clinical	ADJ
aiua-5738	71	30	monitoring	monitoring	NOUN
aiua-5738	71	31	is	be	AUX
aiua-5738	71	32	required	require	VERB
aiua-5738	71	33	(	(	PUNCT
aiua-5738	71	34	1	1	NUM
aiua-5738	71	35	-	-	SYM
aiua-5738	71	36	3	3	NUM
aiua-5738	71	37	-	-	PUNCT
aiua-5738	71	38	6	6	NUM
aiua-5738	71	39	-	-	SYM
aiua-5738	71	40	12	12	NUM
aiua-5738	71	41	months	month	NOUN
aiua-5738	71	42	)	)	PUNCT
aiua-5738	71	43	.	.	PUNCT
aiua-5738	72	1	the	the	DET
aiua-5738	72	2	aim	aim	NOUN
aiua-5738	72	3	of	of	ADP
aiua-5738	72	4	this	this	PRON
aiua-5738	72	5	is	be	AUX
aiua-5738	72	6	to	to	PART
aiua-5738	72	7	monitor	monitor	VERB
aiua-5738	72	8	the	the	DET
aiua-5738	72	9	results	result	NOUN
aiua-5738	72	10	of	of	ADP
aiua-5738	72	11	treatment	treatment	NOUN
aiua-5738	72	12	,	,	PUNCT
aiua-5738	72	13	evaluate	evaluate	VERB
aiua-5738	72	14	any	any	DET
aiua-5738	72	15	adverse	adverse	ADJ
aiua-5738	72	16	events	event	NOUN
aiua-5738	72	17	and	and	CCONJ
aiua-5738	72	18	,	,	PUNCT
aiua-5738	72	19	ultimately	ultimately	ADV
aiua-5738	72	20	,	,	PUNCT
aiua-5738	72	21	prevent	prevent	VERB
aiua-5738	72	22	,	,	PUNCT
aiua-5738	72	23	approximately	approximately	ADV
aiua-5738	72	24	every	every	DET
aiua-5738	72	25	12	12	NUM
aiua-5738	72	26	months	month	NOUN
aiua-5738	72	27	,	,	PUNCT
aiua-5738	72	28	the	the	DET
aiua-5738	72	29	incidental	incidental	ADJ
aiua-5738	72	30	overlap	overlap	NOUN
aiua-5738	72	31	of	of	ADP
aiua-5738	72	32	prostatic	prostatic	ADJ
aiua-5738	72	33	cancer	cancer	NOUN
aiua-5738	72	34	.	.	PUNCT
aiua-5738	73	1	the	the	DET
aiua-5738	73	2	evaluation	evaluation	NOUN
aiua-5738	73	3	of	of	ADP
aiua-5738	73	4	any	any	DET
aiua-5738	73	5	adverse	adverse	ADJ
aiua-5738	73	6	events	event	NOUN
aiua-5738	73	7	and	and	CCONJ
aiua-5738	73	8	,	,	PUNCT
aiua-5738	73	9	in	in	ADP
aiua-5738	73	10	particular	particular	ADJ
aiua-5738	73	11	,	,	PUNCT
aiua-5738	73	12	sexual	sexual	ADJ
aiua-5738	73	13	adverse	adverse	ADJ
aiua-5738	73	14	ones	one	NOUN
aiua-5738	73	15	,	,	PUNCT
aiua-5738	73	16	can	can	AUX
aiua-5738	73	17	not	not	PART
aiua-5738	73	18	exclude	exclude	VERB
aiua-5738	73	19	a	a	DET
aiua-5738	73	20	careful	careful	ADJ
aiua-5738	73	21	investigation	investigation	NOUN
aiua-5738	73	22	of	of	ADP
aiua-5738	73	23	the	the	DET
aiua-5738	73	24	conditions	condition	NOUN
aiua-5738	73	25	of	of	ADP
aiua-5738	73	26	the	the	DET
aiua-5738	73	27	patient	patient	NOUN
aiua-5738	73	28	before	before	ADP
aiua-5738	73	29	starting	start	VERB
aiua-5738	73	30	therapy	therapy	NOUN
aiua-5738	73	31	and	and	CCONJ
aiua-5738	73	32	the	the	DET
aiua-5738	73	33	implications	implication	NOUN
aiua-5738	73	34	that	that	PRON
aiua-5738	73	35	may	may	AUX
aiua-5738	73	36	be	be	AUX
aiua-5738	73	37	determined	determine	VERB
aiua-5738	73	38	by	by	ADP
aiua-5738	73	39	the	the	DET
aiua-5738	73	40	nocebo	nocebo	NOUN
aiua-5738	73	41	effect	effect	NOUN
aiua-5738	73	42	described	describe	VERB
aiua-5738	73	43	above	above	ADV
aiua-5738	73	44	.	.	PUNCT
aiua-5738	74	1	in	in	ADP
aiua-5738	74	2	this	this	DET
aiua-5738	74	3	sense	sense	NOUN
aiua-5738	74	4	,	,	PUNCT
aiua-5738	74	5	it	it	PRON
aiua-5738	74	6	is	be	AUX
aiua-5738	74	7	essential	essential	ADJ
aiua-5738	74	8	to	to	PART
aiua-5738	74	9	administer	administer	VERB
aiua-5738	74	10	dedicated	dedicated	ADJ
aiua-5738	74	11	questionnaires	questionnaire	NOUN
aiua-5738	74	12	(	(	PUNCT
aiua-5738	74	13	e.g.	e.g.	ADV
aiua-5738	74	14	iiefstudy	iiefstudy	ADJ
aiua-5738	74	15	patients	patient	NOUN
aiua-5738	74	16	(	(	PUNCT
aiua-5738	74	17	%	%	INTJ
aiua-5738	74	18	)	)	PUNCT
aiua-5738	74	19	sae	sae	PROPN
aiua-5738	74	20	(	(	PUNCT
aiua-5738	74	21	%	%	INTJ
aiua-5738	74	22	)	)	PUNCT
aiua-5738	74	23	sae	sae	PROPN
aiua-5738	74	24	(	(	PUNCT
aiua-5738	74	25	%	%	INTJ
aiua-5738	74	26	)	)	PUNCT
aiua-5738	74	27	ed	ed	NOUN
aiua-5738	74	28	(	(	PUNCT
aiua-5738	74	29	%	%	NOUN
aiua-5738	74	30	)	)	PUNCT
aiua-5738	75	1	ed	ed	NOUN
aiua-5738	75	2	(	(	PUNCT
aiua-5738	75	3	%	%	INTJ
aiua-5738	75	4	)	)	PUNCT
aiua-5738	75	5	diminished	diminish	VERB
aiua-5738	75	6	(	(	PUNCT
aiua-5738	75	7	%	%	INTJ
aiua-5738	75	8	)	)	PUNCT
aiua-5738	75	9	diminished	diminish	VERB
aiua-5738	75	10	(	(	PUNCT
aiua-5738	75	11	%	%	INTJ
aiua-5738	75	12	)	)	PUNCT
aiua-5738	75	13	ejaculated	ejaculate	VERB
aiua-5738	75	14	(	(	PUNCT
aiua-5738	75	15	%	%	INTJ
aiua-5738	75	16	)	)	PUNCT
aiua-5738	75	17	ejaculated	ejaculate	VERB
aiua-5738	75	18	at	at	ADP
aiua-5738	75	19	6	6	NUM
aiua-5738	75	20	months	month	NOUN
aiua-5738	75	21	at	at	ADP
aiua-5738	75	22	1	1	NUM
aiua-5738	75	23	year	year	NOUN
aiua-5738	75	24	at	at	ADP
aiua-5738	75	25	6	6	NUM
aiua-5738	75	26	months	month	NOUN
aiua-5738	75	27	at	at	ADP
aiua-5738	75	28	1	1	NUM
aiua-5738	75	29	year	year	NOUN
aiua-5738	75	30	libido	libido	NOUN
aiua-5738	75	31	at	at	ADP
aiua-5738	75	32	6	6	NUM
aiua-5738	75	33	months	month	NOUN
aiua-5738	75	34	libido	libido	ADJ
aiua-5738	75	35	at	at	ADP
aiua-5738	75	36	1	1	NUM
aiua-5738	75	37	year	year	NOUN
aiua-5738	75	38	disorder	disorder	NOUN
aiua-5738	75	39	at	at	ADP
aiua-5738	75	40	6	6	NUM
aiua-5738	75	41	months	month	NOUN
aiua-5738	75	42	disorder	disorder	NOUN
aiua-5738	75	43	at	at	ADP
aiua-5738	75	44	1	1	NUM
aiua-5738	75	45	year	year	NOUN
aiua-5738	75	46	all	all	DET
aiua-5738	75	47	patients	patient	NOUN
aiua-5738	75	48	(	(	PUNCT
aiua-5738	75	49	n	n	NOUN
aiua-5738	75	50	=	=	SYM
aiua-5738	75	51	107	107	NUM
aiua-5738	75	52	)	)	PUNCT
aiua-5738	75	53	24.3	24.3	NUM
aiua-5738	75	54	%	%	NOUN
aiua-5738	75	55	29.90	29.90	NUM
aiua-5738	75	56	15.8	15.8	NUM
aiua-5738	75	57	%	%	NOUN
aiua-5738	75	58	20.5	20.5	NUM
aiua-5738	75	59	%	%	NOUN
aiua-5738	75	60	11.2	11.2	NUM
aiua-5738	75	61	%	%	NOUN
aiua-5738	75	62	15.8	15.8	NUM
aiua-5738	75	63	%	%	NOUN
aiua-5738	75	64	8.4	8.4	NUM
aiua-5738	75	65	%	%	NOUN
aiua-5738	75	66	11.2	11.2	NUM
aiua-5738	75	67	%	%	NOUN
aiua-5738	75	68	group	group	NOUN
aiua-5738	75	69	1	1	NUM
aiua-5738	75	70	(	(	PUNCT
aiua-5738	75	71	n	n	NOUN
aiua-5738	75	72	=	=	SYM
aiua-5738	75	73	52	52	NUM
aiua-5738	75	74	)	)	PUNCT
aiua-5738	75	75	11.5	11.5	NUM
aiua-5738	75	76	%	%	NOUN
aiua-5738	75	77	15.3	15.3	NUM
aiua-5738	75	78	5.7	5.7	NUM
aiua-5738	75	79	%	%	NOUN
aiua-5738	75	80	9.6	9.6	NUM
aiua-5738	75	81	3.8	3.8	NUM
aiua-5738	75	82	%	%	NOUN
aiua-5738	75	83	7.7	7.7	NUM
aiua-5738	75	84	5.7	5.7	NUM
aiua-5738	75	85	%	%	NOUN
aiua-5738	75	86	5.7	5.7	NUM
aiua-5738	75	87	group	group	NOUN
aiua-5738	75	88	2	2	NUM
aiua-5738	75	89	(	(	PUNCT
aiua-5738	75	90	n	n	NOUN
aiua-5738	75	91	=	=	SYM
aiua-5738	75	92	55	55	NUM
aiua-5738	75	93	)	)	PUNCT
aiua-5738	75	94	36.3	36.3	NUM
aiua-5738	75	95	%	%	NOUN
aiua-5738	75	96	43.6	43.6	NUM
aiua-5738	75	97	25.4	25.4	NUM
aiua-5738	75	98	%	%	NOUN
aiua-5738	75	99	30.9	30.9	NUM
aiua-5738	75	100	18.1	18.1	NUM
aiua-5738	75	101	%	%	NOUN
aiua-5738	75	102	23.6	23.6	NUM
aiua-5738	75	103	10.9	10.9	NUM
aiua-5738	75	104	%	%	NOUN
aiua-5738	75	105	16.3	16.3	NUM
aiua-5738	75	106	mondaini	mondaini	NOUN
aiua-5738	75	107	n	n	CCONJ
aiua-5738	75	108	,	,	PUNCT
aiua-5738	75	109	et	et	PROPN
aiua-5738	75	110	al	al	PROPN
aiua-5738	75	111	.	.	PUNCT
aiua-5738	76	1	j	j	PROPN
aiua-5738	76	2	sex	sex	PROPN
aiua-5738	76	3	med	med	PROPN
aiua-5738	76	4	2007	2007	NUM
aiua-5738	76	5	;	;	PUNCT
aiua-5738	76	6	4:1708	4:1708	NUM
aiua-5738	76	7	-	-	SYM
aiua-5738	76	8	12	12	NUM
aiua-5738	76	9	.	.	PUNCT
aiua-5738	76	10	table	table	NOUN
aiua-5738	76	11	1	1	NUM
aiua-5738	76	12	.	.	PUNCT
aiua-5738	77	1	315archivio	315archivio	PROPN
aiua-5738	77	2	italiano	italiano	NOUN
aiua-5738	77	3	di	di	NOUN
aiua-5738	77	4	urologia	urologia	PROPN
aiua-5738	77	5	e	e	PROPN
aiua-5738	77	6	andrologia	andrologia	NOUN
aiua-5738	77	7	2015	2015	NUM
aiua-5738	77	8	;	;	PUNCT
aiua-5738	77	9	87	87	NUM
aiua-5738	77	10	,	,	PUNCT
aiua-5738	77	11	4	4	NUM
aiua-5738	77	12	comments	comment	NOUN
aiua-5738	77	13	concerning	concern	VERB
aiua-5738	77	14	the	the	DET
aiua-5738	77	15	real	real	ADJ
aiua-5738	77	16	risk	risk	NOUN
aiua-5738	77	17	of	of	ADP
aiua-5738	77	18	sexual	sexual	ADJ
aiua-5738	77	19	adverse	adverse	ADJ
aiua-5738	77	20	events	event	NOUN
aiua-5738	77	21	secondary	secondary	ADJ
aiua-5738	77	22	to	to	ADP
aiua-5738	77	23	the	the	DET
aiua-5738	77	24	use	use	NOUN
aiua-5738	77	25	of	of	ADP
aiua-5738	77	26	5	5	NUM
aiua-5738	77	27	-	-	PUNCT
aiua-5738	77	28	aris	aris	PROPN
aiua-5738	77	29	ipss	ipss	PROPN
aiua-5738	77	30	)	)	PUNCT
aiua-5738	77	31	and	and	CCONJ
aiua-5738	77	32	to	to	PART
aiua-5738	77	33	perform	perform	VERB
aiua-5738	77	34	endocrinological	endocrinological	ADJ
aiua-5738	77	35	tests	test	NOUN
aiua-5738	77	36	before	before	ADP
aiua-5738	77	37	and	and	CCONJ
aiua-5738	77	38	during	during	ADP
aiua-5738	77	39	treatment	treatment	NOUN
aiua-5738	77	40	.	.	PUNCT
aiua-5738	78	1	as	as	ADP
aiua-5738	78	2	with	with	ADP
aiua-5738	78	3	any	any	DET
aiua-5738	78	4	other	other	ADJ
aiua-5738	78	5	treatment	treatment	NOUN
aiua-5738	78	6	,	,	PUNCT
aiua-5738	78	7	in	in	ADP
aiua-5738	78	8	the	the	DET
aiua-5738	78	9	case	case	NOUN
aiua-5738	78	10	of	of	ADP
aiua-5738	78	11	adverse	adverse	ADJ
aiua-5738	78	12	events	event	NOUN
aiua-5738	78	13	,	,	PUNCT
aiua-5738	78	14	in	in	ADP
aiua-5738	78	15	addition	addition	NOUN
aiua-5738	78	16	to	to	ADP
aiua-5738	78	17	reporting	report	VERB
aiua-5738	78	18	them	they	PRON
aiua-5738	78	19	to	to	ADP
aiua-5738	78	20	the	the	DET
aiua-5738	78	21	appropriate	appropriate	ADJ
aiua-5738	78	22	authority	authority	NOUN
aiua-5738	78	23	,	,	PUNCT
aiua-5738	78	24	their	their	PRON
aiua-5738	78	25	relationship	relationship	NOUN
aiua-5738	78	26	with	with	ADP
aiua-5738	78	27	the	the	DET
aiua-5738	78	28	5a	5a	NUM
aiua-5738	78	29	-	-	PUNCT
aiua-5738	78	30	ris	ris	X
aiua-5738	78	31	must	must	AUX
aiua-5738	78	32	be	be	AUX
aiua-5738	78	33	verified	verify	VERB
aiua-5738	78	34	and	and	CCONJ
aiua-5738	78	35	,	,	PUNCT
aiua-5738	78	36	where	where	SCONJ
aiua-5738	78	37	appropriate	appropriate	ADJ
aiua-5738	78	38	,	,	PUNCT
aiua-5738	78	39	solutions	solution	NOUN
aiua-5738	78	40	must	must	AUX
aiua-5738	78	41	be	be	AUX
aiua-5738	78	42	devised	devise	VERB
aiua-5738	78	43	.	.	PUNCT
aiua-5738	79	1	in	in	ADP
aiua-5738	79	2	addition	addition	NOUN
aiua-5738	79	3	to	to	ADP
aiua-5738	79	4	this	this	PRON
aiua-5738	79	5	,	,	PUNCT
aiua-5738	79	6	the	the	DET
aiua-5738	79	7	patient	patient	NOUN
aiua-5738	79	8	must	must	AUX
aiua-5738	79	9	be	be	AUX
aiua-5738	79	10	reassured	reassure	VERB
aiua-5738	79	11	of	of	ADP
aiua-5738	79	12	the	the	DET
aiua-5738	79	13	fact	fact	NOUN
aiua-5738	79	14	that	that	SCONJ
aiua-5738	79	15	he	he	PRON
aiua-5738	79	16	will	will	AUX
aiua-5738	79	17	in	in	ADP
aiua-5738	79	18	any	any	DET
aiua-5738	79	19	case	case	NOUN
aiua-5738	79	20	be	be	AUX
aiua-5738	79	21	helped	help	VERB
aiua-5738	79	22	to	to	PART
aiua-5738	79	23	overcome	overcome	VERB
aiua-5738	79	24	the	the	DET
aiua-5738	79	25	problem	problem	NOUN
aiua-5738	79	26	.	.	PUNCT
aiua-5738	80	1	conclusions	conclusion	NOUN
aiua-5738	80	2	the	the	DET
aiua-5738	80	3	most	most	ADV
aiua-5738	80	4	recent	recent	ADJ
aiua-5738	80	5	literature	literature	NOUN
aiua-5738	80	6	review	review	NOUN
aiua-5738	80	7	conducted	conduct	VERB
aiua-5738	80	8	by	by	ADP
aiua-5738	80	9	trost	trost	ADJ
aiua-5738	80	10	l	l	PROPN
aiua-5738	80	11	et	et	PROPN
aiua-5738	80	12	al	al	PROPN
aiua-5738	80	13	.	.	PROPN
aiua-5738	81	1	(	(	PUNCT
aiua-5738	81	2	2013	2013	NUM
aiua-5738	81	3	)	)	PUNCT
aiua-5738	81	4	including	include	VERB
aiua-5738	81	5	over	over	ADP
aiua-5738	81	6	62,827	62,827	NUM
aiua-5738	81	7	patients	patient	NOUN
aiua-5738	81	8	,	,	PUNCT
aiua-5738	81	9	showed	show	VERB
aiua-5738	81	10	a	a	DET
aiua-5738	81	11	slight	slight	ADJ
aiua-5738	81	12	increase	increase	NOUN
aiua-5738	81	13	in	in	ADP
aiua-5738	81	14	the	the	DET
aiua-5738	81	15	rate	rate	NOUN
aiua-5738	81	16	of	of	ADP
aiua-5738	81	17	loss	loss	NOUN
aiua-5738	81	18	of	of	ADP
aiua-5738	81	19	libido	libido	NOUN
aiua-5738	81	20	,	,	PUNCT
aiua-5738	81	21	of	of	ADP
aiua-5738	81	22	ed	ed	NOUN
aiua-5738	81	23	,	,	PUNCT
aiua-5738	81	24	and	and	CCONJ
aiua-5738	81	25	ejaculatory	ejaculatory	ADJ
aiua-5738	81	26	disorders	disorder	NOUN
aiua-5738	81	27	in	in	ADP
aiua-5738	81	28	patients	patient	NOUN
aiua-5738	81	29	taking	take	VERB
aiua-5738	81	30	5a	5a	NUM
aiua-5738	81	31	-	-	PUNCT
aiua-5738	81	32	ris	ris	NOUN
aiua-5738	81	33	and	and	CCONJ
aiua-5738	81	34	placebo	placebo	NOUN
aiua-5738	81	35	(	(	PUNCT
aiua-5738	81	36	1.5	1.5	NUM
aiua-5738	81	37	%	%	NOUN
aiua-5738	81	38	1.6	1.6	NUM
aiua-5738	81	39	%	%	NOUN
aiua-5738	81	40	3.4	3.4	NUM
aiua-5738	81	41	%	%	NOUN
aiua-5738	81	42	,	,	PUNCT
aiua-5738	81	43	and	and	CCONJ
aiua-5738	81	44	1.3	1.3	NUM
aiua-5738	81	45	%	%	NOUN
aiua-5738	81	46	respectively	respectively	ADV
aiua-5738	81	47	)	)	PUNCT
aiua-5738	81	48	(	(	PUNCT
aiua-5738	81	49	1	1	NUM
aiua-5738	81	50	)	)	PUNCT
aiua-5738	81	51	.	.	PUNCT
aiua-5738	82	1	the	the	DET
aiua-5738	82	2	authors	author	NOUN
aiua-5738	82	3	of	of	ADP
aiua-5738	82	4	this	this	DET
aiua-5738	82	5	review	review	NOUN
aiua-5738	82	6	conclude	conclude	VERB
aiua-5738	82	7	that	that	SCONJ
aiua-5738	82	8	further	further	ADJ
aiua-5738	82	9	studies	study	NOUN
aiua-5738	82	10	are	be	AUX
aiua-5738	82	11	required	require	VERB
aiua-5738	82	12	using	use	VERB
aiua-5738	82	13	validated	validate	VERB
aiua-5738	82	14	questionnaires	questionnaire	NOUN
aiua-5738	82	15	,	,	PUNCT
aiua-5738	82	16	to	to	PART
aiua-5738	82	17	establish	establish	VERB
aiua-5738	82	18	the	the	DET
aiua-5738	82	19	real	real	ADJ
aiua-5738	82	20	prevalence	prevalence	NOUN
aiua-5738	82	21	,	,	PUNCT
aiua-5738	82	22	clinical	clinical	ADJ
aiua-5738	82	23	relevance	relevance	NOUN
aiua-5738	82	24	and	and	CCONJ
aiua-5738	82	25	potential	potential	ADJ
aiua-5738	82	26	longterm	longterm	NOUN
aiua-5738	82	27	persistence	persistence	NOUN
aiua-5738	82	28	of	of	ADP
aiua-5738	82	29	adverse	adverse	ADJ
aiua-5738	82	30	effects	effect	NOUN
aiua-5738	82	31	related	relate	VERB
aiua-5738	82	32	to	to	ADP
aiua-5738	82	33	the	the	DET
aiua-5738	82	34	use	use	NOUN
aiua-5738	82	35	of	of	ADP
aiua-5738	82	36	5a	5a	NUM
aiua-5738	82	37	-	-	PUNCT
aiua-5738	82	38	ris	ris	X
aiua-5738	82	39	(	(	PUNCT
aiua-5738	82	40	1	1	NUM
aiua-5738	82	41	)	)	PUNCT
aiua-5738	82	42	.	.	PUNCT
aiua-5738	83	1	as	as	SCONJ
aiua-5738	83	2	regards	regard	VERB
aiua-5738	83	3	the	the	DET
aiua-5738	83	4	information	information	NOUN
aiua-5738	83	5	to	to	PART
aiua-5738	83	6	be	be	AUX
aiua-5738	83	7	given	give	VERB
aiua-5738	83	8	to	to	ADP
aiua-5738	83	9	patients	patient	NOUN
aiua-5738	83	10	before	before	ADP
aiua-5738	83	11	starting	start	VERB
aiua-5738	83	12	treatment	treatment	NOUN
aiua-5738	83	13	with	with	ADP
aiua-5738	83	14	5a	5a	NUM
aiua-5738	83	15	-	-	PUNCT
aiua-5738	83	16	ris	ris	PROPN
aiua-5738	83	17	,	,	PUNCT
aiua-5738	83	18	the	the	DET
aiua-5738	83	19	doctor	doctor	NOUN
aiua-5738	83	20	must	must	AUX
aiua-5738	83	21	illustrate	illustrate	VERB
aiua-5738	83	22	,	,	PUNCT
aiua-5738	83	23	in	in	ADP
aiua-5738	83	24	a	a	DET
aiua-5738	83	25	certainly	certainly	ADV
aiua-5738	83	26	comprehensible	comprehensible	ADJ
aiua-5738	83	27	manner	manner	NOUN
aiua-5738	83	28	,	,	PUNCT
aiua-5738	83	29	the	the	DET
aiua-5738	83	30	rationale	rationale	NOUN
aiua-5738	83	31	and	and	CCONJ
aiua-5738	83	32	expected	expect	VERB
aiua-5738	83	33	benefits	benefit	NOUN
aiua-5738	83	34	of	of	ADP
aiua-5738	83	35	the	the	DET
aiua-5738	83	36	therapy	therapy	NOUN
aiua-5738	83	37	:	:	PUNCT
aiua-5738	83	38	a	a	DET
aiua-5738	83	39	reduction	reduction	NOUN
aiua-5738	83	40	in	in	ADP
aiua-5738	83	41	the	the	DET
aiua-5738	83	42	risk	risk	NOUN
aiua-5738	83	43	of	of	ADP
aiua-5738	83	44	bph	bph	NOUN
aiua-5738	83	45	progression	progression	NOUN
aiua-5738	83	46	;	;	PUNCT
aiua-5738	83	47	a	a	DET
aiua-5738	83	48	reduction	reduction	NOUN
aiua-5738	83	49	in	in	ADP
aiua-5738	83	50	the	the	DET
aiua-5738	83	51	risk	risk	NOUN
aiua-5738	83	52	of	of	ADP
aiua-5738	83	53	aur	aur	NOUN
aiua-5738	83	54	;	;	PUNCT
aiua-5738	83	55	an	an	DET
aiua-5738	83	56	improvement	improvement	NOUN
aiua-5738	83	57	in	in	ADP
aiua-5738	83	58	urinary	urinary	ADJ
aiua-5738	83	59	symptoms	symptom	NOUN
aiua-5738	83	60	;	;	PUNCT
aiua-5738	83	61	a	a	DET
aiua-5738	83	62	reduction	reduction	NOUN
aiua-5738	83	63	in	in	ADP
aiua-5738	83	64	the	the	DET
aiua-5738	83	65	risk	risk	NOUN
aiua-5738	83	66	of	of	ADP
aiua-5738	83	67	the	the	DET
aiua-5738	83	68	need	need	NOUN
aiua-5738	83	69	for	for	ADP
aiua-5738	83	70	surgical	surgical	ADJ
aiua-5738	83	71	treatment	treatment	NOUN
aiua-5738	83	72	.	.	PUNCT
aiua-5738	84	1	the	the	DET
aiua-5738	84	2	doctor	doctor	NOUN
aiua-5738	84	3	must	must	AUX
aiua-5738	84	4	also	also	ADV
aiua-5738	84	5	illustrate	illustrate	VERB
aiua-5738	84	6	the	the	DET
aiua-5738	84	7	potential	potential	ADJ
aiua-5738	84	8	onset	onset	NOUN
aiua-5738	84	9	of	of	ADP
aiua-5738	84	10	side	side	NOUN
aiua-5738	84	11	effects	effect	NOUN
aiua-5738	84	12	related	relate	VERB
aiua-5738	84	13	to	to	ADP
aiua-5738	84	14	the	the	DET
aiua-5738	84	15	use	use	NOUN
aiua-5738	84	16	of	of	ADP
aiua-5738	84	17	5a	5a	NUM
aiua-5738	84	18	-	-	PUNCT
aiua-5738	84	19	ris	ris	NOUN
aiua-5738	84	20	.	.	PUNCT
aiua-5738	85	1	as	as	ADV
aiua-5738	85	2	far	far	ADV
aiua-5738	85	3	as	as	SCONJ
aiua-5738	85	4	the	the	DET
aiua-5738	85	5	assessment	assessment	NOUN
aiua-5738	85	6	of	of	ADP
aiua-5738	85	7	sexual	sexual	ADJ
aiua-5738	85	8	adverse	adverse	ADJ
aiua-5738	85	9	events	event	NOUN
aiua-5738	85	10	is	be	AUX
aiua-5738	85	11	concerned	concern	VERB
aiua-5738	85	12	,	,	PUNCT
aiua-5738	85	13	the	the	DET
aiua-5738	85	14	doctor	doctor	NOUN
aiua-5738	85	15	must	must	AUX
aiua-5738	85	16	thoroughly	thoroughly	ADV
aiua-5738	85	17	investigate	investigate	VERB
aiua-5738	85	18	the	the	DET
aiua-5738	85	19	various	various	ADJ
aiua-5738	85	20	aspects	aspect	NOUN
aiua-5738	85	21	of	of	ADP
aiua-5738	85	22	the	the	DET
aiua-5738	85	23	individual	individual	NOUN
aiua-5738	85	24	’s	’s	PART
aiua-5738	85	25	basic	basic	ADJ
aiua-5738	85	26	sexual	sexual	ADJ
aiua-5738	85	27	function	function	NOUN
aiua-5738	85	28	,	,	PUNCT
aiua-5738	85	29	before	before	ADP
aiua-5738	85	30	starting	start	VERB
aiua-5738	85	31	treatment	treatment	NOUN
aiua-5738	85	32	.	.	PUNCT
aiua-5738	86	1	in	in	ADP
aiua-5738	86	2	addition	addition	NOUN
aiua-5738	86	3	to	to	ADP
aiua-5738	86	4	this	this	PRON
aiua-5738	86	5	,	,	PUNCT
aiua-5738	86	6	the	the	DET
aiua-5738	86	7	doctor	doctor	NOUN
aiua-5738	86	8	must	must	AUX
aiua-5738	86	9	always	always	ADV
aiua-5738	86	10	remember	remember	VERB
aiua-5738	86	11	the	the	DET
aiua-5738	86	12	importance	importance	NOUN
aiua-5738	86	13	of	of	ADP
aiua-5738	86	14	the	the	DET
aiua-5738	86	15	documented	document	VERB
aiua-5738	86	16	nocebo	nocebo	NOUN
aiua-5738	86	17	effect	effect	NOUN
aiua-5738	86	18	and	and	CCONJ
aiua-5738	86	19	appropriate	appropriate	ADJ
aiua-5738	86	20	counselling	counselling	NOUN
aiua-5738	86	21	must	must	AUX
aiua-5738	86	22	be	be	AUX
aiua-5738	86	23	provided	provide	VERB
aiua-5738	86	24	in	in	ADP
aiua-5738	86	25	order	order	NOUN
aiua-5738	86	26	to	to	PART
aiua-5738	86	27	reassure	reassure	VERB
aiua-5738	86	28	the	the	DET
aiua-5738	86	29	patient	patient	NOUN
aiua-5738	86	30	that	that	SCONJ
aiua-5738	86	31	he	he	PRON
aiua-5738	86	32	will	will	AUX
aiua-5738	86	33	receive	receive	VERB
aiua-5738	86	34	help	help	NOUN
aiua-5738	86	35	in	in	ADP
aiua-5738	86	36	overcoming	overcome	VERB
aiua-5738	86	37	any	any	DET
aiua-5738	86	38	sexual	sexual	ADJ
aiua-5738	86	39	problems	problem	NOUN
aiua-5738	86	40	that	that	PRON
aiua-5738	86	41	,	,	PUNCT
aiua-5738	86	42	for	for	ADP
aiua-5738	86	43	whatever	whatever	DET
aiua-5738	86	44	reason	reason	NOUN
aiua-5738	86	45	,	,	PUNCT
aiua-5738	86	46	may	may	AUX
aiua-5738	86	47	arise	arise	VERB
aiua-5738	86	48	during	during	ADP
aiua-5738	86	49	treatment	treatment	NOUN
aiua-5738	86	50	.	.	PUNCT
aiua-5738	87	1	medical	medical	ADJ
aiua-5738	87	2	treatment	treatment	NOUN
aiua-5738	87	3	for	for	ADP
aiua-5738	87	4	lower	low	ADJ
aiua-5738	87	5	urinary	urinary	ADJ
aiua-5738	87	6	tract	tract	NOUN
aiua-5738	87	7	symptoms	symptom	NOUN
aiua-5738	87	8	associated	associate	VERB
aiua-5738	87	9	with	with	ADP
aiua-5738	87	10	bph	bph	NOUN
aiua-5738	87	11	must	must	AUX
aiua-5738	87	12	be	be	AUX
aiua-5738	87	13	as	as	ADV
aiua-5738	87	14	individualised	individualised	ADJ
aiua-5738	87	15	as	as	ADP
aiua-5738	87	16	possible	possible	ADJ
aiua-5738	87	17	.	.	PUNCT
aiua-5738	88	1	this	this	PRON
aiua-5738	88	2	ranges	range	VERB
aiua-5738	88	3	from	from	ADP
aiua-5738	88	4	monotherapy	monotherapy	NOUN
aiua-5738	88	5	with	with	ADP
aiua-5738	88	6	a1a	a1a	ADJ
aiua-5738	88	7	-	-	ADJ
aiua-5738	88	8	adrenergic	adrenergic	ADJ
aiua-5738	88	9	blockers	blocker	NOUN
aiua-5738	88	10	,	,	PUNCT
aiua-5738	88	11	to	to	ADP
aiua-5738	88	12	that	that	PRON
aiua-5738	88	13	with	with	ADP
aiua-5738	88	14	5a	5a	NUM
aiua-5738	88	15	-	-	PUNCT
aiua-5738	88	16	ris	ris	NOUN
aiua-5738	88	17	when	when	SCONJ
aiua-5738	88	18	bph	bph	NOUN
aiua-5738	88	19	is	be	AUX
aiua-5738	88	20	at	at	ADP
aiua-5738	88	21	risk	risk	NOUN
aiua-5738	88	22	of	of	ADP
aiua-5738	88	23	progression	progression	NOUN
aiua-5738	88	24	.	.	PUNCT
aiua-5738	89	1	a	a	DET
aiua-5738	89	2	beneficial	beneficial	ADJ
aiua-5738	89	3	synergetic	synergetic	ADJ
aiua-5738	89	4	therapeutic	therapeutic	ADJ
aiua-5738	89	5	effect	effect	NOUN
aiua-5738	89	6	has	have	AUX
aiua-5738	89	7	been	be	AUX
aiua-5738	89	8	observed	observe	VERB
aiua-5738	89	9	for	for	ADP
aiua-5738	89	10	combinations	combination	NOUN
aiua-5738	89	11	of	of	ADP
aiua-5738	89	12	5aris	5aris	NUM
aiua-5738	89	13	and	and	CCONJ
aiua-5738	89	14	a1a	a1a	ADJ
aiua-5738	89	15	-	-	ADJ
aiua-5738	89	16	adrenergic	adrenergic	ADJ
aiua-5738	89	17	blocker	blocker	NOUN
aiua-5738	89	18	(	(	PUNCT
aiua-5738	89	19	tamsulosin	tamsulosin	NOUN
aiua-5738	89	20	and	and	CCONJ
aiua-5738	89	21	dutasteride	dutasteride	NOUN
aiua-5738	89	22	)	)	PUNCT
aiua-5738	89	23	.	.	PUNCT
aiua-5738	90	1	a	a	DET
aiua-5738	90	2	new	new	ADJ
aiua-5738	90	3	alternative	alternative	NOUN
aiua-5738	90	4	to	to	ADP
aiua-5738	90	5	this	this	DET
aiua-5738	90	6	solution	solution	NOUN
aiua-5738	90	7	is	be	AUX
aiua-5738	90	8	treatment	treatment	NOUN
aiua-5738	90	9	with	with	ADP
aiua-5738	90	10	the	the	DET
aiua-5738	90	11	pde5	pde5	NOUN
aiua-5738	90	12	-	-	PUNCT
aiua-5738	90	13	inhibitor	inhibitor	NOUN
aiua-5738	90	14	tadalafil	tadalafil	NOUN
aiua-5738	90	15	that	that	PRON
aiua-5738	90	16	,	,	PUNCT
aiua-5738	90	17	both	both	CCONJ
aiua-5738	90	18	in	in	ADP
aiua-5738	90	19	monotherapy	monotherapy	NOUN
aiua-5738	90	20	and	and	CCONJ
aiua-5738	90	21	in	in	ADP
aiua-5738	90	22	combination	combination	NOUN
aiua-5738	90	23	with	with	ADP
aiua-5738	90	24	the	the	DET
aiua-5738	90	25	5a	5a	NUM
aiua-5738	90	26	-	-	PUNCT
aiua-5738	90	27	ris	ris	PROPN
aiua-5738	90	28	,	,	PUNCT
aiua-5738	90	29	provides	provide	VERB
aiua-5738	90	30	advantages	advantage	NOUN
aiua-5738	90	31	in	in	ADP
aiua-5738	90	32	the	the	DET
aiua-5738	90	33	treatment	treatment	NOUN
aiua-5738	90	34	of	of	ADP
aiua-5738	90	35	lower	low	ADJ
aiua-5738	90	36	urinary	urinary	ADJ
aiua-5738	90	37	tract	tract	NOUN
aiua-5738	90	38	symptoms	symptom	NOUN
aiua-5738	90	39	secondary	secondary	ADJ
aiua-5738	90	40	to	to	ADP
aiua-5738	90	41	bph	bph	VERB
aiua-5738	90	42	,	,	PUNCT
aiua-5738	90	43	especially	especially	ADV
aiua-5738	90	44	with	with	ADP
aiua-5738	90	45	concomitant	concomitant	ADJ
aiua-5738	90	46	ed	ed	NOUN
aiua-5738	90	47	and	and	CCONJ
aiua-5738	90	48	in	in	ADP
aiua-5738	90	49	the	the	DET
aiua-5738	90	50	treatment	treatment	NOUN
aiua-5738	90	51	of	of	ADP
aiua-5738	90	52	lower	low	ADJ
aiua-5738	90	53	urinary	urinary	ADJ
aiua-5738	90	54	tract	tract	NOUN
aiua-5738	90	55	symptoms	symptom	NOUN
aiua-5738	90	56	secondary	secondary	ADJ
aiua-5738	90	57	to	to	ADP
aiua-5738	90	58	bph	bph	NOUN
aiua-5738	90	59	at	at	ADP
aiua-5738	90	60	risk	risk	NOUN
aiua-5738	90	61	of	of	ADP
aiua-5738	90	62	progression	progression	NOUN
aiua-5738	90	63	,	,	PUNCT
aiua-5738	90	64	especially	especially	ADV
aiua-5738	90	65	when	when	SCONJ
aiua-5738	90	66	associated	associate	VERB
aiua-5738	90	67	with	with	ADP
aiua-5738	90	68	ed	ed	PROPN
aiua-5738	90	69	.	.	PUNCT
aiua-5738	91	1	references	reference	NOUN
aiua-5738	91	2	1	1	NUM
aiua-5738	91	3	.	.	PUNCT
aiua-5738	92	1	trost	trost	PROPN
aiua-5738	92	2	l	l	PROPN
aiua-5738	92	3	,	,	PUNCT
aiua-5738	92	4	saitz	saitz	PROPN
aiua-5738	92	5	bs	bs	PROPN
aiua-5738	92	6	,	,	PUNCT
aiua-5738	92	7	hellstrom	hellstrom	NOUN
aiua-5738	92	8	wjg	wjg	VERB
aiua-5738	92	9	.	.	PUNCT
aiua-5738	92	10	side	side	ADJ
aiua-5738	92	11	effects	effect	NOUN
aiua-5738	92	12	of	of	ADP
aiua-5738	92	13	5	5	NUM
aiua-5738	92	14	-	-	PUNCT
aiua-5738	92	15	alpha	alpha	NOUN
aiua-5738	92	16	reductase	reductase	NOUN
aiua-5738	92	17	inhibitors	inhibitor	NOUN
aiua-5738	92	18	:	:	PUNCT
aiua-5738	92	19	a	a	DET
aiua-5738	92	20	comprehensive	comprehensive	ADJ
aiua-5738	92	21	review	review	NOUN
aiua-5738	92	22	.	.	PUNCT
aiua-5738	93	1	sex	sex	PROPN
aiua-5738	93	2	med	med	PROPN
aiua-5738	93	3	rev	rev	PROPN
aiua-5738	93	4	.	.	PROPN
aiua-5738	93	5	2013	2013	NUM
aiua-5738	93	6	;	;	PUNCT
aiua-5738	93	7	1:21	1:21	NUM
aiua-5738	93	8	-	-	SYM
aiua-5738	93	9	41	41	NUM
aiua-5738	93	10	.	.	NOUN
aiua-5738	93	11	2	2	X
aiua-5738	93	12	.	.	NUM
aiua-5738	93	13	abdulmaged	abdulmage	VERB
aiua-5738	93	14	mt	mt	PROPN
aiua-5738	93	15	,	,	PUNCT
aiua-5738	93	16	hassani	hassani	PROPN
aiua-5738	93	17	jma	jma	PROPN
aiua-5738	93	18	,	,	PUNCT
aiua-5738	93	19	guay	guay	X
aiua-5738	93	20	at	at	ADP
aiua-5738	93	21	,	,	PUNCT
aiua-5738	93	22	et	et	PROPN
aiua-5738	93	23	al	al	PROPN
aiua-5738	93	24	.	.	PROPN
aiua-5738	94	1	adverse	adverse	ADJ
aiua-5738	94	2	side	side	NOUN
aiua-5738	94	3	effects	effect	NOUN
aiua-5738	94	4	of	of	ADP
aiua-5738	94	5	5a	5a	NUM
aiua-5738	94	6	-	-	PUNCT
aiua-5738	94	7	reductase	reductase	NOUN
aiua-5738	94	8	inhibitors	inhibitor	NOUN
aiua-5738	94	9	therapy	therapy	NOUN
aiua-5738	94	10	:	:	PUNCT
aiua-5738	94	11	persistent	persistent	ADJ
aiua-5738	94	12	diminished	diminish	VERB
aiua-5738	94	13	libido	libido	NOUN
aiua-5738	94	14	and	and	CCONJ
aiua-5738	94	15	erectile	erectile	ADJ
aiua-5738	94	16	dysfunction	dysfunction	NOUN
aiua-5738	94	17	and	and	CCONJ
aiua-5738	94	18	depression	depression	NOUN
aiua-5738	94	19	in	in	ADP
aiua-5738	94	20	a	a	DET
aiua-5738	94	21	subset	subset	NOUN
aiua-5738	94	22	of	of	ADP
aiua-5738	94	23	patients	patient	NOUN
aiua-5738	94	24	j	j	PROPN
aiua-5738	94	25	sex	sex	NOUN
aiua-5738	94	26	med	med	PROPN
aiua-5738	94	27	.	.	PUNCT
aiua-5738	94	28	2011	2011	NUM
aiua-5738	94	29	;	;	PUNCT
aiua-5738	94	30	8:872	8:872	PROPN
aiua-5738	94	31	-	-	SYM
aiua-5738	94	32	884	884	NUM
aiua-5738	94	33	.	.	PUNCT
aiua-5738	95	1	3	3	X
aiua-5738	95	2	.	.	X
aiua-5738	95	3	russell	russell	PROPN
aiua-5738	95	4	dw	dw	PROPN
aiua-5738	95	5	,	,	PUNCT
aiua-5738	95	6	wilson	wilson	PROPN
aiua-5738	95	7	jd	jd	PROPN
aiua-5738	95	8	.	.	PUNCT
aiua-5738	96	1	steroid	steroid	NOUN
aiua-5738	96	2	5	5	NUM
aiua-5738	96	3	alpha	alpha	NOUN
aiua-5738	96	4	-	-	PUNCT
aiua-5738	96	5	reductase	reductase	NOUN
aiua-5738	96	6	:	:	PUNCT
aiua-5738	96	7	two	two	NUM
aiua-5738	96	8	genes	gene	NOUN
aiua-5738	96	9	/	/	SYM
aiua-5738	96	10	two	two	NUM
aiua-5738	96	11	enzymes	enzyme	NOUN
aiua-5738	96	12	.	.	PUNCT
aiua-5738	97	1	annu	annu	PROPN
aiua-5738	97	2	rev	rev	VERB
aiua-5738	97	3	biochem	biochem	PROPN
aiua-5738	97	4	.	.	PUNCT
aiua-5738	97	5	1994	1994	NUM
aiua-5738	97	6	;	;	PUNCT
aiua-5738	97	7	63:25	63:25	NUM
aiua-5738	97	8	-	-	SYM
aiua-5738	97	9	61	61	NUM
aiua-5738	97	10	.	.	NOUN
aiua-5738	98	1	4	4	NUM
aiua-5738	98	2	.	.	X
aiua-5738	98	3	arteaga	arteaga	NOUN
aiua-5738	98	4	-	-	PUNCT
aiua-5738	98	5	silva	silva	PROPN
aiua-5738	98	6	m	m	PROPN
aiua-5738	98	7	,	,	PUNCT
aiua-5738	98	8	vigueras	vigueras	PROPN
aiua-5738	98	9	-	-	PUNCT
aiua-5738	98	10	villaseñor	villaseñor	PROPN
aiua-5738	98	11	rm	rm	PROPN
aiua-5738	98	12	,	,	PUNCT
aiua-5738	98	13	retana	retana	PROPN
aiua-5738	98	14	-	-	PUNCT
aiua-5738	98	15	márquez	márquez	PROPN
aiua-5738	98	16	s	s	PART
aiua-5738	98	17	,	,	PUNCT
aiua-5738	98	18	et	et	PROPN
aiua-5738	98	19	al	al	PROPN
aiua-5738	98	20	.	.	PUNCT
aiua-5738	98	21	testosterone	testosterone	PROPN
aiua-5738	98	22	,	,	PUNCT
aiua-5738	98	23	androstenedione	androstenedione	NOUN
aiua-5738	98	24	,	,	PUNCT
aiua-5738	98	25	and	and	CCONJ
aiua-5738	98	26	5a	5a	NUM
aiua-5738	98	27	-	-	PUNCT
aiua-5738	98	28	dihydrotestosterone	dihydrotestosterone	NOUN
aiua-5738	98	29	on	on	ADP
aiua-5738	98	30	male	male	ADJ
aiua-5738	98	31	sexual	sexual	ADJ
aiua-5738	98	32	behavior	behavior	NOUN
aiua-5738	98	33	and	and	CCONJ
aiua-5738	98	34	penile	penile	ADJ
aiua-5738	98	35	spines	spine	NOUN
aiua-5738	98	36	in	in	ADP
aiua-5738	98	37	the	the	DET
aiua-5738	98	38	hamster	hamster	NOUN
aiua-5738	98	39	.	.	PUNCT
aiua-5738	99	1	physiology	physiology	NOUN
aiua-5738	99	2	&	&	CCONJ
aiua-5738	99	3	behavior	behavior	PROPN
aiua-5738	99	4	2008	2008	NUM
aiua-5738	99	5	;	;	PUNCT
aiua-5738	99	6	94	94	NUM
aiua-5738	99	7	:	:	PUNCT
aiua-5738	99	8	412	412	NUM
aiua-5738	99	9	-	-	SYM
aiua-5738	99	10	421	421	NUM
aiua-5738	99	11	.	.	NOUN
aiua-5738	99	12	5	5	NUM
aiua-5738	99	13	.	.	X
aiua-5738	99	14	bartsch	bartsch	VERB
aiua-5738	99	15	g	g	NOUN
aiua-5738	99	16	,	,	PUNCT
aiua-5738	99	17	rittmaster	rittmaster	NOUN
aiua-5738	99	18	rs	rs	NOUN
aiua-5738	99	19	,	,	PUNCT
aiua-5738	99	20	klocker	klocker	NOUN
aiua-5738	99	21	h.	h.	PROPN
aiua-5738	99	22	dihydrotestosterone	dihydrotestosterone	PROPN
aiua-5738	99	23	and	and	CCONJ
aiua-5738	99	24	the	the	DET
aiua-5738	99	25	concept	concept	NOUN
aiua-5738	99	26	of	of	ADP
aiua-5738	99	27	5alpha	5alpha	NUM
aiua-5738	99	28	-	-	PUNCT
aiua-5738	99	29	reductase	reductase	NOUN
aiua-5738	99	30	inhibition	inhibition	NOUN
aiua-5738	99	31	in	in	ADP
aiua-5738	99	32	human	human	ADJ
aiua-5738	99	33	benign	benign	ADJ
aiua-5738	99	34	prostatic	prostatic	ADJ
aiua-5738	99	35	hyperplasia	hyperplasia	NOUN
aiua-5738	99	36	.	.	PUNCT
aiua-5738	100	1	world	world	PROPN
aiua-5738	100	2	j	j	PROPN
aiua-5738	100	3	urol	urol	PROPN
aiua-5738	100	4	.	.	PUNCT
aiua-5738	101	1	2002	2002	NUM
aiua-5738	101	2	;	;	PUNCT
aiua-5738	101	3	19:413	19:413	NUM
aiua-5738	101	4	-	-	SYM
aiua-5738	101	5	25	25	NUM
aiua-5738	101	6	.	.	NOUN
aiua-5738	102	1	6	6	NUM
aiua-5738	102	2	.	.	X
aiua-5738	102	3	urysiak	urysiak	VERB
aiua-5738	102	4	-	-	PUNCT
aiua-5738	102	5	czubatka	czubatka	PROPN
aiua-5738	102	6	i	i	PROPN
aiua-5738	102	7	,	,	PUNCT
aiua-5738	102	8	kmiec	kmiec	PROPN
aiua-5738	102	9	ml	ml	AUX
aiua-5738	102	10	,	,	PUNCT
aiua-5738	102	11	broniarczyk	broniarczyk	NOUN
aiua-5738	102	12	-	-	PUNCT
aiua-5738	102	13	dyła	dyła	ADJ
aiua-5738	102	14	g.	g.	PROPN
aiua-5738	102	15	assessment	assessment	NOUN
aiua-5738	102	16	of	of	ADP
aiua-5738	102	17	the	the	DET
aiua-5738	102	18	usefulness	usefulness	NOUN
aiua-5738	102	19	of	of	ADP
aiua-5738	102	20	dihydrotestosterone	dihydrotestosterone	NOUN
aiua-5738	102	21	in	in	ADP
aiua-5738	102	22	the	the	DET
aiua-5738	102	23	diagnostics	diagnostic	NOUN
aiua-5738	102	24	of	of	ADP
aiua-5738	102	25	patients	patient	NOUN
aiua-5738	102	26	with	with	ADP
aiua-5738	102	27	androgenetic	androgenetic	ADJ
aiua-5738	102	28	alopecia	alopecia	NOUN
aiua-5738	102	29	.	.	PUNCT
aiua-5738	103	1	postepy	postepy	ADJ
aiua-5738	103	2	dermatol	dermatol	NOUN
aiua-5738	103	3	alergol	alergol	NOUN
aiua-5738	103	4	.	.	PUNCT
aiua-5738	104	1	2014	2014	NUM
aiua-5738	104	2	;	;	PUNCT
aiua-5738	104	3	31:207	31:207	NUM
aiua-5738	104	4	-	-	SYM
aiua-5738	104	5	15	15	NUM
aiua-5738	104	6	.	.	NOUN
aiua-5738	105	1	7	7	X
aiua-5738	105	2	.	.	X
aiua-5738	105	3	park	park	PROPN
aiua-5738	105	4	t	t	PROPN
aiua-5738	105	5	,	,	PUNCT
aiua-5738	105	6	choi	choi	PROPN
aiua-5738	105	7	jy	jy	PROPN
aiua-5738	105	8	.	.	PROPN
aiua-5738	105	9	efficacy	efficacy	NOUN
aiua-5738	105	10	and	and	CCONJ
aiua-5738	105	11	safety	safety	NOUN
aiua-5738	105	12	of	of	ADP
aiua-5738	105	13	dutasteride	dutasteride	NOUN
aiua-5738	105	14	for	for	ADP
aiua-5738	105	15	the	the	DET
aiua-5738	105	16	treatment	treatment	NOUN
aiua-5738	105	17	of	of	ADP
aiua-5738	105	18	symptomatic	symptomatic	ADJ
aiua-5738	105	19	benign	benign	ADJ
aiua-5738	105	20	prostatic	prostatic	ADJ
aiua-5738	105	21	hyperplasia	hyperplasia	NOUN
aiua-5738	105	22	(	(	PUNCT
aiua-5738	105	23	bph	bph	NOUN
aiua-5738	105	24	):	):	PUNCT
aiua-5738	105	25	a	a	DET
aiua-5738	105	26	systematic	systematic	ADJ
aiua-5738	105	27	review	review	NOUN
aiua-5738	105	28	and	and	CCONJ
aiua-5738	105	29	meta	meta	ADJ
aiua-5738	105	30	-	-	PUNCT
aiua-5738	105	31	analysis	analysis	NOUN
aiua-5738	105	32	.	.	PUNCT
aiua-5738	106	1	world	world	PROPN
aiua-5738	106	2	j	j	PROPN
aiua-5738	106	3	urol	urol	PROPN
aiua-5738	106	4	.	.	PUNCT
aiua-5738	106	5	2014	2014	NUM
aiua-5738	106	6	;	;	PUNCT
aiua-5738	106	7	32:1093	32:1093	NUM
aiua-5738	106	8	-	-	SYM
aiua-5738	106	9	105	105	NUM
aiua-5738	106	10	.	.	NOUN
aiua-5738	106	11	8	8	NUM
aiua-5738	106	12	.	.	PUNCT
aiua-5738	107	1	yim	yim	PROPN
aiua-5738	107	2	e	e	PROPN
aiua-5738	107	3	,	,	PUNCT
aiua-5738	107	4	nole	nole	PROPN
aiua-5738	107	5	kl	kl	PROPN
aiua-5738	107	6	,	,	PUNCT
aiua-5738	107	7	tosti	tosti	PROPN
aiua-5738	107	8	a.	a.	NOUN
aiua-5738	107	9	5a	5a	NUM
aiua-5738	107	10	-	-	PUNCT
aiua-5738	107	11	reductase	reductase	NOUN
aiua-5738	107	12	inhibitors	inhibitor	NOUN
aiua-5738	107	13	in	in	ADP
aiua-5738	107	14	androgenetic	androgenetic	ADJ
aiua-5738	107	15	alopecia	alopecia	NOUN
aiua-5738	107	16	.	.	PUNCT
aiua-5738	108	1	curr	curr	PROPN
aiua-5738	108	2	opin	opin	NOUN
aiua-5738	108	3	endocrinol	endocrinol	NOUN
aiua-5738	108	4	diabetes	diabetes	NOUN
aiua-5738	108	5	obes	obe	NOUN
aiua-5738	108	6	.	.	PUNCT
aiua-5738	108	7	2014	2014	NUM
aiua-5738	108	8	;	;	PUNCT
aiua-5738	108	9	21:493	21:493	NUM
aiua-5738	108	10	-	-	SYM
aiua-5738	108	11	8	8	NUM
aiua-5738	108	12	.	.	NOUN
aiua-5738	108	13	9	9	NUM
aiua-5738	108	14	.	.	X
aiua-5738	108	15	bartsch	bartsch	VERB
aiua-5738	108	16	g	g	NOUN
aiua-5738	108	17	,	,	PUNCT
aiua-5738	108	18	rittmaster	rittmaster	NOUN
aiua-5738	108	19	rs	rs	NOUN
aiua-5738	108	20	,	,	PUNCT
aiua-5738	108	21	klocker	klocker	NOUN
aiua-5738	108	22	h.	h.	PROPN
aiua-5738	108	23	dihydrotestosterone	dihydrotestosterone	PROPN
aiua-5738	108	24	and	and	CCONJ
aiua-5738	108	25	the	the	DET
aiua-5738	108	26	concept	concept	NOUN
aiua-5738	108	27	of	of	ADP
aiua-5738	108	28	5alpha	5alpha	NUM
aiua-5738	108	29	-	-	PUNCT
aiua-5738	108	30	reductase	reductase	NOUN
aiua-5738	108	31	inhibition	inhibition	NOUN
aiua-5738	108	32	in	in	ADP
aiua-5738	108	33	human	human	ADJ
aiua-5738	108	34	benign	benign	ADJ
aiua-5738	108	35	prostatic	prostatic	ADJ
aiua-5738	108	36	hyperplasia	hyperplasia	NOUN
aiua-5738	108	37	.	.	PUNCT
aiua-5738	109	1	world	world	PROPN
aiua-5738	109	2	j	j	PROPN
aiua-5738	109	3	urol	urol	PROPN
aiua-5738	109	4	.	.	PUNCT
aiua-5738	110	1	2002	2002	NUM
aiua-5738	110	2	;	;	PUNCT
aiua-5738	110	3	19:413	19:413	NUM
aiua-5738	110	4	-	-	SYM
aiua-5738	110	5	25	25	NUM
aiua-5738	110	6	.	.	PUNCT
aiua-5738	111	1	10	10	NUM
aiua-5738	111	2	.	.	PUNCT
aiua-5738	112	1	mcconnell	mcconnell	PROPN
aiua-5738	112	2	jd	jd	PROPN
aiua-5738	112	3	,	,	PUNCT
aiua-5738	112	4	bruskewitz	bruskewitz	PROPN
aiua-5738	112	5	r	r	PROPN
aiua-5738	112	6	,	,	PUNCT
aiua-5738	112	7	walsh	walsh	NOUN
aiua-5738	112	8	p	p	PROPN
aiua-5738	112	9	,	,	PUNCT
aiua-5738	112	10	et	et	PROPN
aiua-5738	112	11	al	al	PROPN
aiua-5738	112	12	.	.	PUNCT
aiua-5738	113	1	the	the	DET
aiua-5738	113	2	effect	effect	NOUN
aiua-5738	113	3	of	of	ADP
aiua-5738	113	4	finasteride	finasteride	NOUN
aiua-5738	113	5	on	on	ADP
aiua-5738	113	6	the	the	DET
aiua-5738	113	7	risk	risk	NOUN
aiua-5738	113	8	of	of	ADP
aiua-5738	113	9	acute	acute	ADJ
aiua-5738	113	10	urinary	urinary	ADJ
aiua-5738	113	11	retention	retention	NOUN
aiua-5738	113	12	and	and	CCONJ
aiua-5738	113	13	the	the	DET
aiua-5738	113	14	need	need	NOUN
aiua-5738	113	15	for	for	ADP
aiua-5738	113	16	surgical	surgical	ADJ
aiua-5738	113	17	treatment	treatment	NOUN
aiua-5738	113	18	among	among	ADP
aiua-5738	113	19	men	man	NOUN
aiua-5738	113	20	with	with	ADP
aiua-5738	113	21	benign	benign	ADJ
aiua-5738	113	22	prostatic	prostatic	ADJ
aiua-5738	113	23	hyperplasia	hyperplasia	NOUN
aiua-5738	113	24	.	.	PUNCT
aiua-5738	114	1	finasteride	finasteride	ADJ
aiua-5738	114	2	long	long	ADJ
aiua-5738	114	3	-	-	PUNCT
aiua-5738	114	4	term	term	NOUN
aiua-5738	114	5	efficacy	efficacy	NOUN
aiua-5738	114	6	and	and	CCONJ
aiua-5738	114	7	safety	safety	NOUN
aiua-5738	114	8	study	study	NOUN
aiua-5738	114	9	group	group	NOUN
aiua-5738	114	10	.	.	PUNCT
aiua-5738	115	1	n	n	PROPN
aiua-5738	115	2	engl	engl	PROPN
aiua-5738	115	3	j	j	PROPN
aiua-5738	115	4	med	med	PROPN
aiua-5738	115	5	.	.	PUNCT
aiua-5738	116	1	1998	1998	NUM
aiua-5738	116	2	;	;	PUNCT
aiua-5738	117	1	338:557	338:557	PROPN
aiua-5738	117	2	-	-	SYM
aiua-5738	117	3	63	63	NUM
aiua-5738	117	4	.	.	PUNCT
aiua-5738	117	5	11	11	NUM
aiua-5738	117	6	.	.	PUNCT
aiua-5738	118	1	roehrborn	roehrborn	ADJ
aiua-5738	118	2	cg	cg	PROPN
aiua-5738	118	3	,	,	PUNCT
aiua-5738	118	4	boyle	boyle	PROPN
aiua-5738	118	5	p	p	PROPN
aiua-5738	118	6	,	,	PUNCT
aiua-5738	118	7	nickel	nickel	PROPN
aiua-5738	118	8	jc	jc	PROPN
aiua-5738	118	9	,	,	PUNCT
aiua-5738	118	10	et	et	PROPN
aiua-5738	118	11	al	al	PROPN
aiua-5738	118	12	.	.	PROPN
aiua-5738	118	13	efficacy	efficacy	NOUN
aiua-5738	118	14	and	and	CCONJ
aiua-5738	118	15	safety	safety	NOUN
aiua-5738	118	16	of	of	ADP
aiua-5738	118	17	a	a	DET
aiua-5738	118	18	dual	dual	ADJ
aiua-5738	118	19	inhibitor	inhibitor	NOUN
aiua-5738	118	20	of	of	ADP
aiua-5738	118	21	5	5	NUM
aiua-5738	118	22	-	-	PUNCT
aiua-5738	118	23	alpha	alpha	NOUN
aiua-5738	118	24	-	-	PUNCT
aiua-5738	118	25	reductase	reductase	NOUN
aiua-5738	118	26	types	type	NOUN
aiua-5738	118	27	1	1	NUM
aiua-5738	118	28	and	and	CCONJ
aiua-5738	118	29	2	2	NUM
aiua-5738	118	30	(	(	PUNCT
aiua-5738	118	31	dutasteride	dutasteride	NOUN
aiua-5738	118	32	)	)	PUNCT
aiua-5738	118	33	in	in	ADP
aiua-5738	118	34	men	man	NOUN
aiua-5738	118	35	with	with	ADP
aiua-5738	118	36	benign	benign	ADJ
aiua-5738	118	37	prostatic	prostatic	ADJ
aiua-5738	118	38	hyperplasia	hyperplasia	NOUN
aiua-5738	118	39	.	.	PUNCT
aiua-5738	119	1	urology	urology	NOUN
aiua-5738	119	2	.	.	PUNCT
aiua-5738	120	1	2002	2002	NUM
aiua-5738	120	2	;	;	PUNCT
aiua-5738	120	3	60:434	60:434	NUM
aiua-5738	120	4	-	-	SYM
aiua-5738	120	5	41	41	NUM
aiua-5738	120	6	.	.	PUNCT
aiua-5738	121	1	12	12	NUM
aiua-5738	121	2	.	.	PUNCT
aiua-5738	122	1	mcconnell	mcconnell	PROPN
aiua-5738	122	2	jd	jd	PROPN
aiua-5738	122	3	,	,	PUNCT
aiua-5738	122	4	bruskewitz	bruskewitz	PROPN
aiua-5738	122	5	r	r	PROPN
aiua-5738	122	6	,	,	PUNCT
aiua-5738	122	7	walsh	walsh	NOUN
aiua-5738	122	8	r	r	PROPN
aiua-5738	122	9	,	,	PUNCT
aiua-5738	122	10	et	et	PROPN
aiua-5738	122	11	al	al	PROPN
aiua-5738	122	12	.	.	PUNCT
aiua-5738	123	1	the	the	DET
aiua-5738	123	2	effect	effect	NOUN
aiua-5738	123	3	of	of	ADP
aiua-5738	123	4	finasteride	finasteride	NOUN
aiua-5738	123	5	on	on	ADP
aiua-5738	123	6	the	the	DET
aiua-5738	123	7	risk	risk	NOUN
aiua-5738	123	8	of	of	ADP
aiua-5738	123	9	acute	acute	ADJ
aiua-5738	123	10	urinary	urinary	ADJ
aiua-5738	123	11	retention	retention	NOUN
aiua-5738	123	12	and	and	CCONJ
aiua-5738	123	13	the	the	DET
aiua-5738	123	14	need	need	NOUN
aiua-5738	123	15	for	for	ADP
aiua-5738	123	16	surgical	surgical	ADJ
aiua-5738	123	17	treatment	treatment	NOUN
aiua-5738	123	18	among	among	ADP
aiua-5738	123	19	men	man	NOUN
aiua-5738	123	20	with	with	ADP
aiua-5738	123	21	benign	benign	ADJ
aiua-5738	123	22	prostatic	prostatic	ADJ
aiua-5738	123	23	hyperplasia	hyperplasia	NOUN
aiua-5738	123	24	.	.	PUNCT
aiua-5738	124	1	finasteride	finasteride	ADJ
aiua-5738	124	2	long	long	ADJ
aiua-5738	124	3	-	-	PUNCT
aiua-5738	124	4	term	term	NOUN
aiua-5738	124	5	efficacy	efficacy	NOUN
aiua-5738	124	6	and	and	CCONJ
aiua-5738	124	7	safety	safety	NOUN
aiua-5738	124	8	study	study	NOUN
aiua-5738	124	9	group	group	NOUN
aiua-5738	124	10	.	.	PUNCT
aiua-5738	125	1	n	n	PROPN
aiua-5738	125	2	engl	engl	PROPN
aiua-5738	125	3	j	j	PROPN
aiua-5738	125	4	med	med	PROPN
aiua-5738	125	5	.	.	PUNCT
aiua-5738	126	1	1998	1998	NUM
aiua-5738	126	2	;	;	PUNCT
aiua-5738	127	1	338:557	338:557	PROPN
aiua-5738	127	2	-	-	SYM
aiua-5738	127	3	63	63	NUM
aiua-5738	127	4	.	.	PUNCT
aiua-5738	127	5	13	13	NUM
aiua-5738	127	6	.	.	PUNCT
aiua-5738	128	1	otberg	otberg	PROPN
aiua-5738	128	2	n	n	PROPN
aiua-5738	128	3	,	,	PUNCT
aiua-5738	128	4	finner	finner	PROPN
aiua-5738	128	5	am	am	PROPN
aiua-5738	128	6	,	,	PUNCT
aiua-5738	128	7	shapiro	shapiro	PROPN
aiua-5738	128	8	j.	j.	PROPN
aiua-5738	128	9	androgenetic	androgenetic	PROPN
aiua-5738	128	10	alopecia	alopecia	PROPN
aiua-5738	128	11	.	.	PUNCT
aiua-5738	129	1	endocrinol	endocrinol	NOUN
aiua-5738	129	2	metab	metab	PROPN
aiua-5738	129	3	clin	clin	PROPN
aiua-5738	129	4	north	north	PROPN
aiua-5738	129	5	am	am	PROPN
aiua-5738	129	6	.	.	PUNCT
aiua-5738	130	1	2007	2007	NUM
aiua-5738	130	2	;	;	PUNCT
aiua-5738	130	3	36:379	36:379	NUM
aiua-5738	130	4	-	-	SYM
aiua-5738	130	5	98	98	NUM
aiua-5738	130	6	.	.	PUNCT
aiua-5738	131	1	14	14	NUM
aiua-5738	131	2	.	.	PUNCT
aiua-5738	132	1	traish	traish	PROPN
aiua-5738	132	2	am	am	PROPN
aiua-5738	132	3	,	,	PUNCT
aiua-5738	132	4	hassani	hassani	PROPN
aiua-5738	132	5	j	j	PROPN
aiua-5738	132	6	,	,	PUNCT
aiua-5738	132	7	guay	guay	X
aiua-5738	132	8	at	at	ADP
aiua-5738	132	9	,	,	PUNCT
aiua-5738	132	10	et	et	PROPN
aiua-5738	132	11	al	al	PROPN
aiua-5738	132	12	.	.	PROPN
aiua-5738	133	1	adverse	adverse	ADJ
aiua-5738	133	2	side	side	NOUN
aiua-5738	133	3	effects	effect	NOUN
aiua-5738	133	4	of	of	ADP
aiua-5738	133	5	5a	5a	NUM
aiua-5738	133	6	-	-	PUNCT
aiua-5738	133	7	reductase	reductase	NOUN
aiua-5738	133	8	inhibitors	inhibitor	NOUN
aiua-5738	133	9	therapy	therapy	NOUN
aiua-5738	133	10	:	:	PUNCT
aiua-5738	133	11	persistent	persistent	ADJ
aiua-5738	133	12	diminished	diminish	VERB
aiua-5738	133	13	libido	libido	NOUN
aiua-5738	133	14	and	and	CCONJ
aiua-5738	133	15	erectile	erectile	ADJ
aiua-5738	133	16	dysfunction	dysfunction	NOUN
aiua-5738	133	17	and	and	CCONJ
aiua-5738	133	18	depression	depression	NOUN
aiua-5738	133	19	in	in	ADP
aiua-5738	133	20	a	a	DET
aiua-5738	133	21	subset	subset	NOUN
aiua-5738	133	22	of	of	ADP
aiua-5738	133	23	patients	patient	NOUN
aiua-5738	133	24	.	.	PUNCT
aiua-5738	134	1	j	j	PROPN
aiua-5738	134	2	sex	sex	PROPN
aiua-5738	134	3	med	med	PROPN
aiua-5738	134	4	.	.	PUNCT
aiua-5738	135	1	8:872	8:872	PROPN
aiua-5738	135	2	-	-	SYM
aiua-5738	135	3	84	84	NUM
aiua-5738	135	4	.	.	PUNCT
aiua-5738	136	1	15	15	NUM
aiua-5738	136	2	.	.	PUNCT
aiua-5738	137	1	irwig	irwig	PROPN
aiua-5738	137	2	ms	ms	PROPN
aiua-5738	137	3	,	,	PUNCT
aiua-5738	137	4	kolukula	kolukula	PROPN
aiua-5738	137	5	s.	s.	PROPN
aiua-5738	137	6	persistent	persistent	ADJ
aiua-5738	137	7	sexual	sexual	ADJ
aiua-5738	137	8	side	side	NOUN
aiua-5738	137	9	effects	effect	NOUN
aiua-5738	137	10	of	of	ADP
aiua-5738	137	11	finasteride	finasteride	NOUN
aiua-5738	137	12	for	for	ADP
aiua-5738	137	13	male	male	ADJ
aiua-5738	137	14	pattern	pattern	NOUN
aiua-5738	137	15	hair	hair	NOUN
aiua-5738	137	16	loss	loss	NOUN
aiua-5738	137	17	.	.	PUNCT
aiua-5738	138	1	j	j	PROPN
aiua-5738	138	2	sex	sex	PROPN
aiua-5738	138	3	med	med	PROPN
aiua-5738	138	4	.	.	PUNCT
aiua-5738	138	5	2011	2011	NUM
aiua-5738	138	6	;	;	PUNCT
aiua-5738	138	7	8:1747	8:1747	X
aiua-5738	138	8	-	-	SYM
aiua-5738	138	9	53	53	NUM
aiua-5738	138	10	.	.	PUNCT
aiua-5738	138	11	16	16	NUM
aiua-5738	138	12	.	.	PUNCT
aiua-5738	139	1	trost	trost	PROPN
aiua-5738	139	2	l	l	NOUN
aiua-5738	139	3	,	,	PUNCT
aiua-5738	139	4	saitz	saitz	PROPN
aiua-5738	139	5	tr	tr	VERB
aiua-5738	139	6	,	,	PUNCT
aiua-5738	139	7	hellstrom	hellstrom	NOUN
aiua-5738	139	8	wjg	wjg	VERB
aiua-5738	139	9	.	.	PUNCT
aiua-5738	140	1	side	side	ADJ
aiua-5738	140	2	effects	effect	NOUN
aiua-5738	140	3	of	of	ADP
aiua-5738	140	4	5	5	NUM
aiua-5738	140	5	-	-	PUNCT
aiua-5738	140	6	alpha	alpha	NOUN
aiua-5738	140	7	reductase	reductase	NOUN
aiua-5738	140	8	inhibitors	inhibitor	NOUN
aiua-5738	140	9	:	:	PUNCT
aiua-5738	140	10	a	a	DET
aiua-5738	140	11	comprehensive	comprehensive	ADJ
aiua-5738	140	12	review	review	NOUN
aiua-5738	140	13	.	.	PUNCT
aiua-5738	141	1	sex	sex	PROPN
aiua-5738	141	2	med	med	PROPN
aiua-5738	141	3	rev	rev	PROPN
aiua-5738	141	4	.	.	PROPN
aiua-5738	141	5	2013	2013	NUM
aiua-5738	141	6	;	;	PUNCT
aiua-5738	141	7	1:24	1:24	NUM
aiua-5738	141	8	-	-	SYM
aiua-5738	141	9	41	41	NUM
aiua-5738	141	10	.	.	PUNCT
aiua-5738	142	1	17	17	NUM
aiua-5738	142	2	.	.	PUNCT
aiua-5738	143	1	erdemir	erdemir	PROPN
aiua-5738	143	2	f	f	PROPN
aiua-5738	143	3	,	,	PUNCT
aiua-5738	143	4	harbin	harbin	PROPN
aiua-5738	143	5	a	a	PROPN
aiua-5738	143	6	,	,	PUNCT
aiua-5738	143	7	hellstrom	hellstrom	NOUN
aiua-5738	143	8	wj	wj	PROPN
aiua-5738	143	9	.	.	PUNCT
aiua-5738	144	1	5	5	NUM
aiua-5738	144	2	-	-	PUNCT
aiua-5738	144	3	alpha	alpha	ADJ
aiua-5738	144	4	reductase	reductase	NOUN
aiua-5738	144	5	inhibitors	inhibitor	NOUN
aiua-5738	144	6	and	and	CCONJ
aiua-5738	144	7	erectile	erectile	ADJ
aiua-5738	144	8	dysfunction	dysfunction	NOUN
aiua-5738	144	9	:	:	PUNCT
aiua-5738	144	10	the	the	DET
aiua-5738	144	11	connection	connection	NOUN
aiua-5738	144	12	.	.	PUNCT
aiua-5738	145	1	j	j	PROPN
aiua-5738	145	2	sex	sex	PROPN
aiua-5738	145	3	med	med	PROPN
aiua-5738	145	4	.	.	PUNCT
aiua-5738	145	5	2008	2008	NUM
aiua-5738	145	6	;	;	PUNCT
aiua-5738	146	1	5:2917	5:2917	X
aiua-5738	146	2	-	-	SYM
aiua-5738	146	3	24	24	NUM
aiua-5738	146	4	.	.	PUNCT
aiua-5738	146	5	18	18	NUM
aiua-5738	146	6	.	.	PUNCT
aiua-5738	147	1	sato	sato	PROPN
aiua-5738	147	2	a	a	DET
aiua-5738	147	3	,	,	PUNCT
aiua-5738	147	4	takeda	takeda	NOUN
aiua-5738	147	5	a.	a.	NOUN
aiua-5738	147	6	evaluation	evaluation	NOUN
aiua-5738	147	7	of	of	ADP
aiua-5738	147	8	efficacy	efficacy	NOUN
aiua-5738	147	9	and	and	CCONJ
aiua-5738	147	10	safety	safety	NOUN
aiua-5738	147	11	of	of	ADP
aiua-5738	147	12	finasteride	finasteride	ADJ
aiua-5738	147	13	1	1	NUM
aiua-5738	147	14	mg	mg	NOUN
aiua-5738	147	15	in	in	ADP
aiua-5738	147	16	3177	3177	NUM
aiua-5738	147	17	japanese	japanese	ADJ
aiua-5738	147	18	men	man	NOUN
aiua-5738	147	19	with	with	ADP
aiua-5738	147	20	androgenic	androgenic	ADJ
aiua-5738	147	21	alopecia	alopecia	NOUN
aiua-5738	147	22	.	.	PUNCT
aiua-5738	148	1	dermatol	dermatol	NOUN
aiua-5738	148	2	.	.	PUNCT
aiua-5738	149	1	2012	2012	NUM
aiua-5738	149	2	;	;	PUNCT
aiua-5738	149	3	39:27	39:27	NUM
aiua-5738	149	4	-	-	SYM
aiua-5738	149	5	32	32	NUM
aiua-5738	149	6	.	.	PUNCT
aiua-5738	150	1	19	19	NUM
aiua-5738	150	2	.	.	X
aiua-5738	151	1	irwing	irwe	VERB
aiua-5738	151	2	ms	ms	PROPN
aiua-5738	151	3	.	.	PROPN
aiua-5738	151	4	persistent	persistent	ADJ
aiua-5738	151	5	sexual	sexual	ADJ
aiua-5738	151	6	side	side	NOUN
aiua-5738	151	7	effects	effect	NOUN
aiua-5738	151	8	of	of	ADP
aiua-5738	151	9	finasteride	finasteride	ADJ
aiua-5738	151	10	:	:	PUNCT
aiua-5738	151	11	could	could	AUX
aiua-5738	151	12	they	they	PRON
aiua-5738	151	13	be	be	AUX
aiua-5738	151	14	permanent	permanent	ADJ
aiua-5738	151	15	?	?	PUNCT
aiua-5738	152	1	j	j	PROPN
aiua-5738	152	2	sex	sex	PROPN
aiua-5738	152	3	med	med	PROPN
aiua-5738	152	4	.	.	PUNCT
aiua-5738	152	5	2012	2012	NUM
aiua-5738	152	6	;	;	PUNCT
aiua-5738	152	7	9:2927	9:2927	NUM
aiua-5738	152	8	-	-	SYM
aiua-5738	152	9	293	293	NUM
aiua-5738	152	10	.	.	PUNCT
aiua-5738	153	1	20	20	NUM
aiua-5738	153	2	.	.	PUNCT
aiua-5738	154	1	elzanaty	elzanaty	PROPN
aiua-5738	154	2	s	s	PART
aiua-5738	154	3	,	,	PUNCT
aiua-5738	154	4	giwercman	giwercman	ADJ
aiua-5738	154	5	yl	yl	NOUN
aiua-5738	154	6	,	,	PUNCT
aiua-5738	154	7	giwercman	giwercman	ADJ
aiua-5738	154	8	a.	a.	NOUN
aiua-5738	154	9	significant	significant	ADJ
aiua-5738	154	10	impact	impact	NOUN
aiua-5738	154	11	of	of	ADP
aiua-5738	154	12	archivio	archivio	NOUN
aiua-5738	154	13	italiano	italiano	X
aiua-5738	154	14	di	di	X
aiua-5738	154	15	urologia	urologia	PROPN
aiua-5738	154	16	e	e	PROPN
aiua-5738	154	17	andrologia	andrologia	NOUN
aiua-5738	154	18	2015	2015	NUM
aiua-5738	154	19	;	;	PUNCT
aiua-5738	154	20	87	87	NUM
aiua-5738	154	21	,	,	PUNCT
aiua-5738	154	22	4	4	NUM
aiua-5738	154	23	f.	f.	PROPN
aiua-5738	154	24	pirozzi	pirozzi	PROPN
aiua-5738	154	25	farina	farina	PROPN
aiua-5738	154	26	,	,	PUNCT
aiua-5738	154	27	a.	a.	NOUN
aiua-5738	154	28	pischedda	pischedda	NOUN
aiua-5738	154	29	316	316	NUM
aiua-5738	154	30	5alpha	5alpha	NUM
aiua-5738	154	31	-	-	PUNCT
aiua-5738	154	32	reductase	reductase	NOUN
aiua-5738	154	33	type	type	NOUN
aiua-5738	154	34	2	2	NUM
aiua-5738	154	35	polymorphisms	polymorphism	NOUN
aiua-5738	154	36	on	on	ADP
aiua-5738	154	37	sperm	sperm	NOUN
aiua-5738	154	38	concentration	concentration	NOUN
aiua-5738	154	39	and	and	CCONJ
aiua-5738	154	40	motility	motility	NOUN
aiua-5738	154	41	int	int	NOUN
aiua-5738	154	42	.	.	PUNCT
aiua-5738	155	1	j	j	PROPN
aiua-5738	155	2	androl	androl	PROPN
aiua-5738	155	3	.	.	PUNCT
aiua-5738	155	4	2006	2006	NUM
aiua-5738	155	5	;	;	PUNCT
aiua-5738	155	6	29:414	29:414	NUM
aiua-5738	155	7	-	-	SYM
aiua-5738	155	8	420	420	NUM
aiua-5738	155	9	.	.	PUNCT
aiua-5738	156	1	21	21	NUM
aiua-5738	156	2	.	.	PUNCT
aiua-5738	157	1	aua	aua	PROPN
aiua-5738	157	2	guideline	guideline	NOUN
aiua-5738	157	3	:	:	PUNCT
aiua-5738	157	4	managemant	managemant	NOUN
aiua-5738	157	5	of	of	ADP
aiua-5738	157	6	benign	benign	ADJ
aiua-5738	157	7	prostatic	prostatic	ADJ
aiua-5738	157	8	hyperplasia	hyperplasia	NOUN
aiua-5738	157	9	(	(	PUNCT
aiua-5738	157	10	bph	bph	NOUN
aiua-5738	157	11	)	)	PUNCT
aiua-5738	157	12	;	;	PUNCT
aiua-5738	157	13	panel	panel	NOUN
aiua-5738	157	14	members	member	NOUN
aiua-5738	157	15	:	:	PUNCT
aiua-5738	157	16	kt	kt	PROPN
aiua-5738	157	17	mcvary	mcvary	NOUN
aiua-5738	157	18	(	(	PUNCT
aiua-5738	157	19	chair	chair	NOUN
aiua-5738	157	20	)	)	PUNCT
aiua-5738	157	21	,	,	PUNCT
aiua-5738	157	22	cg	cg	NOUN
aiua-5738	157	23	roehrborn	roehrborn	ADJ
aiua-5738	157	24	(	(	PUNCT
aiua-5738	157	25	cochair	cochair	NOUN
aiua-5738	157	26	)	)	PUNCT
aiua-5738	157	27	,	,	PUNCT
aiua-5738	157	28	et	et	PROPN
aiua-5738	157	29	al	al	PROPN
aiua-5738	157	30	.	.	PROPN
aiua-5738	157	31	;	;	PUNCT
aiua-5738	157	32	copyright	copyright	NOUN
aiua-5738	157	33	2010	2010	NUM
aiua-5738	157	34	american	american	PROPN
aiua-5738	157	35	urological	urological	PROPN
aiua-5738	157	36	association	association	PROPN
aiua-5738	157	37	education	education	NOUN
aiua-5738	157	38	and	and	CCONJ
aiua-5738	157	39	research	research	PROPN
aiua-5738	157	40	,	,	PUNCT
aiua-5738	157	41	inc	inc	PROPN
aiua-5738	157	42	®	®	PROPN
aiua-5738	157	43	;1	;1	X
aiua-5738	157	44	-	-	PUNCT
aiua-5738	157	45	496	496	NUM
aiua-5738	157	46	.	.	PUNCT
aiua-5738	157	47	22	22	NUM
aiua-5738	157	48	.	.	PUNCT
aiua-5738	158	1	roehrborn	roehrborn	ADJ
aiua-5738	158	2	cg	cg	NOUN
aiua-5738	158	3	,	,	PUNCT
aiua-5738	158	4	siami	siami	VERB
aiua-5738	158	5	p	p	NOUN
aiua-5738	158	6	,	,	PUNCT
aiua-5738	158	7	barkin	barkin	PROPN
aiua-5738	158	8	j	j	PROPN
aiua-5738	158	9	,	,	PUNCT
aiua-5738	158	10	et	et	PROPN
aiua-5738	158	11	al	al	PROPN
aiua-5738	158	12	.	.	PUNCT
aiua-5738	159	1	combat	combat	PROPN
aiua-5738	159	2	study	study	NOUN
aiua-5738	159	3	group	group	NOUN
aiua-5738	159	4	.	.	PUNCT
aiua-5738	160	1	the	the	DET
aiua-5738	160	2	effects	effect	NOUN
aiua-5738	160	3	of	of	ADP
aiua-5738	160	4	combination	combination	NOUN
aiua-5738	160	5	therapy	therapy	NOUN
aiua-5738	160	6	with	with	ADP
aiua-5738	160	7	dutasteride	dutasteride	NOUN
aiua-5738	160	8	and	and	CCONJ
aiua-5738	160	9	tamsulosin	tamsulosin	VERB
aiua-5738	160	10	on	on	ADP
aiua-5738	160	11	clinical	clinical	ADJ
aiua-5738	160	12	outcomes	outcome	NOUN
aiua-5738	160	13	in	in	ADP
aiua-5738	160	14	men	man	NOUN
aiua-5738	160	15	with	with	ADP
aiua-5738	160	16	symptomatic	symptomatic	ADJ
aiua-5738	160	17	benign	benign	ADJ
aiua-5738	160	18	prostatic	prostatic	ADJ
aiua-5738	160	19	hyperplasia	hyperplasia	NOUN
aiua-5738	160	20	:	:	PUNCT
aiua-5738	160	21	4	4	NUM
aiua-5738	160	22	-	-	PUNCT
aiua-5738	160	23	year	year	NOUN
aiua-5738	160	24	results	result	NOUN
aiua-5738	160	25	from	from	ADP
aiua-5738	160	26	the	the	DET
aiua-5738	160	27	combat	combat	NOUN
aiua-5738	160	28	study	study	NOUN
aiua-5738	160	29	.	.	PUNCT
aiua-5738	161	1	eur	eur	PROPN
aiua-5738	161	2	urol	urol	PROPN
aiua-5738	161	3	.	.	PUNCT
aiua-5738	162	1	2010	2010	NUM
aiua-5738	162	2	;	;	PUNCT
aiua-5738	162	3	57:123	57:123	NUM
aiua-5738	162	4	-	-	SYM
aiua-5738	162	5	31	31	NUM
aiua-5738	162	6	.	.	PUNCT
aiua-5738	163	1	23	23	NUM
aiua-5738	163	2	.	.	PUNCT
aiua-5738	164	1	wessels	wessels	PROPN
aiua-5738	164	2	h	h	PROPN
aiua-5738	164	3	,	,	PUNCT
aiua-5738	164	4	roy	roy	PROPN
aiua-5738	164	5	j	j	PROPN
aiua-5738	164	6	,	,	PUNCT
aiua-5738	164	7	bannow	bannow	PROPN
aiua-5738	164	8	j	j	PROPN
aiua-5738	164	9	,	,	PUNCT
aiua-5738	164	10	et	et	PROPN
aiua-5738	164	11	al	al	PROPN
aiua-5738	164	12	.	.	PROPN
aiua-5738	164	13	incidence	incidence	NOUN
aiua-5738	164	14	and	and	CCONJ
aiua-5738	164	15	severity	severity	NOUN
aiua-5738	164	16	of	of	ADP
aiua-5738	164	17	sexual	sexual	ADJ
aiua-5738	164	18	adverse	adverse	ADJ
aiua-5738	164	19	experiences	experience	NOUN
aiua-5738	164	20	in	in	ADP
aiua-5738	164	21	finasteride	finasteride	NOUN
aiua-5738	164	22	and	and	CCONJ
aiua-5738	164	23	placebo	placebo	NOUN
aiua-5738	164	24	treated	treat	VERB
aiua-5738	164	25	men	man	NOUN
aiua-5738	164	26	with	with	ADP
aiua-5738	164	27	benign	benign	ADJ
aiua-5738	164	28	prostatic	prostatic	ADJ
aiua-5738	164	29	hyperplasia	hyperplasia	NOUN
aiua-5738	164	30	.	.	PUNCT
aiua-5738	165	1	urology	urology	NOUN
aiua-5738	165	2	.	.	PUNCT
aiua-5738	166	1	2003	2003	NUM
aiua-5738	166	2	;	;	PUNCT
aiua-5738	166	3	61:579	61:579	NUM
aiua-5738	166	4	-	-	SYM
aiua-5738	166	5	84	84	NUM
aiua-5738	166	6	.	.	PUNCT
aiua-5738	167	1	24	24	NUM
aiua-5738	167	2	.	.	PUNCT
aiua-5738	168	1	fda	fda	PROPN
aiua-5738	168	2	warns	warn	VERB
aiua-5738	168	3	men	man	NOUN
aiua-5738	168	4	of	of	ADP
aiua-5738	168	5	serious	serious	ADJ
aiua-5738	168	6	side	side	NOUN
aiua-5738	168	7	effects	effect	NOUN
aiua-5738	168	8	from	from	ADP
aiua-5738	168	9	these	these	DET
aiua-5738	168	10	drugs	drug	NOUN
aiua-5738	168	11	—	—	PUNCT
aiua-5738	168	12	but	but	CCONJ
aiua-5738	168	13	keeps	keep	VERB
aiua-5738	168	14	them	they	PRON
aiua-5738	168	15	on	on	ADP
aiua-5738	168	16	the	the	DET
aiua-5738	168	17	market	market	NOUN
aiua-5738	168	18	(	(	PUNCT
aiua-5738	168	19	http://www.fda.gov/drugs/drugsafety/	http://www.fda.gov/drugs/drugsafety/	PROPN
aiua-5738	168	20	informationbydrugclass	informationbydrugclass	NOUN
aiua-5738	168	21	/	/	SYM
aiua-5738	168	22	ucm299754.htm	ucm299754.htm	NOUN
aiua-5738	168	23	)	)	PUNCT
aiua-5738	168	24	25	25	NUM
aiua-5738	168	25	.	.	PUNCT
aiua-5738	169	1	seftel	seftel	PROPN
aiua-5738	169	2	a	a	PRON
aiua-5738	169	3	,	,	PUNCT
aiua-5738	169	4	rosen	rosen	PROPN
aiua-5738	169	5	r	r	PROPN
aiua-5738	169	6	,	,	PUNCT
aiua-5738	169	7	kuritzky	kuritzky	ADJ
aiua-5738	169	8	l.	l.	PROPN
aiua-5738	169	9	physician	physician	PROPN
aiua-5738	169	10	perceptions	perception	NOUN
aiua-5738	169	11	of	of	ADP
aiua-5738	169	12	sexual	sexual	ADJ
aiua-5738	169	13	dysfunction	dysfunction	NOUN
aiua-5738	169	14	related	relate	VERB
aiua-5738	169	15	to	to	ADP
aiua-5738	169	16	benign	benign	ADJ
aiua-5738	169	17	prostatic	prostatic	ADJ
aiua-5738	169	18	hyperplasia	hyperplasia	NOUN
aiua-5738	169	19	(	(	PUNCT
aiua-5738	169	20	bph	bph	NOUN
aiua-5738	169	21	)	)	PUNCT
aiua-5738	169	22	symptoms	symptom	NOUN
aiua-5738	169	23	and	and	CCONJ
aiua-5738	169	24	sexual	sexual	ADJ
aiua-5738	169	25	side	side	NOUN
aiua-5738	169	26	effects	effect	NOUN
aiua-5738	169	27	related	relate	VERB
aiua-5738	169	28	to	to	ADP
aiua-5738	169	29	bph	bph	NOUN
aiua-5738	169	30	medications	medication	NOUN
aiua-5738	169	31	international	international	ADJ
aiua-5738	169	32	journal	journal	NOUN
aiua-5738	169	33	of	of	ADP
aiua-5738	169	34	impotence	impotence	NOUN
aiua-5738	169	35	research	research	NOUN
aiua-5738	169	36	.	.	PUNCT
aiua-5738	170	1	2007	2007	NUM
aiua-5738	170	2	;	;	PUNCT
aiua-5738	170	3	19:386	19:386	NUM
aiua-5738	170	4	-	-	SYM
aiua-5738	170	5	392	392	NUM
aiua-5738	170	6	.	.	NOUN
aiua-5738	170	7	26	26	NUM
aiua-5738	170	8	.	.	PUNCT
aiua-5738	171	1	mondaini	mondaini	PROPN
aiua-5738	171	2	n	n	PROPN
aiua-5738	171	3	,	,	PUNCT
aiua-5738	171	4	gontero	gontero	NOUN
aiua-5738	171	5	p	p	NOUN
aiua-5738	171	6	,	,	PUNCT
aiua-5738	171	7	giubilei	giubilei	VERB
aiua-5738	171	8	g	g	NOUN
aiua-5738	171	9	,	,	PUNCT
aiua-5738	171	10	et	et	PROPN
aiua-5738	171	11	al	al	PROPN
aiua-5738	171	12	.	.	PROPN
aiua-5738	171	13	bartoletti	bartoletti	PROPN
aiua-5738	171	14	.	.	PUNCT
aiua-5738	172	1	finasteride	finasteride	ADJ
aiua-5738	172	2	5	5	NUM
aiua-5738	172	3	mg	mg	NOUN
aiua-5738	172	4	and	and	CCONJ
aiua-5738	172	5	sexual	sexual	ADJ
aiua-5738	172	6	side	side	NOUN
aiua-5738	172	7	effects	effect	NOUN
aiua-5738	172	8	:	:	PUNCT
aiua-5738	172	9	how	how	SCONJ
aiua-5738	172	10	many	many	ADJ
aiua-5738	172	11	of	of	ADP
aiua-5738	172	12	these	these	PRON
aiua-5738	172	13	are	be	AUX
aiua-5738	172	14	related	relate	VERB
aiua-5738	172	15	to	to	ADP
aiua-5738	172	16	a	a	DET
aiua-5738	172	17	nocebo	nocebo	NOUN
aiua-5738	172	18	phenomenon	phenomenon	NOUN
aiua-5738	172	19	?	?	PUNCT
aiua-5738	173	1	j	j	PROPN
aiua-5738	173	2	sex	sex	PROPN
aiua-5738	173	3	med	med	PROPN
aiua-5738	173	4	.	.	PUNCT
aiua-5738	173	5	2007	2007	NUM
aiua-5738	173	6	;	;	PUNCT
aiua-5738	173	7	4:1708	4:1708	NUM
aiua-5738	173	8	-	-	SYM
aiua-5738	173	9	12	12	NUM
aiua-5738	173	10	.	.	PUNCT
aiua-5738	174	1	27	27	NUM
aiua-5738	174	2	.	.	PUNCT
aiua-5738	175	1	european	european	PROPN
aiua-5738	175	2	medicines	medicine	NOUN
aiua-5738	175	3	agency	agency	NOUN
aiua-5738	175	4	.	.	PUNCT
aiua-5738	176	1	18	18	NUM
aiua-5738	176	2	october	october	PROPN
aiua-5738	176	3	2012	2012	NUM
aiua-5738	176	4	ema/647346/	ema/647346/	VERB
aiua-5738	176	5	2012	2012	NUM
aiua-5738	176	6	committee	committee	NOUN
aiua-5738	176	7	for	for	ADP
aiua-5738	176	8	medicinal	medicinal	ADJ
aiua-5738	176	9	products	product	NOUN
aiua-5738	176	10	for	for	ADP
aiua-5738	176	11	human	human	ADJ
aiua-5738	176	12	use	use	NOUN
aiua-5738	176	13	(	(	PUNCT
aiua-5738	176	14	chmp	chmp	ADJ
aiua-5738	176	15	)	)	PUNCT
aiua-5738	176	16	.	.	PUNCT
aiua-5738	177	1	assessment	assessment	NOUN
aiua-5738	177	2	report	report	NOUN
aiua-5738	177	3	cialis	ciali	VERB
aiua-5738	177	4	tadalafil	tadalafil	ADJ
aiua-5738	177	5	procedure	procedure	NOUN
aiua-5738	177	6	no	no	PROPN
aiua-5738	177	7	.	.	PUNCT
aiua-5738	178	1	emea	emea	PROPN
aiua-5738	178	2	/	/	SYM
aiua-5738	178	3	h	h	PROPN
aiua-5738	178	4	/	/	SYM
aiua-5738	178	5	c/	c/	NOUN
aiua-5738	178	6	000436	000436	NUM
aiua-5738	178	7	/	/	SYM
aiua-5738	178	8	ii/0060	ii/0060	PROPN
aiua-5738	178	9	28	28	NUM
aiua-5738	178	10	.	.	PUNCT
aiua-5738	179	1	volkov	volkov	PROPN
aiua-5738	179	2	aa	aa	PROPN
aiua-5738	179	3	,	,	PUNCT
aiua-5738	179	4	petrichko	petrichko	PROPN
aiua-5738	179	5	mi	mi	PROPN
aiua-5738	179	6	,	,	PUNCT
aiua-5738	179	7	budnik	budnik	PROPN
aiua-5738	179	8	nv	nv	PROPN
aiua-5738	179	9	.	.	PROPN
aiua-5738	179	10	correction	correction	NOUN
aiua-5738	179	11	of	of	ADP
aiua-5738	179	12	erectile	erectile	ADJ
aiua-5738	179	13	dysfunction	dysfunction	NOUN
aiua-5738	179	14	in	in	ADP
aiua-5738	179	15	patients	patient	NOUN
aiua-5738	179	16	with	with	ADP
aiua-5738	179	17	benign	benign	ADJ
aiua-5738	179	18	prostate	prostate	NOUN
aiua-5738	179	19	hyperplasia	hyperplasia	NOUN
aiua-5738	179	20	using	use	VERB
aiua-5738	179	21	daily	daily	ADJ
aiua-5738	179	22	administration	administration	NOUN
aiua-5738	179	23	of	of	ADP
aiua-5738	179	24	tadalafil	tadalafil	PROPN
aiua-5738	179	25	5	5	NUM
aiua-5738	179	26	mg	mg	NOUN
aiua-5738	179	27	against	against	ADP
aiua-5738	179	28	the	the	DET
aiua-5738	179	29	background	background	NOUN
aiua-5738	179	30	of	of	ADP
aiua-5738	179	31	combined	combined	ADJ
aiua-5738	179	32	drug	drug	NOUN
aiua-5738	179	33	therapy	therapy	NOUN
aiua-5738	179	34	.	.	PUNCT
aiua-5738	180	1	urologiia	urologiia	PROPN
aiua-5738	180	2	.	.	PUNCT
aiua-5738	181	1	2013	2013	NUM
aiua-5738	181	2	;	;	PUNCT
aiua-5738	181	3	54:50	54:50	NUM
aiua-5738	181	4	-	-	SYM
aiua-5738	181	5	2	2	NUM
aiua-5738	181	6	.	.	NOUN
aiua-5738	181	7	29	29	NUM
aiua-5738	181	8	.	.	PUNCT
aiua-5738	182	1	casabé	casabé	PROPN
aiua-5738	182	2	a	a	PRON
aiua-5738	182	3	,	,	PUNCT
aiua-5738	182	4	roehrborn	roehrborn	ADJ
aiua-5738	182	5	cg	cg	NOUN
aiua-5738	182	6	,	,	PUNCT
aiua-5738	182	7	da	da	PROPN
aiua-5738	182	8	pozzo	pozzo	X
aiua-5738	182	9	lf	lf	PROPN
aiua-5738	182	10	,	,	PUNCT
aiua-5738	182	11	et	et	PROPN
aiua-5738	182	12	al	al	PROPN
aiua-5738	182	13	.	.	PROPN
aiua-5738	182	14	efficacy	efficacy	NOUN
aiua-5738	182	15	and	and	CCONJ
aiua-5738	182	16	safety	safety	NOUN
aiua-5738	182	17	of	of	ADP
aiua-5738	182	18	the	the	DET
aiua-5738	182	19	coadministration	coadministration	NOUN
aiua-5738	182	20	of	of	ADP
aiua-5738	182	21	tadalafil	tadalafil	PROPN
aiua-5738	182	22	once	once	ADV
aiua-5738	182	23	daily	daily	ADV
aiua-5738	182	24	with	with	ADP
aiua-5738	182	25	finasteride	finasteride	NOUN
aiua-5738	182	26	for	for	ADP
aiua-5738	182	27	6	6	NUM
aiua-5738	182	28	months	month	NOUN
aiua-5738	182	29	in	in	ADP
aiua-5738	182	30	men	man	NOUN
aiua-5738	182	31	with	with	ADP
aiua-5738	182	32	lower	low	ADJ
aiua-5738	182	33	urinary	urinary	ADJ
aiua-5738	182	34	tract	tract	NOUN
aiua-5738	182	35	symptoms	symptom	NOUN
aiua-5738	182	36	and	and	CCONJ
aiua-5738	182	37	prostatic	prostatic	ADJ
aiua-5738	182	38	enlargement	enlargement	NOUN
aiua-5738	182	39	secondary	secondary	ADJ
aiua-5738	182	40	to	to	ADP
aiua-5738	182	41	benign	benign	ADJ
aiua-5738	182	42	prostatic	prostatic	ADJ
aiua-5738	182	43	hyperplasia	hyperplasia	NOUN
aiua-5738	182	44	.	.	PUNCT
aiua-5738	183	1	j	j	PROPN
aiua-5738	183	2	urol	urol	PROPN
aiua-5738	183	3	.	.	PUNCT
aiua-5738	183	4	2014	2014	NUM
aiua-5738	183	5	;	;	PUNCT
aiua-5738	183	6	191:727	191:727	NUM
aiua-5738	183	7	-	-	SYM
aiua-5738	183	8	33	33	NUM
aiua-5738	183	9	.	.	PUNCT
aiua-5738	184	1	correspondence	correspondence	NOUN
aiua-5738	184	2	antonella	antonella	PROPN
aiua-5738	184	3	pischedda	pischedda	PROPN
aiua-5738	184	4	,	,	PUNCT
aiua-5738	184	5	md	md	PROPN
aiua-5738	184	6	furio	furio	PROPN
aiua-5738	184	7	pirozzi	pirozzi	PROPN
aiua-5738	184	8	farina	farina	PROPN
aiua-5738	184	9	,	,	PUNCT
aiua-5738	184	10	(	(	PUNCT
aiua-5738	184	11	corresponding	correspond	VERB
aiua-5738	184	12	autor	autor	NOUN
aiua-5738	184	13	)	)	PUNCT
aiua-5738	184	14	andro@tin.it	andro@tin.it	NOUN
aiua-5738	184	15	associate	associate	NOUN
aiua-5738	184	16	professor	professor	NOUN
aiua-5738	184	17	of	of	ADP
aiua-5738	184	18	urology	urology	NOUN
aiua-5738	184	19	università	università	PROPN
aiua-5738	184	20	di	di	PROPN
aiua-5738	184	21	sassari	sassari	PROPN
aiua-5738	184	22	specialist	specialist	PROPN
aiua-5738	184	23	in	in	ADP
aiua-5738	184	24	urology	urology	NOUN
aiua-5738	184	25	and	and	CCONJ
aiua-5738	184	26	andrology	andrology	NOUN
aiua-5738	184	27	director	director	NOUN
aiua-5738	184	28	,	,	PUNCT
aiua-5738	184	29	department	department	NOUN
aiua-5738	184	30	of	of	ADP
aiua-5738	184	31	andrological	andrological	PROPN
aiua-5738	184	32	urology	urology	NOUN
aiua-5738	184	33	aou	aou	X
aiua-5738	184	34	di	di	X
aiua-5738	184	35	sassari	sassari	PROPN
aiua-5738	184	36	via	via	ADP
aiua-5738	184	37	matteotti	matteotti	PROPN
aiua-5738	184	38	,	,	PUNCT
aiua-5738	184	39	14	14	NUM
aiua-5738	184	40	sassari	sassari	PROPN
aiua-5738	184	41	,	,	PUNCT
aiua-5738	184	42	italy	italy	PROPN